0001171843-23-000739.txt : 20230207 0001171843-23-000739.hdr.sgml : 20230207 20230207080151 ACCESSION NUMBER: 0001171843-23-000739 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medicenna Therapeutics Corp. CENTRAL INDEX KEY: 0001807983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39458 FILM NUMBER: 23592815 BUSINESS ADDRESS: STREET 1: 2 BLOOR ST W., 7TH FLOOR CITY: TORONTO STATE: A6 ZIP: M4W 3E2 BUSINESS PHONE: 416 648-5555 MAIL ADDRESS: STREET 1: 2 BLOOR ST W., 7TH FLOOR CITY: TORONTO STATE: A6 ZIP: M4W 3E2 6-K 1 f6k_020723.htm FORM 6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2023

 

Commission File Number: 001-39458

 

Medicenna Therapeutics Corp.
(Translation of registrant's name into English)

 

2 Bloor St. W., 7th Floor
Toronto, Ontario M4W 3E2, Canada

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.


Form 20-F [ X ]      Form 40-F [     ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [  ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [  ]

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MEDICENNA THERAPEUTICS CORP.
       
       
       
Date: February 7, 2023 By:  /s/ Elizabeth Williams  
  Name: Elizabeth Williams
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EXHIBIT INDEX

 

 

Exhibit Description
   
99.1 Interim Financial Statements for the period ended December 31, 2022
   
99.2 Management’s Discussion and Analysis for the period ended December 31, 2022
   
99.3 Form 52- 109F2 Certification of Interim Filings Full Certificate – CEO
   
99.4 Form 52- 109F2 Certification of Interim Filings Full Certificate – CFO
   
99.5 News release dated February 7, 2022

 

 

 

 

 

 

 

EX-99.1 2 exh_991.htm EXHIBIT 99.1

Exhibit 99.1

 

 

 

 

 

 

 

 

Interim condensed consolidated financial statements of

 

Medicenna Therapeutics Corp.

(Expressed in Canadian Dollars)

 

For the three and nine months ended December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

Medicenna Therapeutics Corp.

Interim Condensed Consolidated Statements of Financial Position

(Expressed in thousands of Canadian Dollars, except for share and per share amounts)

(Unaudited)

 

 

as at

     December 31, 2022      March 31, 2022  
    $    $ 

Assets

        
Current assets          
Cash and cash equivalents   36,153    20,535 
Prepaids and deposits   1,780    1,548 
Other receivables   179    1,308 
    38,112    23,391 
Intangible assets (Note 8)   62    65 
    38,174    23,456 

Liabilities

          
Current liabilities          
Accounts payable and accrued liabilities   2,989    2,621 
    2,989    2,621 

Warrant derivative (Note 6)

   1,960    - 
    4,949    2,621 

Shareholders' Equity

          
Common shares (Note 3)   100,924    83,671 
Contributed surplus (Notes 4 and 5)   9,292    7,926 
Accumulated other comprehensive income   134    171 
Deficit   (77,125)   (70,933)
    33,225    20,835 
    38,174    23,456 

 

 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 

 

1

 

 

Medicenna Therapeutics Corp.

Interim Condensed Consolidated Statements of Loss and Comprehensive Loss

(Expressed in thousands of Canadian Dollars, except for share and per share amounts)

(Unaudited)

 

     3 months ended December 31,
2022
    3 months ended December 31,
2021
    9 months ended
December 31, 2022
     9 months ended
December 31, 2021
 
     $      $      $      $  
Operating expenses                    
General and administration (Note 10)   1,976    1,990    6,266    5,821 
Research and development (Note 10)   2,945    2,907    7,718    13,525 
                     
Total operating expenses   4,921    4,897    13,984    19,346 
                     
Finance income   (340)   (16)   (532)   (60)
Change in fair value of warrant derivative (Note 6)   (3,747)   -    (5,547)   - 
Foreign exchange (gain) loss   307    (74)   (1,713)   85 
    (3,780)   (90)   (7,792)   25 
                     
Net loss for the period   (1,141)   (4,807)   (6,192)   (19,371)
Cumulative translation adjustment   (23)   (4)   (37)   (18)
Comprehensive loss for the period   (1,164)   (4,811)   (6,229)   (19,389)
                     
Basic and diluted loss per share for the period   (0.02)   (0.09)   (0.10)   (0.36)
                     
Weighted average number of common shares outstanding (Note 3)   69,637,469    53,995,700    63,132,537    53,864,572 

 

 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 

 

2

 

 

 

Medicenna Therapeutics Corp.

Interim Condensed Consolidated Statements of Cash Flows

(Expressed in thousands of Canadian Dollars)

(Unaudited)

 

     Nine months ended December 31, 2022      Nine months ended December 31, 2021  
    $    $ 
Operating activities          
Net loss for the period   (6,192)   (19,371)
Items not involving cash          
Depreciation   3    30 
Stock based compensation   1,177    1,186 
Unrealized foreign exchange   (1,072)   121 
Accrued interest   (122)   (40)
Change in fair value of warrant derivative (Note 6)   (5,547)   - 
Changes in non-cash working capital          
Other receivables, prepaids and deposits   1,019    (878)
Accounts payable and accrued liabilities   368    (1,735)
    (10,366)   (20,687)
Investing activities          
Acquisition of marketable securities   -    (10,000)
Disposition of marketable securities   -    20,050 
    -    10,050 
Financing activities          
Repayment of lease liabilities   -    (21)
Issuance of share capital on ATM, net of issuance costs (Note 3)   848    3,408 
Issuance of share capital and warrants on public offering, net of issuance costs (Note 3)   23,912    - 
Warrant amendment (Note 4)   189    - 
Warrant and option exercises (Notes 4 and 5)   -    406 
    24,949    3,793 

Effect of foreign exchange on cash

   1,035    (139)
Net increase (decrease) in cash   15,618    (6,983)
Cash, beginning of period   20,535    30,375 
Cash, end of period   36,153    23,392 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 

 

 

3

 

 

 

Medicenna Therapeutics Corp.

Interim Condensed Consolidated Statements of Changes in Shareholders' Equity

(Expressed in thousands Canadian Dollars, except for share and per share amounts)

(Unaudited)

 

   Common shares issued and outstanding    Contributed surplus      Accumulated other comprehensive income      Deficit      Total
shareholders' equity
 
     Number      Amount              
         $    $    $    $    $ 
Balance, March 31, 2021   53,547,709    79,587    6,680    234    (48,356)   38,145 
Stock based compensation   -    -    1,186    -    -    1,186 
Warrant and option exercises   351,170    576    (170)   -    -    406 
Issued on ATM facility (note 6)   1,671,995    3,408    -    -    -    3,408 
Cumulative translation adjustment   -    -    -    (18)   -    (18)
Net loss for the period   -    -    -    -    (19,371)   (19,371)
Balance, December 31, 2021   55,570,874    83,571    7,696    216    (67,727)   23,756 
                               
Balance, March 31, 2022   55,647,479    83,671    7,926    171    (70,933)   20,835 
Stock based compensation   -    -    1,177    -    -    1,177 
Issued on ATM financing (Note 3)   656,656    848    -    -    -    848 
Issued pursuant to public offering, net of warrant derivative (Note 3)   13,333,334    16,405    -    -    -    16,405 
Warrant amendment (Note 4)   -    -    189    -         189 
Cumulative translation adjustment   -    -    -    (37)   -    (37)
Net loss for the period   -    -    -    -    (6,192)   (6,192)
Balance, December 31, 2022   69,637,469    100,924    9,292    134    (77,125)   33,225 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

4

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

 

 

 

1.Nature of business and liquidity

 

The Company's principal business activity is the development and commercialization of IL-2, IL-4 and IL-13 Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Medicenna has four wholly owned subsidiaries, Medicenna Therapeutics Inc. (“MTI”) (British Columbia), Medicenna Biopharma Inc. (“MBI”) (Delaware), Medicenna Biopharma Inc. (“MBIBC”) (British Columbia) and Medicenna Australia PTY Ltd (“MAL”) (Australia). Medicenna is traded on both the Toronto Stock Exchange and the Nasdaq Capital Market (“Nasdaq”) under the symbol ‘’MDNA”.

 

Aa at December 31, 2022, the head and registered office is located at 2 Bloor St W, 7th Floor, Toronto, Ontario, Canada.

 

Since inception, the Company has devoted its resources to funding R&D programs, including securing intellectual property rights and licenses, conducting discovery research, manufacturing drug supplies, initiating preclinical and clinical studies, submitting regulatory dossiers and providing administrative support to R&D activities, which has resulted in an accumulated deficit of $77.1 million as of December 31, 2022. With current finance income only consisting of interest earned on excess cash, cash equivalents and marketable securities, losses are expected to continue while the Company’s R&D programs are advanced.

 

We currently do not earn any revenues from our product candidates and are therefore considered to be in the development stage. As required, the Company will continue to finance its operations through the sale of equity or pursue non-dilutive funding sources available to the Company in the future. The continuation of our research and development activities for MDNA55, MDNA11 and the BiSKITsTM platform and the commercialization of MDNA55 is dependent upon our ability to successfully finance and complete our research and development programs through a combination of equity financing and revenues from strategic partners. We have no current sources of revenues from strategic partners.

 

Management has forecasted that the Company’s current level of cash will be sufficient to execute its current planned expenditures into Q2 of calendar 2024.

 

2.Basis of presentation and significant accounting policies

 

a)Statement of compliance

 

These interim condensed consolidated financial statements have been prepared in accordance with International Accounting Standards (“IAS”) 34 ‘Interim Financial Reporting’ (IAS 34) using accounting policies consistent with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and the Interpretations of the International Financial Reporting and Interpretations Committee (“IFRIC”).

 

The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Company’s audited financial statements for the year ended March 31, 2022.

 

The interim condensed consolidated financial statements were approved by the Company’s Board of Directors and authorized for issue on February 6, 2023.

 

b)Functional and presentation currency

 

The functional currency of an entity and its subsidiary is the currency of the primary economic environment in which the entity operates. The functional currency of the parent company is the Canadian dollar and the functional currency of MBI is the US dollar, the functional currency of MTI and MBI BC is the Canadian dollar, the functional currency of MAL is the Australian dollar, and the presentation currency of the parent company is the Canadian dollar.

 

5

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

2.Basis of presentation and significant accounting policies cont’d

 

c)Significant accounting judgments, estimates and assumptions

 

The preparation of these unaudited interim condensed consolidated financial statements in accordance with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and reported amounts of assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and reported amounts of revenues and expenses during the reporting period. Actual outcomes could differ from these estimates.

 

The unaudited interim condensed consolidated financial statements include estimates, which, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the unaudited interim condensed consolidated financial statements and may require accounting adjustments based on future occurrences. The estimates and underlying assumptions are reviewed on a regular basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised and in any future periods affected.

 

The accompanying unaudited interim condensed consolidated financial statements are prepared in accordance with IFRS and follow the same accounting policies and methods of application as the audited consolidated financial statements of the Company for the year ended March 31, 2022. They do not include all of the information and disclosures required by IFRS for annual financial statements. In the opinion of management, all adjustments considered necessary for fair presentation have been included in these unaudited condensed consolidated interim financial statements. Operating results for the nine months ended December 31, 2022, are not necessarily indicative of the results that may be expected for the full year ended March 31, 2023. For further information, see the Company’s audited consolidated financial statements including notes thereto for the year ended March 31, 2022.

 

d)Warrant derivative

 

When a warrant exercise price is denominated in a currency which differs from the Company’s functional currency, the financial instruments are treated as liabilities and measured at fair value. The fair value of the warrants are calculated using the black-scholes model. The change in the liability has been recorded in the interim condensed consolidated statement of loss and comprehensive loss.

 

e)COVID-19 Pandemic

 

The COVID-19 pandemic continues to cause significant financial market and social disruption. The Company cannot presently predict the scope and severity of any potential business shutdowns or disruptions related to COVID-19, the impact of any new variants nor the impact of the vaccines that are now accessible. If the Company or any of the third parties with whom it engages, were to experience shutdowns or other business disruptions due to the pandemic, its ability to conduct its business in the manner and on the timelines presently planned could be materially and negatively impacted. The Company will continue to monitor developments of the pandemic and continuously assess its potential further impact on its operations to prevent any disruptions to the conduct of its business and clinical trials. In the event of a prolonged continuation of the pandemic, it is not clear what the potential impact may be on the Company's business, financial position and financial performance.

 

3.Share capital

 

Authorized

 

Unlimited common shares

 

Equity Issuances

 

August 2022 Public Offering

 

On August 10, 2022, pursuant to an underwritten public offering, 13,333,334 units were sold at a purchase price of US$1.50 per unit for gross proceeds of US$20.0 million ($25.6 million). Each unit included one common share with a fair value of US$1.06 and one common share purchase warrant with a fair value of US$0.44 (see Note 6). Each common share purchase warrant entitles the holder to purchase one common share at an exercise price of US$1.85 until August 9, 2027. We incurred transaction costs of $2.2 million (US1.7 million) of which $1.6 million (US$1.2 million) were allocated to share issue costs and $0.6 million (US$0.5 million) were allocated to operating expenses, based on their relative fair values.

6

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

 

3.Share capital cont’d

 

At-The-Market Facility

 

On December 30, 2020, the Company entered into a sales agreement with SVB Leerink acting as sales agent, pursuant to which the Company may, from time to time sell, through at-the-market (“ATM”) on the NASDAQ such number of common shares as would have an aggregate offering price of up to US$25.0 million (the ATM Offering), which expired December 30, 2022.

 

During the nine months ended December 31, 2022, the Company issued 656,656 common shares (December 31, 2021 – 1,671,995) for gross proceeds of US$0.8 million (December 31, 2021 - US$2.9 million) at an average price of US$1.20 (December 31, 2021 - US$1.76). The Company received; net of commissions US$0.7 million (December 31, 2021 - US$2.8 million). In total, we incurred share issuance costs (including commissions) of US$0.1 million (December 31, 2021 - US$0.1 million).

 

Calculation of loss per share

 

Loss per common share is calculated using the weighted average number of common shares outstanding. For the three and nine ended December 31, 2022, and 2021, the calculation was as follows:

 

  

Three months ended

December 31,

 

Nine months ended

December 31,

    2022    2021    2022    2021 
Common shares issued and outstanding, beginning of year   69,637,469    53,843,785    55,647,479    53,547,709 
ATM issuances   -    135,453    600,210    135,453 
Shares issued on 2022 Public Offering   -    -    6,884,848    - 
Effect of warrants and options exercised   -    16,462    -    181,410 
Weighted average shares outstanding, end of period   69,637,469    53,995,700    63,132,537    53,864,572 

 

The effect of any potential exercise of the Company’s stock options and warrants outstanding during the year has been excluded from the calculation of diluted loss per common share as it would be anti- dilutive.

 

4.Warrants

 

Warrant continuity:

 

    Number of Warrants    Weighted average exercise price 
Warrants outstanding at March 31, 2021   4,018,993   $1.82 
Warrants expired during the period   (18,000)   2.00 
Warrants exercised during the period   (169,246)   1.59 
Warrants outstanding at June 30, 2021   3,831,747   $1.83 
Warrants exercised during the period   (41,950)   1.57 
Warrants outstanding at September 30, 2021   3,789,797   $1.83 
Warrants exercised during the period   (55,094)   1.30 
Warrants outstanding at December 31, 2021   3,734,703   $1.84 
Warrants expired during the period   (770,161)   3.10 
Warrants outstanding at March 31 and June 30, 2022   2,964,542   $1.51 
Common share purchase warrants issued in the 2022 Public Offering   13,333,334    2.39 
Warrants outstanding at September 30, 2022   16,297,876   $2.23 
Warrants expired during the period   (112,490)   1.75 
Warrants outstanding at December 31, 2022   16,185,386   $2.23 

 

7

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

4.Warrants cont’d

 

There were no warrants exercised during the nine months ended December 31, 2022.

 

At December 31, 2022, warrants were outstanding and exercisable, enabling holders to acquire common shares as follows:

 

Number of Warrants  Exercise Price  Expiry Date
      $    
 1,549,052    1.75   July 17, 2023
 1,303,000    1.20   December 21, 2023
 13,333,334    US 1.85   August 9, 2027
 16,185,386         

 

Warrants outstanding and exercisable, totaling 1,549,052 due to expire on October 17, 2022, and issued on October 17, 2019, as part of a public offering of an aggregate of 5,307,693 units of the Company, were extended to July 17, 2023. In total, we incurred non-cash financing fees of $0.2 million relating to these warrants during the nine months ended December 31, 2022.

 

5.Stock options

 

During the nine months ended December 31, 2022, the Company granted 1,290,713 stock options at an average exercise price of $1.44 per share. 997,608 of the options were granted to the Company’s officers and employees and vest 1/3 after one year, 1/3 after two years and 1/3 after three years, and have a ten-year life; and 293,105 options were granted to Directors of the Company at a price of $1.45 and vest 50% upon issuance and 50% after 1 year and have a five-year life.

During the nine months ended December 31, 2021, the Company granted 968,056 stock options at an average exercise price of $3.72 per share. 812,706 of the options were granted to the Company’s officers and employees and vest 1/3 after one year, 1/3 after two years and 1/3 after three years, and have a ten-year life; and 20,000 stock options granted to a consultant vest 1/3 after one year, 1/3 after two years and 1/3 after three years, and have a ten-year life. 135,350 options were granted to Directors of the Company at a price of $3.14 and vest 50% upon issuance and 50% after 1 year and have a five-year life.

 

Stock option transactions for the nine months ended December 31, 2022 and 2021 are set forth below:

 

     Number of options      Weighted average exercise price  
Balance outstanding at March 31, 2021   4,155,084    1.96 
Granted   370,000    4.66 
Forfeited   (62,480)   5.11 
Balance outstanding at June 30, 2021   4,462,604   $2.14 
Granted   598,056    3.14 
Exercised   (84,880)   1.47 
Forfeited   (302,640)   3.28 
Balance outstanding at September 30 and December 31, 2021   4,673,140   $2.17 
Granted   129,000    2.28 
Forfeited   (337,500)   4.92 
Balance outstanding at March 31, 2022   4,464,640   $2.00 
Granted   1,115,713    1.45 
Balance outstanding at June 30, 2022   5,580,353   $1.89 
Granted   175,000    1.36 
Balance outstanding at September 30 and December 31, 2022   5,755,353   $1.88 

 

8

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

5.Stock options cont’d

 

The following table summarizes information about stock options outstanding at December 31, 2022:

 

   Options Outstanding  Options Exercisable
Exercise Prices  Options  Weighted average remaining contractual life  Weighted average exercise price  Options  Weighted average exercise price
$     Years  $     $
1.00-1.99   3,245,713    6.74    1.27    1,747,500    1.15 
2.00-2.99   1,679,000    4.08    2.08    1,550,000    2.06 
3.00-5.19   830,640    4.80    3.82    131,458    5.11 
    5,755,353    5.68    1.88    3,428,958    1.64 

 

The following assumptions were used in the Black-Scholes option-pricing model to determine the fair value of stock options granted during the period:

 

   December 31, 2022  March 31, 2022
       
Exercise price   $1.36-1.45    $2.05-4.85 
Risk free interest rate   4.85%   1.0%
Expected life of options   5 years     5 years  
Expected volatility   90%   90%
Expected dividend yield   -    - 
Forfeiture rate   0% – 15%    0% – 15% 
Weighted average fair value of options granted during the period  $1.04   $2.58 

 

6.Warrant Derivative

 

On August 10, 2022, pursuant to an underwritten public offering, 13,333,334 units were sold at a purchase price of US$1.50 per unit for gross proceeds of US$20.0 million ($25.6 million). Each unit included one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to purchase one common share at an exercise price of US$1.85 until August 9, 2027. We incurred transaction costs of $2.2 million (US$1.7 million) of which $1.6 million (US$1.2 million) were allocated to share issue costs and $0.6 million (US$0.5 million) were allocated to operating expenses, based on their relative fair values.

 

Under IFRS 9 Financial Instruments and IAS 32 Financial Instruments: Presentation, warrants with an exercise price denominated in a currency that differs from an entity's functional currency are treated as a derivative measured at fair value with subsequent changes in fair value accounted for through the consolidated statement of loss. Our warrants with an exercise price of US$1.85 meet this requirement and we have presented the value of these warrants as a non-current liability on the consolidated statement of financial position. Upon exercise, the recorded liability will be included in our share capital along with the proceeds from the exercise. If these warrants expire, the related liability is reversed through the consolidated statement of loss. There is no cash flow impact as a result of the accounting treatment for changes in the fair value of the warrant derivative or when warrants expire unexercised.

 

Estimating the fair value for our warrant derivative requires determining the most appropriate valuation model which is dependent on the terms and conditions of the issuance. This estimate also requires determining the most appropriate inputs to the valuation model, including the expected life of the warrant derivative, expected share price volatility and expected dividend yield and making assumptions about them.

 

9

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

6.Warrant Derivative cont’d

 

A reconciliation of the change in fair value of the warrant derivative is as follows:

 

     Fair value of Warrant Derivatives  
    

$

 
Balance, August 11, 2022   7,507 
Change in fair value of warrant derivative   (2,230)
Foreign exchange loss   430 
Balance September 30, 2022   5,707 
Change in fair value of warrant derivative   (3,711)
Foreign exchange loss
   (36)
Balance December 31, 2022
   1,960 

 

We use historical data to estimate the expected dividend yield and expected volatility of our stock in determining the fair value of the warrants. The risk-free interest rate is based on U.S. Department of Treasury benchmark treasury yield rates in effect at the time of valuation and the expected life of the warrants represents the estimated length of time the warrants are expected to remain outstanding.

 

The following table summarizes the key assumptions used in the Black-Scholes valuation of the warrant derivative at December 31, 2022:

 

     December 31, 2022      August 11, 2022  
       
Fair value of warrants  $0.15   $0.56 
Underlying share price  $0.64   $1.33 
Risk free interest rate   4.85%   3.15%
Expected hold period to exercise   2.75 years    3.0 years 
Expected share price volatility   85%   85%
Expected dividend yield   Nil    Nil 

 

The following table summarizes our outstanding warrant derivative for the nine months ending December 31, 2022:

 

  Exercise Price      Outstanding Beginning of the Period      Granted during the Period      Outstanding, End of the Period      Weighted Average Remaining Contractual Life (years)  
 US$1.85    -    13,333,334    13,333,334    4.61 

 

7.Government assistance

 

CPRIT assistance

 

In February 2015, the Company received notice that it had been awarded a grant by the Cancer Prevention Research Institute of Texas (“CPRIT”) whereby the Company was eligible to receive up to US$14.1 million on eligible expenditures over a three-year period related to the development of the Company’s phase 2b clinical program for MDNA55. As of March 31, 2022, the grant with CPRIT was complete.

 

10

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

7.Government assistance cont’d

 

Of the US$14.1 million grant approved by CPRIT, Medicenna had received US$14.1 million from CPRIT at March 31, 2022.

 

Under the terms of the grant, the Company is required to pay a royalty to CPRIT, comprised of 3-5% of revenues on net sales of MDNA55 until aggregate royalty payments equal 400% of the grant funds received at which time the ongoing royalty will be 0.5% of revenues. At this time the royalty is not probable and therefore no liability has been recorded. In addition, the Company must maintain a presence in Texas for three years following completion of the grant.

 

8.Commitments

 

Intellectual property

 

On August 21, 2015, the Company exercised its right to enter into two license agreements (the “Stanford License Agreements”) with the Board of Trustees of the Leland Stanford Junior University (“Stanford”). In connection with this licensing agreement, the Company issued 649,999 common shares with a value of $0.1 million to Stanford and affiliated inventors. The value of these shares has been recorded as an intangible asset that is being amortized over the life of the underlying patents. As at December 31, 2022, the Company’s intangible assets have a remaining capitalized net book value of $62 thousand (March 31, 2022 - $65 thousand).

 

The Company has entered into various license agreements with respect to accessing patented technology. In order to maintain these agreements, the Company is obligated to pay certain costs based on timing or certain milestones within the agreements, the timing of which is uncertain. These costs include ongoing license fees, patent prosecution and maintenance costs, royalty and other milestone payments. As at December 31, 2022, the Company is obligated to pay the following:

 

Given the current development plans and expected timelines of the Company it is assumed that project milestones of US$0.3 million will be due in the next five years.
Project milestone payments, assuming continued success in the development programs, of uncertain timing totaling US$2.0 million and an additional US$2.0 million in sales milestones.

 

Contractual obligations 

Less than 1 year

  1-3 years  3-5 years  Total
    

$

    

$

    

$

    

$

 
Patent licensing costs   203    1,232    312    1,747 

 

As at December 31, 2022, the Company had obligations to make future payments, representing significant research and development and manufacturing contracts and other commitments that are known and committed in the amount of approximately $3.4 million, of which $2.4 million has been paid or accrued as at December 31, 2022. Most of these agreements are cancellable by the Company with notice. These commitments include agreements for manufacturing and preclinical studies.

 

9.Related party disclosures

 

(a)Key management personnel

 

Key management personnel, which consists of the Company’s officers (President and Chief Executive Officer, Chief Financial Officer, Chief Development Officer, former Chief Medical Officer and former Chief Scientific Officer) and directors, earned the following compensation for the following periods:

 

11

Medicenna Therapeutics Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the Three and Nine months ended December 31, 2022 and 2021

(Tabular amounts expressed in thousands of Canadian Dollars, except for share and per share amounts)

 

9.Related party disclosures cont’d

 

   Three months ended
December 31,
  Nine months ended
December 31,
     2022      2021      2022      2021  
    $    $    $    $ 
Salaries and wages   331    511    836    1,272 
Board fees   95    77    247    217 
Stock option expense   261    349    972    895 
    687    937    2,055    2,384 

 

(b)Amounts payable to related parties

 

As at December 31, 2022, the Company had trade and other payables in the normal course of business, owing to directors and officers of $0.1 million, (2021 - $0.1 million) related to board fees and accrued vacation.

 

10.Components of Expenses

 

   Three months ended
December 31,
  Nine months ended
December 31,
     2022      2021      2022      2021  
General and Administration Expenses   $    $    $    $ 
                     
Depreciation expense   2    10    4    30 
Stock based compensation   183    232    724    676 
Facilities and operations   149    109    422    291 
Public company expenses   1,213    1,351    3,587    4,116 
Transaction costs, warrant derivative (Note 6)   -    -    652    - 
Salaries and benefits   429    288    877    708 
    1,976    1,990    6,266    5,821 

 

   Three months ended
December 31,
  Nine months ended
December 31,
     2022      2021      2022      2021  
Research and Development Expenses   $    $    $    $ 
                     
Chemistry, manufacturing, and controls   146    173    686    6,588 
Regulatory   15    69    52    458 
Discovery and pre-clinical   295    522    1,166    2,822 
Clinical   1,221    934    2,752    1,956 
Salaries and benefits   780    751    1,839    2,061 
Licensing, patent, legal fees and royalties   303    255    739    783 
Stock based compensation   156    194    452    511 
CPRIT grant claimed in eligible expenses (Note 7)   -    -    -    (1,753)
Other research and development expenses   29    9    32    99 
    2,945    2,907    7,718    13,525 

 

 

12

 

 

EX-99.2 3 exh_992.htm EXHIBIT 99.2

Exhibit 99.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Management’s Discussion and Analysis

 

For the Three and Nine Months Ended

December 31, 2022

 

 

DATE OF REPORT: February 6, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS

 

The following management’s discussion and analysis (“MD&A”) has been prepared as at February 6, 2023 for the three and nine months ended December 31, 2022 and should be read in conjunction with the unaudited interim condensed consolidated financial statements of Medicenna Therapeutics Corp. for the three and nine months ended December 31, 2022 and 2021, and the annual consolidated financial statements and accompanying notes for the years ended March 31, 2022 and 2021 (the “Annual Financial Statements”), which have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Our IFRS accounting policies are set out in note 2 of the Annual Financial Statements and all dollar amounts are expressed in Canadian dollars unless otherwise noted.

 

All references in this MD&A to “the Company”, “Medicenna”, “we”, “us”, or “our” and similar expressions refer to Medicenna Therapeutics Corp. and the subsidiaries through which it conducts its business, unless otherwise indicated.

 

FORWARD-LOOKING STATEMENTS

 

This MD&A contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on current beliefs, expectations, or assumptions regarding the future of the business, future plans and strategies, operational results and other future conditions of the Company. These statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. All statements contained herein other than statements of historical fact regarding the prospects of the Company’s industry or its prospects, plans, financial position or business strategy may constitute forward-looking statements and can generally be identified by the use of forward-looking words, such as “plan”, “expect”, “is expected”, “budget”, “scheduled”, “estimate”, “forecast”, “contemplate”, “intend”, “anticipate”, or “believe” or variations (including negative variations) of such words and phrases, or statements that certain actions, events or results “may”, “could”, “would”, “might”, “shall” or “will” be taken, occur or be achieved and similar expressions are generally intended to identify forward-looking statements.

 

By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that predictions, forecasts, projections and other forward-looking statements will not be achieved. The Company cautions readers not to place undue reliance on these statements as a number of important factors could cause the actual results to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates and intentions expressed in such forward-looking statements. Risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and statements include, but are not limited to, the risks described under the heading “Risks and Uncertainties” in this MD&A, the Company’s annual information form for the fiscal year ended March 31, 2022 (the “Annual Information Form”) and the Company’s annual report on Form 20-F for the fiscal year ended March 31, 2022 (the “Annual Report on Form 20-F”) filed with the U.S. Securities and Exchange Commission.

 

Forward-looking statements in this MD&A include, but are not limited to:

 

the therapeutic potential and clinical development and related milestones of the Company’s Superkines and Empowered Superkines including MDNA11, the BiSKITsTM platform and bizaxofusp (formerly MDNA55);
the timely completion of the milestones related to the MDNA11 ABILITY Study (as defined below)
the impact of the delay on clinical data;
the clinical trial collaboration and supply agreement with Merck;

 

 2

 

a potential strategic partnership to facilitate bizaxofusp’s further development and commercialization; and
the use of proceeds from public equity offerings and the necessity for the Company to have recourse to such public equity offerings.

 

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended, including the following:

 

the lack of product revenue and inability to continue operations and research and development without sufficient funding;
the Company’s requirements for, and our ability to obtain, future funding on favourable terms or at all;
the Company’s history of losses and expectations of future losses;
the Company’s inability to complete development of or the inability to commercialize (if approved) the Company’s product candidates, which are in the early stages of development;
the expense, length, and uncertainty of clinical drug development programs;
the inability to achieve publicly announced milestones according to schedule, or at all;
the risk that competitors may develop and market products that are more effective that the Company’s product candidates or that the products developed by competitors may render the Company’s product candidates obsolete or uncompetitive;
the Company’s inability to secure a partnership for bizaxofusp (formerly MDNA55);
the costs and uncertainty associated with extensive government regulation;
the obtaining of regulatory approvals, including delays or negative outcomes from the regulatory approval process;
the potential negative results from clinical trials or studies, or adverse safety events involving the targets of the Company’s products, including in the demonstration of efficacy and safety;
the pharmacokinetic (“PK”) and pharmacodynamic (“PD”) properties of MDNA11;
the tumour response data from our clinical trials;
the risk of product liability claims;
the Company’s inability to enroll subjects in clinical trials or complete clinical trials on a timely basis
the failure of our product candidates to receive the marketing approval or market acceptance necessary for commercial success;
the potential for environmental exposure to hazardous or radioactive materials that are used in the Company’s discovery and development process;
the disruption in the availability of key components for ongoing clinical studies that could delay clinical studies, product testing, and regulatory approval of the Company’s product candidates;
the Company’s reliance on third parties for the planning, conduct, and monitoring of preclinical and clinical trials and for the manufacture of drug product;
the Company’s reliance on contract manufacturers over whom the Company has limited control;
the loss of license rights due to breach of license agreements;
the conditions and restrictions of the Cancer Prevention Research Institute of Texas (“CPRIT”) grant;
the potential uses of proceeds generated under Company’s offerings;
the ability to protect the Company’s intellectual property and proprietary technology;
the ability for the Company to obtain patent’s term extensions;
the potential involvement in intellectual property litigation;
the risk that third-parties to whom we rely for product development may not adequately protect the Company’s trade secrets;
the risk of product liability claims;
the limitations surrounding intellectual property rights
the volatility in the price of our common shares

 

 3

 

 

the dilution of investor’s voting power and reductions in earnings per share owing to future issuances of equity or the conversion of securities into common shares;
the fact that future profits will likely be used for the continued growth of the Company’s business and not for the payment of dividends
the Company’s treatment as a passive foreign investment company and potential adverse U.S. federal income tax consequences associated with such treatment;
the difficulty U.S. investors may face in bringing actions against the Company for violations of U.S. federal or state securities laws and challenges in enforcing the judgments of U.S. courts against the Company and its directors and executive officers;
the Company’s status as a foreign private issuer under applicable U.S. securities laws;
the ability of the Company’s significant shareholders to assert a material influence over the Company’s operations and governance;
the adverse impact of factors outside our control, such as global health pandemics, natural disasters, geopolitical conflict and macroeconomic challenges;
the Company’s ability to successfully manage its growth;
the failure of any acquired business, product, service, or alliance to yield expected benefits;
the Company’s dependence upon certain key personnel, the loss of whom could adversely affect our ability to achieve our business objectives;
changes in government regulations that could impact our business and operations;
failure to comply with the U.S. Foreign Corrupt Practices Act, the Canadian Corruption of Foreign Public Officials Act and other global corruption and anti-bribery laws;
a failure to comply with healthcare laws;
foreign currency exchange risks relating to the relative value of the United States dollar;
the failure of our disclosure controls and procedures to detect all errors or prevent all incidences of fraud;
the failure to maintain an effective system of internal controls;
the vulnerability of the computer and information systems of the Company, its consultants and contractors, and third-parties on which the Company relies, to security breaches or failure; and
the pursuit of opportunities for further research and development or additional business opportunities.

 

The forward-looking information in this MD&A does not include a full assessment or reflection of the impacts of the COVID-19 pandemic. The continued evolution of COVID-19 and its variants, as well as periodic spikes in infection rates and local outbreaks, in spite of safety measures or vaccinations, could cause disruptions to our operations or those of third parties with whom we engage. The COVID-19 pandemic has led to global supply chain challenges, which could adversely impact our ability to conduct business in the manner and timelines presently planned. As new variants of the virus appear, especially variants that are more easily spread, cause more serious outcomes, or are resistant to existing vaccines, new health orders and safety protocols could further impact our operations. The Company will continue to monitor developments of the pandemic and continuously assess its potential further impact on its operations to prevent any disruptions to the conduct of its business and clinical trials. In the event of a prolonged continuation of the pandemic, it is not clear what the potential impact may be on the Company's business, financial position and financial performance.

 

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the assumption was made.

 

Although the forward-looking statements contained in this MD&A are based upon what the Company’s management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements.

 

Any forward-looking statements represent the Company’s estimates only as of the date of this MD&A and should not be relied upon as representing the Company’s estimates as of any subsequent date. The Company undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events, except as may be required by securities laws.

 

 4

 

COMPANY OVERVIEW

 

The Company's principal business activity is the development and commercialization of Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Medicenna has four wholly owned subsidiaries, Medicenna Therapeutics Inc. (British Columbia), Medicenna Biopharma Inc. (Delaware), Medicenna Biopharma Inc. (British Columbia) and Medicenna Australia PTY Ltd (Australia). On November 13, 2017, Medicenna continued under the Canada Business Corporations Act. On August 24, 2020, Medicenna began trading on the Nasdaq Capital Market (“Nasdaq”) under the symbol “MDNA.

 

Medicenna is an immunotherapy company developing novel, highly selective versions of interleukin-2 (“IL-2”), interleukin-4 (“IL-4”) and interleukin-13 (“IL-13”) tunable cytokines, called “Superkines”. These Superkines can be developed either on their own as short or long-acting therapeutics or fused with cell killing proteins to generate Empowered Superkines that precisely deliver potent payloads to cancer cells without harming adjacent healthy cells. Superkines can also be fused with a large variety of proteins, antibodies and even other Superkines to incorporate two synergistic therapeutic activities into one molecule, creating novel Bi-Functional SuperKine ImmunoTherapies referred to by Medicenna as BiSKITsTM. Medicenna’s mission is to become the leader in the development and commercialization of Superkines, Empowered Superkines and BiSKITsä for the treatment of a broad range of cancers and other diseases. The Company seeks to achieve its goals by drawing on its expertise, and that of world-class collaborators and advisors, to develop Revolutionary Medicines using Evolutionary Superkines. Compared to naturally occurring cytokines – that bind to multiple receptors on many cell types – Superkines are engineered with unique selectivity toward specific receptor subtypes and defined target cell subsets to precisely activate or inhibit relevant signalling pathways or immune cells in order to improve therapeutic efficacy and safety.

 

Medicenna has built diverse platforms, each comprised of a pipeline of Superkine candidates in-licensed from Leland Stanford Junior University (“Stanford”). This includes the MDNA109 platform that consists of IL-2 agonists, IL-2 antagonists and partial agonists of IL-2. Additional assets from Stanford also include several super-agonists of IL-4 and IL-13 and dual IL-4/IL-13 antagonists. In addition, Medicenna has also independently developed therapeutic agents based on its Empowered Superkine and BiSKITsä platforms.

 

The most advanced of these programs is the MDNA109 platform which is a genetically engineered IL-2 Superkine designed to specifically bind to CD122 (IL-2Rβ) with high affinity. To further enhance its selectivity, two additional mutations (FEAA) were incorporated in MDNA109 to abolish binding to CD25. To improve the PK properties of the highly selective version of MDNA109 (MDNA109FEAA), it was genetically fused to protein scaffolds such as the Fc domain of IgG1 (MDNA19) or human albumin (MDNA11) effectively increasing the size of the Superkine and improving its half-life to avoid frequent daily dosing required for Proleukinâ.

 

We believe that, unlike Proleukinâ, both MDNA11 and MDNA19, have superior PK properties, lack CD25 binding to improve safety and reduce immune suppression, potently stimulate effector T cells, reverse natural killer (“NK”) cell exhaustion and act with exceptional synergy when combined with checkpoint inhibitors.

 

Although MDNA19 was initially identified as the Company’s lead IL-2 candidate, a pilot non-human primate study comparing MDNA11 with MDNA19 demonstrated that the former had better PK and PD features. Medicenna is therefore advancing the clinical development of MDNA11 as it is a more promising molecule and has been selected as the lead IL-2 Superkine candidate. Medicenna initiated the Phase 1/2 ABILITY Study (A Beta-only IL-2 ImmunoTherapY Study) with MDNA11 (the “ABILITY Study”) in the third calendar quarter of 2021. MDNA19 remains relevant for Medicenna as it provides unique design features in the development of our BiSKITsTM platform. Our BiSKITsTM platform allows us to develop designer Superkines by fusing them to other proteins, antibodies, cytokines or other Superkines resulting in two distinct but synergistic functions into one molecule: a BiSKITTM.

 

 5

 

Complementing our Superkine platform is bizaxofusp (formerly MDNA55), Medicenna’s Empowered Superkine, for the treatment of recurrent glioblastoma (“rGBM”), the most common and uniformly fatal form of brain cancer. Bizaxofusp is a fusion of a circularly permuted version of IL-4, fused to a potent fragment of the bacterial toxin, Pseudomonas exotoxin (“PE”), and is designed to preferentially target tumor cells that over-express the interleukin 4 receptor (“IL-4R”). Bizaxofusp has been studied in five clinical trials in 132 patients, including 112 patients with rGBM, the results of which support our belief that it has superior efficacy when compared to the current standard of care (“SOC”). Bizaxofusp has secured Orphan Drug Status from the United States Food and Drug Administration (“FDA”) and the European Medicines Agency (“EMA”) as well as Fast Track Designation from the FDA for the treatment of rGBM and other types of high-grade glioma. We continue to pursue a strategic partnership to facilitate bizaxofusp’s further development and commercialization.

 

ACHIEVEMENTS & HIGHLIGHTS

 

The following are the achievements and highlights for the quarter ended December 31, 2022 through to the date hereof:

 

·On November 10, 2022, the Company announced new safety, PK, and PD data from the first four dose escalation cohorts of the Phase 1/2 ABILITY Study of MDNA11, the Company’s “beta-only” long-acting IL-2 super-agonist. The data were featured in two posters presented at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, which took place from November 8 – 12, 2022.

 

·In December 2022, previously reported data from the Phase 1/2 ABILITY Study of MDNA11 were featured in an oral presentation at the 2022 Immunotherapy Bridge Conference. The presentation, titled “Early Results of an IL-2 Superkine (MDNA11) from the Phase 1/2 ABILITY Study in Advanced Solid Tumors was delivered by Arash Yavari, M.B.B.S., DPhil., M.R.C.P., Principal Investigator at the Radcliffe Department of Medicine, University of Oxford and Principal Clinical Advisor to Medicenna.

 

·Subsequent to the quarter end, on January 5, 2023, Medicenna announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,542,312 titled “IL-2 Superagonists in Combination with Anti-PD-1.” The patent provides intellectual property (IP) protection for methods of treating cancer with an IL-2 Superkine such as MDNA11 and a PD1 (for example, pembrolizumab), PDL1 or CTLA-4 checkpoint inhibitor in combination, as planned in the on-going ABILITY Study, or as a single agent using our BiSKIT™ (Bifunctional SuperKine for ImmunoTherapy) platform. The patent’s term extends into at least 2039 without accounting for any potential extensions.

 

·Subsequent to the quarter end, in January 2023, the full results of a single-arm Phase 2b trial of bizaxofusp (formerly MDNA55) in patients with recurrent glioblastoma were published in the peer-reviewed journal Neuro-Oncology. Results showed the trial met its primary endpoint, with median overall survival (mOS) in the primary and supportive analysis populations exceeding the trial’s pre-defined success criteria and the mOS historically achieved with currently approved therapies.

 

FINANCING UPDATE

 

Nine months ended December 31, 2022

 

August 2022 Public Offering

 

On August 10, 2022, pursuant to an underwritten public offering, we sold 13,333,334 units at a purchase price of US$1.50 per unit for gross proceeds of US$20.0 million ($25.6 million). Each unit included one common share with a fair value of US$1.06 and one common share purchase warrant with a fair value of US$0.44. Each common share purchase warrant entitles the holder to purchase one common share at an exercise price of US$1.85 until August 9, 2027. We incurred transaction costs of $2.2 million (US$1.7 million) of which $1.6 million (US$1.2 million) were allocated to share issue costs and $0.6 million (US$0.5 million) were allocated to operating expenses, based on their relative fair values.

 

 6

 

At-The-Market Facility

 

On December 30, 2020, the Company entered into a sales agreement with SVB Securities LLC (f/k/a SVB Leerink LLC) (“SVB Securities”) acting as sales agent (the “ATM Agreement”), pursuant to which the Company may, from time to time sell, through an at-the-market (“ATM”) offering on the Nasdaq such number of common shares as would have an aggregate offering price of up to US$25.0 million (the “ATM Facility”). The ATM Facility expired on December 30, 2022. During the nine months ended December 31, 2022, the Company issued 656,656 common shares (December 31, 2021 – 1,671,995) for gross proceeds of US$0.8 million (December 31, 2021 - US$2.9 million) at an average price of US$1.20 (December 31, 2021 - US$1.76). The Company received, net of commissions, US$0.7 million (December 31, 2021 - US$2.8 million). In total, the Company incurred share issuance costs (including commissions) of US$0.1 million (December 31, 2021 - US$0.1 million).

 

Warrants

 

During the nine months ended December 31, 2022, no warrants were exercised.

 

The term of the warrants outstanding and exercisable, totaling 1,549,052 due to expire on October 17, 2022, and issued on October 17, 2019, as part of a public offering of an aggregate of 5,307,693 units of the Company, was extended on October 17, 2022 to July 17, 2023.

 

Nine months ended December 31, 2021

 

During the nine months ended December 31, 2021, 266,290 warrants were exercised for proceeds of $0.4 million, the details of which are described below:

 

Number of Warrants   Exercise Price  

Proceeds

   Expiry Date
    $   $    
50,000    1.20   60,000   December 21, 2023
71,744    1.30   93,267   October 17, 2021
144,546    1.75   252,955   October 17, 2022
266,290        406,222    

 

NASDAQ LISTING

 

On October 28, 2022, the Company announced that on October 25, 2022, it received a notice from the Nasdaq Stock Market LLC (the ‘Nasdaq Notice”), stating that the Company was not in compliance with the minimum bid price requirement of US$1.00 (the “Minimum Bid Requirement”) per share under the Nasdaq Listing Rule 5450(a)(1) based upon the closing bid price of the Company’s common shares for the 30 consecutive business days prior to the date of the Nasdaq Notice. The Nasdaq Notice had no immediate effect on the listing or trading of the Company’s common shares on Nasdaq, and the Company’s operations currently remain unaffected by the receipt of the Nasdaq Notice.

 

Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days from the date of the Nasdaq Notice, or until April 24, 2023, to regain compliance with the Minimum Bid Requirement, during which time the Company’s common shares will continue to trade on Nasdaq. If at any time before April 24, 2023, the bid price of the Company’s common shares closes at or above US$1.00 per share for a minimum of 10 consecutive business days, the Company will regain compliance with the Minimum Bid Requirement. If the Company does not regain compliance with the Minimum Bid Requirement by April 24, 2023, the Company may be eligible, upon satisfaction of certain Nasdaq listing requirements, for an additional period of 180 calendar days to regain compliance or its common shares may be subject to delisting from Nasdaq.

 

 7

 

The Company is closely monitoring the closing bid price of its common shares and is considering its options to regain compliance with the Minimum Bid Requirement under the Nasdaq Listing Rules. This notice does not have any impact on the Company’s TSX listing.

 

RESEARCH & DEVELOPMENT UPDATE

 

Superkine Platform

 

MDNA11

 

On September 14, 2021, we announced that we had dosed the first patient in a Phase 1/2 clinical study of MDNA11. Medicenna’s Phase 1/2 ABILITY Study is designed to assess the safety, PK, PD, and anti-tumor activity of various doses of MDNA11 administered intravenously every two weeks, in patients with advanced solid tumors. The basket, dose finding study includes a dose escalation phase followed by a dose expansion phase with both an MDNA11 monotherapy arm as well as a combination arm designed to evaluate MDNA11 with a checkpoint inhibitor. The study will include patients with melanoma and renal cell carcinoma where Proleukinâ is known to have clinical activity, as well as cluster of other tumor types in order to explore the pan-tumor potential of MDNA11. The study also permits alternative dosing schedules, as well as options for intra-patient dose escalation. The ABILITY Study is currently enrolling patients at clinical sites in Australia, Canada and the United States.

 

 

On May 2, 2022, Medicenna announced new clinical data from the third cohort of the Phase 1/2 ABILITY Study of MDNA11. These data were subsequently updated in July as described below.

 

On May 11, 2022 , Medicenna presented additional clinical data from the Phase 1/2 ABILITY Study during a poster presentation at the 9th Annual Frontiers in Cancer Immunotherapy Meeting, organized by the New York Academy of Sciences. These data were subsequently updated in July as described below.

 

On July 27, 2022, Medicenna announced new clinical data on safety, PK, PD and anti-tumor activity from the Phase 1/2 ABILITY Study of MDNA11 which were presented at the Cytokine Based Drug Development Summit, held in Boston. These data were subsequently updated on September 28, 2022 and November 10, 2022 and are described below.

 

 8

 

In the dose escalation portion of the ABILITY Study, MDNA11 is administered intravenously, as a monotherapy, once every two weeks to patients with advanced solid tumors. The trial’s first two cohorts evaluated MDNA11 doses ≤ 10 µg/kg. The trial’s third cohort was administered a dose of 30 µg/kg. Patients in the fourth and fifth dose escalation cohorts receive two 30 µg/kg “priming” doses of MDNA11 before stepping up to receive fixed doses of 60 and 90 µg/kg, respectively.

 

Key data from patients enrolled in the trial’s four initial dose escalation cohorts include:

 

Demographics:

-Patients enrolled in the study to date (N=14) have failed up to four lines of prior systemic therapy.
-11 of 14 patients have relapsed, were not tolerant to or did not respond to at least one prior immunotherapy with a checkpoint inhibitor.

 

Safety:

-MDNA11 treatment in Cohort 4 (comprised of two step-up doses of 30 µg/kg followed by fixed doses of 60 µg/kg every two weeks) was not associated with any dose-limiting toxicities.
-The Safety Review Committee approved dose escalation for Cohort 5 to the 90 µg/kg dose every two weeks following two priming doses at 30 µg/kg.
-Subsequent to the quarter end, the Safety Review Committee approved dose escalation for Cohort 6 to a target dose of 120 µg/kg dose every two weeks following three priming doses at 30, 60 and 90 µg/kg.
-Significant increases in eosinophil count from baseline have not been observed with MDNA11 treatment. Extremely high eosinophil count is associated with vascular leak syndrome which is a known side effect of high-dose recombinant human IL-2 (Proleukin®).

 

 

Pharmacokinetics:

-The pharmacokinetic data from the first three cohorts demonstrated similar trends following each of three repeat doses which suggests lack of immunogenicity or insignificant levels of anti-drug-antibodies.
-Dose dependent increase in the Cmax and Area Under the Curve were also observed.

 

 9

 

 

Pharmacodynamics:

-In addition to dose-dependent increases in lymphocyte counts and lymphocyte kinetics, MDNA11 preferentially expanded anti-cancer NK and CD8+ T cells without stimulating proliferation of pro-tumor Treg cells.

 

 

 

 10

 

 

 

Anti-tumor Activity: 

-Of the 14 evaluable patients with at least one on-treatment imaging scan, five patients achieved tumor control (defined as stable disease, partial response, or complete response as per RECIST 1.1) during the monotherapy dose-escalation portion of the MDNA11 ABILITY Study as follows:

 

1.Metastatic Leiomyosarcoma Stage IV (Dose Level 2 @ 10 µg/kg); stable disease.
2.Metastatic Melanoma Grade 4C (initially enrolled at Dose Level 2 @ 10 µg/kg Q2W with subsequent intra-patient dose escalations to Dose Level 3 @30 µg/kg and Dose Level 4 @60 µg/kg), stable disease.
3.Metastatic Sarcoma Stage IV (Dose Level 3 @ 30 µg/kg), stable disease
4.Pancreatic Ductal Adenocarcinoma (PDAC) Stage IV (Dose Level 4 @ 60 µg/kg following 2 priming doses of 30 µg/kg), confirmed partial response.
5.Non-clear cell 3L renal cell carcinoma patient (Dose Level 4 @ 60 µg/kg following 2 priming doses of 30 µg/kg), stable disease.

 

 

 

 11

 

 

 

On September 13, 2022 we announced that we had entered into a Clinical Trial Collaboration and Supply Agreement (“CTCSA”) with Merck (known as MSD outside the United States and Canada) to evaluate MDNA11 in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 (programmed death receptor-1) therapy, in the ongoing Phase 1/2 ABILITY Study. Under the terms of the CTCSA, Medicenna will sponsor the study and Merck will supply KEYTRUDA®. The two companies will establish a Joint Development Committee to optimally advance the study’s combination arm.

 

Medicenna anticipates completing the following upcoming milestones related to the MDNA11 ABILITY Study:

1)Initial PK/PD data from the ABILITY study’s fifth dose escalation cohort and updated anti-tumor activity data from the first four dose escalation cohorts are expected in calendar Q1 2023.
2)Early anti-tumor activity data from the ABILITY study’s sixth dose escalation cohort and single agent expansion phase (Phase 2) are expected in calendar Q3 2023.
3)Early anti-tumor activity data from the ABILITY study’s combination arm are expected in calendar Q4 2023.

 

There has been a slight delay to milestone number 2 due to the addition of Cohort 6 to the escalation portion of the study.

 

BiSKITsTM (Bi-functional SuperKine ImmunoTherapies) Platform

 

Our BiSKITsTM platform allows us to develop designer Superkines by fusing them to other proteins, antibodies, cytokines or other Superkines to combine two distinct but synergistic functions into one molecule: a BiSKITTM.

 

On April 8, 2022, we announced new preclinical data highlighting the potent anti-tumor efficacy of the next-generation BiSKIT, anti-PD1-MDNA109FEAA, in an electronic poster at the AACR Annual Meeting. BiSKITs can target cancers where other immunotherapies have failed to be effective. One example of this is MDNA223, an IL-2 Superkine fused to a checkpoint inhibitor (anti-PD1). MDNA223 is a BiSKIT designed to activate cancer killing immune cells via the IL-2 receptor while simultaneously preventing their exhaustion through the validated method of blocking PD-1 signaling. Combining these two functions into a single molecule allows us to simultaneously engage both of these important targets on the same immune cells (also known as cis-binding).

 

 12

 

On September 22, 2022, in vitro data presented at Cytokines 2022 demonstrated that MDNA223’s potency was similar to that of a control anti-PD1 antibody while displaying high-affinity for IL-2 receptor beta (IL-2Rβ) and no binding to IL-2 receptor alpha (IL-2Rα). This enhanced IL-2Rβ selectivity resulted in potent and preferential stimulation of anti-cancer CD8+ T cells over pro-tumor Treg cells. In vivo murine data showed MDNA223 exhibiting a prolonged pharmacodynamic response extending beyond the duration of pharmacokinetic exposure.

 

 

Data from murine tumor models of colon, skin and breast cancer using a mouse version of MDNA223 (i.e MDNA223m) showed dose-dependent and statistically significant improvements in efficacy compared to co-administration of the anti-PD-1 antibody and IL-2 super-agonist (MDNA19) at equivalent molar doses, demonstrating the advantage of exploiting the BiSKIT’s cis-binding potential. These data demonstrate the therapeutic synergy resulting from the BiSKIT’s ability to concurrently target PD1 and the IL-2 receptor on the same immune cells (cis-binding approach).

 

 

 

 

 

 

 

 

 

 

 

 13

 

 

 

Subsequent to the quarter end, on January 5, 2023, Medicenna announced that the USPTO has issued U.S. Patent No. 11,542,312 titled “IL-2 Superagonists in Combination with Anti-PD-1.” The patent provides IP protection for methods of treating cancer with an IL-2 Superkine such as MDNA11 and a PD1 (for example, pembrolizumab), PDL1 or CTLA-4 checkpoint inhibitor in combination, as planned in the on-going ABILITY Study, or as a single agent using our BiSKIT™ (Bifunctional SuperKine for ImmunoTherapy) platform. The patent’s term extends into at least 2039 without accounting for any potential extensions.

 

Medicenna’s IL-4 and IL-13 Superkines are engineered versions of wild type cytokines which possess enhanced affinity and selectivity for either the Type 1 or Type 2 IL4 receptors or dedicated IL13 receptors such as IL13Ra2. This selectivity is achieved through mutations of the IL-4 or IL-13 proteins to enhance affinity for binding to specific IL4R or IL13R subunits. Additional mutations have also been engineered to modulate their bioactivity, resulting in Superkines with enhanced signaling (super-agonists) or the ability to block signaling (super-antagonists).

 

On April 8, 2022, Medicenna announced new preclinical data on its long-acting IL-13 super-antagonist, Fc-MDNA413, in an electronic poster at the AACR Annual Meeting. Fc-MDNA413 is derived from Medicenna’s Superkine platform and comprises of an IL-13 super-antagonist (MDNA413) fused to the Fc domain for half-life extension.

 

On September 22, 2022, data presented at Cytokines 2022 showed that Fc-MDNA413 blocks the IL-4 and IL-13 pathways that polarize Tumor Associated Macrophages (“TAMs”) to the M2a phenotype and stimulate proliferation of Myeloid Derived Suppressor Cells (“MDSCs”). Both, TAMs and MDSCs that are known to promote cancer growth, especially in immunologically cold tumors. In vitro analyses showed that Fc- MDNA413 is 300-times more selective for IL-13Rα1 (over-expressed by TAMs and MDSCs) over IL-13Rα2 (a decoy receptor) compared to wild type Fc-IL13. This superior binding profile enabled Fc-MDNA413 to potently inhibit IL-4/IL-13 mediated functions as measured by blockade of pSTAT6 signaling, TF-1 cell proliferation, and M2a polarization of macrophages. In murine studies, Fc-MDNA413 demonstrated sustainable serum exposure at a dose that was well tolerated and inhibited tumor growth as a single agent in melanoma and colon cancer models. In addition, Fc-MDNA413 synergized with MDNA19 in a murine melanoma model, highlighting the advantages of co-targeting suppressive and effector immune cells within an otherwise cold tumor microenvironment.

 

Medicenna is currently screening and optimizing a variety of IL-2/IL-4/IL-13 Superkines as part of our BiSKITsTM platform with the goal of having a BiSKIT candidate IND-ready by the end of calendar year 2023.

 

 14

 

Bizaxofusp (formerly MDNA55)

 

Bizaxofusp has been studied in five clinical trials in 132 patients, including 112 patients with rGBM, suggesting potentially superior efficacy when compared to the current SOC. The Company has secured Orphan Drug Status from the FDA and the EMA as well as Fast Track Designation from the FDA.

 

A Phase 2b clinical trial with bizaxofusp was completed in a multi-center, open-label, single-arm study in patients with first or second recurrence or progression of GBM after surgery or radiotherapy ± adjuvant therapy or other experimental therapies. Subsequently, a separate blinded study that collected rGBM survival and prognostic data from 81 patients, that had contemporaneously received treatment at major clinical centres using current SOC, were used to establish a matched External Control Arm (“ECA”). The blinded survival data from the matched ECA (established by matching with the bizaxofusp treated population based on 11 different prognostic factors using propensity scoring methods) were then used as a control arm versus survival data from the Phase 2b bizaxofusp trial.

 

On September 29, 2020, Medicenna had an End of Phase 2 (EOP2) meeting with the FDA to discuss future development and commercialization of bizaxofusp, if approved for rGBM. On October 15, 2020, we announced that the FDA agreed that we could conduct an innovative open-label hybrid Phase 3 trial that allows use of a substantial number of patients (two-thirds) from a matched ECA to support marketing authorization of bizaxofusp for rGBM. Medicenna is pursuing strategic partnerships to assist with additional clinical development of bizaxofusp, as well as preparing the program for commercialization and its subsequent launch in various countries where marketing authorization has been granted.

 

In January 2023, the full results of a single-arm Phase 2b trial of bizaxofusp (recently named as per WHO International Non-proprietary Names) in patients with recurrent glioblastoma were published in the peer-reviewed journal Neuro-Oncology. Results showed the trial met its primary endpoint, with mOS in the primary and supportive analysis populations exceeding the trial’s pre-defined success criteria and the mOS historically achieved with currently approved therapies.

 

SELECTED FINANCIAL INFORMATION

 

All tabular amounts below are presented in thousands of Canadian dollars, except for per share amounts.

 

   Three months ended
December 31,
   Nine months ended
December 31,
 
   2022   2021   2022   2021 
   $   $   $   $ 
General and Administration   1,976    1,990    6,266    5,821 
Research and Development   2,945    2,907    7,718    13,525 
Change in fair value of warrant derivative   (3,747)   -    (5,547)   - 
Foreign exchange (gain) loss   307    (74)   (1,713)   85 
Net Loss   (1,141)   (4,807)   (6,192)   (19,371)
Basic and Diluted Loss per Share   (0.02)   (0.09)   (0.10)   (0.36)
Total Assets   38,174    26,107    38,174    26,107 
Total Liabilities   4,949    4,107    4,949    4,107 

 

We have not earned revenue in any of the previous fiscal years, other than income from interest earned on our cash and cash equivalents and marketable securities.

 

For the nine months ended December 31, 2022, we reported a net loss of $6.2 million ($0.10 loss per share), compared to a net loss $19.4 million ($0.36 loss per share) for the nine months ended December 31, 2021. The decrease in net loss for the nine-month period ended December 31, 2022, compared with the nine-month period ended December 31, 2021, was partially as a result of decreased research and development expenditures related to the MDNA11 program, where GMP manufacturing and IND-enabling studies were completed in the prior year. There was a foreign exchange gain of $1.7 million during the nine-month period ended December 31, 2022, compared to a loss of $0.1 million in the nine months ended December 31, 2021, as a result of gain on USD cash and cash equivalents. There was a non-cash change in the fair value of the warrant derivative (gain) of $3.7 million and $5.5 million for the three and nine months ended December 31, 2022, respectively. These reductions were offset by a reimbursement of $1.8 million under the grant from CPRIT in the period ended December 31, 2021 which offset R&D expenditures in the prior year period.

 

 15

 

For the three months ended December 31, 2022, we reported a net loss of $1.1 million ($0.02 loss per share), compared to a net loss of $4.8 million ($0.09 loss per share) for the three months ended December 31, 2021 respectively. The decrease in net loss for the three-month period ended December 31, 2022, compared with the three-month period ended December 31, 2021, was primarily due to non-cash change in the fair value of the warrant derivative (gain) of $3.7 million for the three months ended December 31, 2022.

 

Cash utilized in operating activities for the nine months ended December 31, 2022 was $10.4 million, compared to cash utilized in operating activities for the nine months ended December 31, 2021 of $20.7 million. The decrease in cash utilized in the nine months ended December 31, 2022 compared to the nine months ended December 31, 2021 is primarily the result of decreased research and development expenses, and unrealized foreign exchange gain.

 

RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDING DECEMBER 31, 2022

 

Research and Development (“R&D”) Expenses

 

   Three months ended
December 31,
   Nine months ended
December 31,
 
   2022   2021   2022   2021 
   $   $   $   $ 
Chemistry, manufacturing, and controls   146    173    686    6,588 
Regulatory   15    69    52    458 
Discovery and pre-clinical   295    522    1,166    2,822 
Clinical   1,221    934    2,752    1,956 
Salaries and benefits   780    751    1,839    2,061 
Licensing, patent legal fees and royalties   303    255    739    783 
Stock based compensation   156    194    452    511 
CPRIT grant claimed on eligible expenses   -    -    -    (1,753)
Other research and development expenses   29    9    32    99 
    2,945    2,907    7,718    13,525 

 

R&D expenses of $2.9 million and $7.7 million were incurred during the three and nine months ended December 31, 2022, respectively, compared with $2.9 million and $13.5 million incurred in the three and nine months ended December 31, 2021, respectively.

 

The decrease in R&D expenses during the nine months ended December 31, 2022 compared to the nine months ended December 31, 2021 is primarily attributable to:

 

·One-time higher chemistry, manufacturing and controls costs (“CMC”), associated with the first scale-up GLP and GMP manufacturing of MDNA11 required to supply adequate drug product for IND-enabling studies and the ABILITY Study, completed in the prior year period.
·Discovery and pre-clinical expenses associated with the one-time GLP compliant MDNA11 IND enabling studies, completed in prior year period.

 

 16

 

 

·Decrease in regulatory costs due to the preparation of regulatory filings necessary to initiate the MDNA11 ABILITY study incurred in the prior year period.
·Lower salary and benefits costs due to reduced headcount in the current year.

 

The above decreases were partially offset by an increase in clinical costs as more patients were enrolled in MDNA11 ABLILITY Study in the three and nine months ended December 31, 2022, and by the reimbursement of previously incurred expenses with respect to the CPRIT grant of $1.8 million in the nine months ended December 31, 2021.

 

The increase in R&D expenses during the three months ended December 31, 2022, compared to the three months ended December 31, 2021 is primarily attributable to higher clinical costs as additional patients enrolled in the MDNA11 ABILITY Study.

 

The above increases were partially offset by decreased discovery and pre-clinical expenses associated with the one-time GLP compliant MDNA11 IND enabling studies, decrease in regulatory costs due to the preparation of regulatory filings necessary to initiate the MDNA11 ABILITY study both completed in the prior year period.

 

General and Administrative (“G&A”) Expenses

 

   Three months ended
December 31,
   Nine months ended
December 31,
 
   2022   2021   2022   2021 
   $   $   $   $ 
Depreciation expense   2    10    4    30 
Stock based compensation   183    232    724    676 
Facilities and operations   149    109    422    291 
Public company expenses   1,213    1,351    3,587    4,116 
Transaction costs, warrant derivative   -    -    652    - 
Salaries and benefits   429    288    877    708 
    1,976    1,990    6,266    5,821 

 

G&A expenses of $2.0 million and $6.3 million were incurred during the three and nine months ended December 31, 2022, respectively, compared with $2.0 million and $5.8 million during the three and nine months ended December 31, 2021, respectively.

 

The increase in G&A expenses in the nine-month period ended December 31, 2022, compared to the nine-month period ended December 31, 2021, primarily relates to one-time transaction costs associated with the warrant derivative partially offset by a reduction in directors and officers liability insurance premiums.

 

The decrease in G&A expenses in the three-month period ended December 31, 2022, compared to the three-month period ended December 31, 2021, is primarily attributable to a reduction in directors and officers liability insurance premiums, partially offset by increased salary costs to support ongoing operations and finance expense on warrant amendment.

 

 17

 

SUMMARY OF QUARTERLY FINANCIAL RESULTS:

 

 

Dec. 31

2022

Sep. 30

2022

Jun. 30

2022

Mar. 31

2022

Dec. 31

2021

Sep. 30

2021

Jun. 30

2021

Mar. 31

2021

  $ $ $ $ $ $ $ $
Revenue - - - - - - - -
General and administration 1,976 2,371 1,919 1,936 1,990 1,964 1,867 2,009
Research and development 2,945 2,362 2,411 1,191 2,907 6,269 4,349 3,701
Change in fair value of warrant derivative (3,747) (1,800) - - - - - -
Net loss (1,141) (896) (4,155) (3,206) (4,807) (8,178) (6,386) (5,813)
Basic and diluted loss per share            (0.02)            (0.01)            (0.07)            (0.06)            (0.09)            (0.15)            (0.12)            (0.11)
Total assets   38,174   42,560   20,140   23,456   26,107   30,093   37,336   42,252
Total liabilities 4,949 8,644 2,147 2,621 2,351 5,431 4,958 4,107

 

R&D expenses fluctuate quarter over quarter based on activities ongoing during that period. The higher expenditures from the quarter ended March 31, 2021 through to the quarter ended September 30, 2021 are primarily related to one-time higher CMC costs, associated with the scale-up GLP and GMP manufacturing of MDNA11 which was predominantly completed in the quarter ended September 30, 2021. Refundable tax credits of $0.7 million contributed to a decrease in R&D expenses during the quarter ended March 31, 2022. R&D expenses increased in the quarter ended December 31, 2022, as activity in the MDNA11 ABILITY study expands.

 

G&A expenses have remained consistent quarter over quarter, with the exception of the quarter ended September 30, 2022, which saw an increase in expenses due to one-time transaction costs associated with a warrant derivative established as part of the August 2022 public offering.

 

There was a non-cash change in the fair value of the warrant derivative (gain) totalling $1.8 million in the quarter ended September 30, 2022, and $3.7 million in the quarter ended December 31, 2022.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Since inception, the Company has devoted its resources to funding R&D programs, including securing intellectual property rights and licenses, conducting discovery research, manufacturing drug supplies, initiating preclinical and clinical studies, submitting regulatory dossiers and providing administrative support to R&D activities, which has resulted in an accumulated deficit of $77.1 million as of December 31, 2022. With current revenues only consisting of interest earned on excess cash, cash equivalents and marketable securities, losses are expected to continue while the Company’s R&D programs are advanced.

 

We currently do not earn any revenues from our product candidates and are therefore considered to be in the development stage. As required, the Company will continue to finance its operations through the sale of equity or pursue non-dilutive funding sources available to the Company in the future. The continuation of our research and development activities for bizaxofusp, MDNA11 and the BiSKITsTM platform and the commercialization of bizaxofusp is dependent upon our ability to successfully finance and complete our research and development programs through a combination of equity financing and revenues from strategic partners. We have no current sources of revenues from strategic partners.

 

Management has forecasted that the Company’s current level of cash will be sufficient to execute its current planned expenditures for more than the next 12 months without further financing. The company’s cash is expected to fund operations into calendar Q2 of 2024.

 

 18

 

CASH POSITION

 

At December 31, 2022, we had a cash, cash equivalents and marketable securities balance of $36.2 million, compared to $20.5 million at March 31, 2022. We invest cash in excess of current operational requirements in highly rated and liquid instruments. Working capital at December 31, 2022 was $35.1 million (March 31, 2022 - $20.8 million).

 

On August 10, 2022, pursuant to an underwritten public offering, we sold 13,333,334 units at a purchase price of US$1.50 per unit for gross proceeds of US$20.0 million ($25.6 million). Each unit included one common share with a fair value of US$1.06 and one common share purchase warrant with a fair value of US$0.44. Each common share purchase warrant entitles the holder to purchase one common share at an exercise price of US$1.85 until August 9, 2027. We incurred transaction costs of $2.2 million (US$1.7 million) of which $1.6 million (US$1.2 million) were allocated to share issue costs and $0.6 million (US$0.5 million) were allocated to operating expenses, based on their relative fair values.

 

We do not expect to generate positive cash flow from operations for the foreseeable future due to additional R&D expenses, including expenses related to drug discovery, preclinical testing, clinical trials, chemistry, manufacturing and controls and operating expenses associated with supporting these activities. It is expected that negative cash flow from operations will continue until such time, if ever, that we receive marketing authorization to commercialize any of our product candidates under development and/or royalty or milestone revenue from any such products should they exceed our expenses.

 

CONTRACTUAL OBLIGATIONS

 

CPRIT Assistance

 

In February 2015, the Company received notice that it had been awarded a grant by the CPRIT whereby the Company was eligible to receive up to US$14.1 million on eligible expenditures over a three-year period related to the development of the Company’s Phase 2b clinical program for bizaxofusp. As of March 31, 2022, all of the US$14.1 million had been received and the grant with CPRIT is complete.

 

Under the terms of the grant, the Company is required to pay a royalty to CPRIT, comprised of 3-5% of revenues on net sales of bizaxofusp until aggregate royalty payments equal 400% of the grant funds received at which time the ongoing royalty will be 0.5% of revenues. At this time the royalty is not probable and therefore no liability has been recorded. In addition, the Company must maintain a presence in Texas for three years following completion of the grant.

 

Refundable tax credits

 

In June 2022, the company received $0.7 million through our Australian R&D incentive program relating to the year ended March 31, 2022. The amount receivable was recorded as a reduction in research and development expenses in the year ended March 31, 2022.

 

Intellectual Property

 

The Company has entered into various license agreements with respect to accessing patented technology. In order to maintain these agreements, the Company is obligated to pay certain costs based on timing or certain milestones within the agreements, the timing of which is uncertain. These costs include ongoing license fees, patent prosecution and maintenance costs, royalty and other milestone payments. As at December 31, 2022, the Company is obligated to pay the following:

 

·Given the current development plans and expected timelines of the Company it is assumed that project milestones of US$0.3 million will be due in the next five years.
·Project milestone payments, assuming continued success in the development programs, of uncertain timing totaling US$2.0 million and an additional US$2.0 million in sales milestones.

 

 19

 

As part of these license agreements, the Company has committed to make certain royalty payments based on net sales to the NIH and Stanford.

 

Future commitments

 

As of December 31, 2022, we have the following obligations to make future payments, representing contracts and other commitments that are known and committed:

 

  Payments Due by Period
 Contractual obligations Less than 1 year 1-3 years 3-5 years Total
Patent licensing costs, minimum annual royalties per license agreements $ 203 $ 1,232 $ 312 $ 1,747
         

 

The Company cannot reasonably estimate future royalties which may be due upon the marketing authorization of bizaxofusp or MDNA11.

 

As at the date of this report, we had obligations to make future payments, representing significant research and development and manufacturing contracts and other commitments that are known and committed in the amount of approximately $3.4 million, of which $2.4 million has been paid or accrued at December 31, 2022. Most of these agreements are cancellable by the Company with notice. These commitments include agreements for clinical contract research organizations, manufacturing, and preclinical studies.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

The Company has no material undisclosed off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our results of operations, financial condition, revenues or expenses, liquidity, capital expenditures or capital resources that is material to investors.

 

TRANSACTIONS WITH RELATED PARTIES

 

Key management personnel, which consists of the Company’s officers (Dr. Fahar Merchant, President and Chief Executive Officer, Ms. Elizabeth Williams, Chief Financial Officer, Ms. Rosemina Merchant, Chief Development Officer, Dr. Mann Muhsin, former Chief Medical Officer, and Dr. Kevin Moulder, former Chief Scientific Officer) and directors, received the following compensation for the following periods:

 

   Three months ended
December 31,
   Nine months ended
December 31,
 
   2022   2021   2022   2021 
   $   $   $   $ 
 Salaries and wages   331    511    836    1,272 
 Board fees   95    77    247    217 
 Stock option expense   261    349    972    895 
    687    937    2,055    2,384 

 

As at December 31, 2022, the Company had trade and other payables in the normal course of business, owing to directors and officers of $0.1 million (2021: $0.1 million) related to accrued bonuses, board fees and accrued vacation.

 

 20

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

The significant accounting policies of the Company are described in note 2 of the Annual Financial Statements and available on SEDAR at www.sedar.com and included in the Annual Report on Form 20-F filed on EDGAR at www.sec.gov.

 

Estimates and assumptions are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The determination of estimates requires the exercise of judgement based on various assumptions and other factors such as historical experience and current and expected economic conditions. Actual results could differ from those estimates. Critical judgements in applying the Company’s accounting policies are detailed in the Annual Financial Statements, filed on SEDAR at www.sedar.com and included in the Annual Report on Form 20-F filed on EDGAR at www.sec.gov.

 

FINANCIAL INSTRUMENTS

 

Financial instruments are defined as a contractual right or obligation to receive or deliver cash on another financial asset. The Company recognizes financial instruments based on their classification. Depending on the financial instrument’s classification, changes in subsequent measurements are recognized in net loss or other comprehensive loss.

 

A description of the financial instruments, their fair value and risk management is included in notes 2, 5 and 6 of the Annual Financial Statements, filed on SEDAR at www.sedar.com and included in the Annual Report on Form 20-F filed on EDGAR at www.sec.gov/edgar.

 

2020 Public Offering and USE OF PROCEEDS

 

The following table provides an update on the anticipated use of proceeds raised as part of the public offering of common shares of the Company which was completed on March 17, 2020 (the “2020 Public Offering”) along with amounts actually expended. Following completion of the 2020 Public Offering, Medicenna selected MDNA11 as its lead IL-2 candidate over MDNA19 to progress to the clinic and, as such, proceeds from the 2020 Public Offering, which were initially allocated to the development of MDNA19, have been re-directed to the development of MDNA11 in the same proportions. As of December 31, 2022, the following expenditures have been incurred (in thousands of Canadian dollars):

 

Item Amount to Spend Spent to Date Adjustments Remaining to Spend
Preclinical development $ 3,300 $ 3,300 - -
Manufacturing of clinical batch $ 4,400 $ 4,400 - -
Clinical development $ 13,150 $ 7,993 - $ 5,157
General corporate and working capital purposes $ 11,350 $ 11,350 - -
Total $ 32,200 $ 27,043 $ - $ 5,157

 

2022 Public Offering and USE OF PROCEEDS

 

The following table provides an update on the anticipated use of proceeds raised in the 2022 Public Offering along with amounts actually expended. As of December 31, 2022, the following expenditures have been incurred (in thousands of Canadian dollars):

 

Item Amount to Spend Spent to Date Adjustments Remaining to Spend
Phase 1/2 MDNA11 ABILITY Study US$ 8,000 - - US$ 8,000
Pre-clinical development of a BiSKIT candidate US$ 8,000 US$ 295 - US$ 7,705
Total US$ 16,000 US$ 295 $ - US$ 15,705

 

 21

 

ATM Facility

 

On December 30, 2020, the Company entered into the ATM Agreement with SVB Securities acting as sales agent, pursuant to which the Company may, from time to time sell, through ATM offerings, on the Nasdaq such number of common shares as would have an aggregate offering price of up to US$25.0 million. This agreement expired on December 30, 2022. During the nine-month period ended December 31, 2022, the Company issued 656,656 common shares, raising total gross proceeds of $1.0 million under the ATM Facility.

 

RISKS AND UNCERTAINTIES

 

The Company is an immunotherapy company that operates in a highly competitive industry that is dependent on a number of factors that include the Company’s capacity to raise additional funding on reasonable terms when necessary, secure partnerships for the development of its product candidates, obtain necessary regulatory approvals and achieve market acceptance, face disruption in availability of key components for ongoing clinical studies, obtain positive results from pre-clinical and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely on third party providers, protect its intellectual property, and face litigation risk in connection thereof. An investment in the Common Shares is subject to a number of risks and uncertainties, including the risks related to the Company being a foreign private issuer.

 

In addition, the Company may, from time to time, announce or publish preliminary or interim data from its clinical trials. Preliminary and interim data remains subject to audit and verification procedures that may result in the final data being materially different from the preliminary or interim data. Preliminary and interim results of a clinical trial are not necessarily predictive of final results. There can be no assurance that favorable interim or preliminary data will result in favorable final data. Preliminary and interim data are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues, patient data are further examined and reviewed, more patient data become available, and the Company prepares and issues its final clinical study report. As a result, preliminary and interim data should be viewed with caution until the final, complete data are available. Material adverse changes in the final data compared to the preliminary or interim data could significantly harm the Company’s business, prospects, financial condition and results of operations.

 

An investor should carefully consider these risks, as well as the risks described in the Company’s Annual Information Form and the Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission, as well as the other information filed with the securities regulators before investing in the Common Shares. If any of such described risks occur, or if others occur, the Company’s business, financial condition and the results of operations could be seriously harmed and investors could lose all or part of their investment.

 

There are important risks which management believes could impact the Company’s business. For information on risks and uncertainties, please also refer to the “Risk Factors” section of the Company’s most recent Annual Information Form filed on SEDAR at www.sedar.com and included in the Annual Report on Form 20-F filed on EDGAR at www.sec.gov/edgar.

 

DISCLOSURE CONTROLS AND INTERNAL CONTROL OVER FINANCIAL REPORTING

 

The Company has implemented a system of internal controls that it believes adequately protects the assets of the Company and is appropriate for the nature of its business and the size of its operations. The internal control system was designed to provide reasonable assurance that all transactions are accurately recorded, that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that our assets are safeguarded.

 

 22

 

These internal controls include disclosure controls and procedures designed to ensure that information required to be disclosed by the Company is accumulated and communicated as appropriate to allow timely decisions regarding required disclosure.

 

Internal control over financial reporting means a process designed by or under the supervision of the Chief Executive Officer and the Chief Financial Officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS as issued by the IASB.

 

The internal controls are not expected to prevent and detect all misstatements due to error or fraud. There were no changes in our internal control over financial reporting that occurred during the three and nine month period ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

As of December 31, 2022, the Company’s management has assessed the effectiveness of our internal control over financial reporting and disclosure controls and procedures using the Committee of Sponsoring Organizations of the Treadway Commission’s 2013 framework. Based on their evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that these controls and procedures are effective.

 

OTHER MD&A REQUIREMENTS

 

Outstanding Share Data

 

As at the date of this report, the Company has the following securities outstanding:

 

  Number
Common shares 69,637,469
Warrants 16,185,386
Stock options 5,755,353
Total 91,578,208

 

For a detailed summary of the outstanding securities convertible into, exercisable or exchangeable for voting or equity securities of Medicenna as at March 31, 2022, refer to notes 9, 10, and 11 of the Annual Financial Statements of the Company.

 

Additional information relating to the Company, including the Company’s Annual Information Form and the Annual Report on Form 20-F, is available under the Company’s profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov, respectively.

 

 

23

 

EX-99.3 4 exh_993.htm EXHIBIT 99.3

Exhibit 99.3 

 

FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE


I, Fahar Merchant, Chairman, President and Chief Executive Officer of Medicenna Therapeutics Corp. (“Medicenna”) certify the following:

1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Medicenna (the “issuer”) for the interim period ended December 31, 2022.

2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

 

A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

I.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

II.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

B.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.


5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (COSO 2013 Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

5.2 ICFR – material weakness relating to design: N/A

 

5.3 Limitation on scope of design: N/A


6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on October 1, 2022 and ended on December 31, 2022 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

Date: February 7, 2023

/s/ Fahar Merchant
Fahar Merchant

Chairman, President and Chief Executive Officer

 

 

 

 

EX-99.4 5 exh_994.htm EXHIBIT 99.4

Exhibit 99.4 

 

FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE


I, Elizabeth Williams, Chief Financial Officer of Medicenna Therapeutics Corp. (“Medicenna”) certify the following:

1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Medicenna (the “issuer”) for the interim period ended December 31, 2022.

2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

 

A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

I.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

II.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

B.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.


5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (COSO 2013 Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

5.2 ICFR – material weakness relating to design: N/A

 

5.3 Limitation on scope of design: N/A


6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on October 1, 2022 and ended on December 31, 2022 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

Date: February 7, 2023

/s/ Elizabeth Williams
Elizabeth Williams

Chief Financial Officer

 

 

 



EX-99.5 6 exh_995.htm EXHIBIT 99.5 EdgarFiling

Exhibit 99.5

Medicenna Reports Third Quarter Fiscal 2023 Financial Results and Operational Highlights

  • Phase 1/2 ABILITY study advancing to sixth dose escalation cohort following positive review of safety and pharmacodynamic data from fifth cohort

  • Initial PK/PD data from ABILITY’s fifth dose escalation cohort expected alongside updated anti-tumor data in calendar Q1 2023

  • $36.2 million in cash and cash equivalents at December 31, 2022 provides expected runway through the completion of the ABILITY study and through calendar Q2 2024

  • Management hosting conference call and webcast today at 8:30 am ET

TORONTO and HOUSTON, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunotherapy company, today announced its financial results and operational highlights for the quarter ended December 31, 2022, and that the Phase 1/2 ABILITY study of MDNA11 has advanced to a sixth dose escalation cohort. All dollar amounts are in Canadian currency unless otherwise noted.

“Encouraged with MDNA11’s tolerability profile in end-stage cancer patients together with its enduring trend demonstrating dose-dependent expansion of lymphocytes, we are pleased to advance the ABILITY study to the sixth dose escalation cohort,” said Dr. Fahar Merchant, President and CEO of Medicenna. “MDNA11 has thus far functioned as intended, by displaying durable tumor control with better tolerability upon repeat dosing, showing dose-dependent increase in exposure without immunogenicity, and boosting anti-cancer immune cell expansion without pro-tumoral immune suppression. With these attributes together with early signs of anti-tumor activity, we hope to bolster MDNA11’s efficacy in a select group of less advanced cancer patients at the optimum dose in ABILITY’s upcoming Phase 2 monotherapy dose expansion cohort.”

Program highlights for the quarter ended December 31, 2022, along with recent developments include:

MDNA11: IL-2 Superkine Program
Enrollment is complete in the fifth dose escalation cohort of the Phase 1/2 ABILITY study of MDNA11, with no dose-limiting toxicities, dose interruptions, dose de-escalations, or treatment discontinuations due to safety issues observed to date. Preliminary pharmacodynamic (PD) data showed enhanced stimulation of lymphocyte expansion relative to baseline in the fifth cohort compared to all prior dose escalation cohorts, demonstrating MDNA11’s ability to boost immune activity may be enhanced at higher doses. Based on these findings, the trial has advanced to a sixth dose escalation cohort. Participants in the sixth dose escalation cohort will receive 30, 60, and 90 µg/kg “priming” doses of MDNA11 followed by a further step-up to a fixed 120 µg/kg dose. MDNA11 is dosed intravenously every two weeks in the ABILITY study.

In November 2022, Medicenna presented safety, pharmacokinetic (PK), and PD data from the first four (low and mid) dose escalation cohorts of the ABILITY study at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting. Safety data indicated that MDNA11 was well tolerated with no dose limiting toxicities observed. PK data showed dose-dependent increases in exposure that were sustained with repeat dosing, suggesting there is no clinically meaningful anti-drug-antibody response to MDNA11. PD data showed dose-dependent stimulation of anti-cancer immunity, with MDNA11 preferentially stimulating the proliferation and expansion of anti-cancer CD8+ T and NK cells but not Tregs (associated with pro-tumor immune pathways) or eosinophils (associated with vascular leak syndrome, a known side effect of the only approved IL-2 therapy).

The results presented at the SITC meeting provide mechanistic support for previously reported anti-tumor activity data demonstrating MDNA11’s single-agent potential in advanced solid tumors unresponsive to established treatments. These data show that five of fourteen (36%) evaluable patients in the ABILITY study’s first four dose escalation cohorts achieved tumor control (partial response or stable disease), including one fourth-line metastatic pancreatic cancer patient who achieved a confirmed partial response.

In December 2022, previously reported data from the Phase 1/2 ABILITY study of MDNA11 were featured in an oral presentation at the 2022 Immunotherapy Bridge Conference. The presentation, titled “Early Results of an IL-2 Superkine (MDNA11) from the Phase 1/2 ABILITY Study in Advanced Solid Tumors was delivered by Arash Yavari, M.B.B.S., DPhil., M.R.C.P., Principal Investigator at the Radcliffe Department of Medicine, University of Oxford and Principal Clinical Advisor to Medicenna.

 

 

Bizaxofusp (formerly MDNA55): Empowered IL-4 Superkine Program
In January 2023, the full results of a single-arm Phase 2b trial of bizaxofusp (formerly MDNA55) in patients with recurrent glioblastoma were published in the peer-reviewed journal Neuro-Oncology. Results showed that the trial met its primary endpoint, with median overall survival (mOS) in the primary and supportive analysis populations exceeding the trial’s pre-defined success criteria. Medicenna continues to pursue potential partnership opportunities to facilitate bizaxofusp’s further development and, if approved, commercialization.

Intellectual Property
In January 2023, the U.S. Patent and Trademark Office issued U.S. Patent No. 11,542,312. The patent provides intellectual property protection for methods of treating cancer with an IL-2 Superkine and PD1/PDL1 or CTLA-4 checkpoint inhibitor, administered in combination or as a single agent BiSKIT™. The patent’s term extends into at least 2039 without accounting for any potential extensions.

Expected Upcoming Milestones

Initial PK/PD data from the ABILITY study’s fifth dose escalation cohort and updated anti-tumor activity data from the first four dose escalation cohorts are expected in calendar Q1 2023.

Early anti-tumor activity data from the ABILITY study’s sixth dose escalation cohort and single agent expansion phase (Phase 2) are expected in calendar Q3 2023.

Early anti-tumor activity data from the ABILITY study’s combination arm are expected in calendar Q4 2023.

Financial Results

Medicenna had cash and cash equivalents of $36.2 million at December 31, 2022. These funds are expected to provide the Company with sufficient capital to execute its current planned expenditures through the completion of the ABILITY study and through calendar Q2 2024 based on its current plans and projections.

Net loss for the quarter ended December 31, 2022, was $1.1 million, or ($0.02) per share, compared to a net loss of $4.8 million or ($0.09) per share for the quarter ended December 31, 2021. The decrease in net loss for the quarter ended December 31, 2022, compared with the quarter ended December 31, 2021, was primarily a result of a non-cash gain of $3.7 million related to the change in valuation of a non-cash warrant liability associated with the August 2022 financing.

Research and development expenses of $2.9 million were incurred during the quarter ended December 31, 2022, compared with $2.9 million incurred in the quarter ended December 31, 2021. Research and development expenses were consistent quarter over quarter.

General and administrative expenses of $2.0 million were incurred during the quarter ended December 31, 2022, compared with $2.0 million during the quarter ended December 31, 2021. General and administrative expenses were consistent quarter over quarter.

Medicenna’s condensed consolidated interim financial statements for the quarter ended December 31, 2022 and the related management’s discussion and analysis (MD&A) will be available on SEDAR at www.sedar.com and EDGAR at www.sec.gov.

Conference Call and Webcast
Medicenna will host a conference call and webcast today at 8:30 am ET. To access the call please dial 1-877-407-9716 from the United States or 1-201-493-6779 internationally and refer to conference ID: 13735304. To access the live webcast, visit this link to the event. Following the live webcast, an archived version of the call will be available on Medicenna’s website.

 

 

 

 

About Medicenna
Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna’s long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITs™ program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna’s IL-4 Empowered Superkine, bizaxofusp (formerly MDNA55), has been studied in 5 clinical trials including a Phase 2b trial for recurrent GBM, the most common and uniformly fatal form of brain cancer. Bizaxofusp has obtained Fast-Track and Orphan Drug status from the FDA and FDA/EMA, respectively.

Forward Looking Statements
This news release contains forward-looking statements within the meaning of applicable securities laws that relate to the future operations of the Company, plans and projections and other statements that are not historical facts including, but not limited to, statements related to the clinical potential, safety and tolerability profile and development of MDNA11, the clinical potential an development of bizaxofusp (formerly MDNA55) and partnering efforts in connection therewith, intellectual property protection, expected upcoming milestones and cash runway and planned expenditures. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expect”, “believe”, “seek”, “potentially” and similar expressions. and are subject to risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the risks detailed in the latest Annual Information Form and Annual Report on Form 20-F of the Company and in other filings made by the Company with the applicable securities regulators from time to time in Canada and the United States.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date hereof and except as required by law, we do not intend and do not assume any obligation to update or revise publicly any of the included forward-looking statements.

Further Information

For further information about the Company please contact:

Elizabeth Williams, Chief Financial Officer, 416-648-5555, ewilliams@medicenna.com  

Investor Contact

For more investor information, please contact:

Dan Ferry, Managing Director, LifeSci Advisors, 617-430-7576, daniel@lifesciadvisors.com

 

 

 

GRAPHIC 7 logo.jpg GRAPHIC begin 644 logo.jpg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end GRAPHIC 8 abilityschema.jpg GRAPHIC begin 644 abilityschema.jpg M_]C_X 02D9)1@ ! 0$ D "0 #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#'!T?_: P# 0 "$0,1 #\ O]$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 7"U;>ZC3]B=74T<4D@D:S9D!(P?00NZHARE_D M@_\ IV?O1C4F8I,PB?QJWGZ'0?[K^\GQJWGZ%0?[K^\NUR6PQ2V2M,D3'D5/ M%S0?S0IV:2F(P:>+_<".%*ZEJQ.Y7EKY5 ^=L=TH6QQN.#+ 2=GTM/5ZU8T4 ML<\+)8GA\;VAS7 [B#P*K?E+T_0TM#!=*2G9!*91%((VAH<""0<=HQ]J[')G M7/JM+NAD>7&FG=&W/4W (^TE&M.]HOLLB.JZVKBY19HXZJ9C!-!AK9" /$9U M*X52^K_]),_]-!^PQ6C==46:RRSGGG#8Y&EA)[!D8*[J/1%HGT(A( ))P!Q)4=K-!VJ.&IE8<32/R6-/S1@C)_ M[]&MR@ZMJZ.=UEH620NG@>>][6MLH:9Y0+E>M0TMNJ*6D9%-M9=&'!PPTGK)[%8JI+1/^D"C_I) M?V'J[47Z>TVKF1$1'=5W*9=ZCX8H[=232,,<>VX1N()^*)K'.<<^E51;?\ ^)^4XU!\:$5!ES_(C^3^IH]:MVI,PI93 M3M:Z<,/-AQP"[&[/FRCSZ4[K6NBNJM=TM@E=1T\7A-?G'M\WZE"7 M.!P]@('J1=*]HM-+)2B(CT"YNH+J+)8ZJX$-+HF>(UW!SCN:/: M0NDJWY5;ILQ45J8[>XF>0>8;F_\ -[$<]2VVLRTZ'E2N$E?3LJZ6C93ND:V5 MS&N!:TG>1ERM14CJ'3)M.F[-7[!#YV$3^9Q\9OKP2/\ 95H:-NGPMI:CG<[, ML;>9D[=IN[?Z1@^M'+1O;,UL[RA>M=85VFJVEAI(*>1LL9>XRAQ(.<;L$*:* MJN5?^%;?_0._:1TUK36F88?C5O/T.@_W7]Y&\JMWR-JBH2.L!KQ_S*?:6IH' M:5M;G01DFF9DE@W[EU7T%'*PLDI('M/$.C!",1IZDQG4>DNU6RCKJ?P M2>1P;&X.VF.)ZO,5-U2>OK-363436T3.:AGB$P8.##D@@>;=GUJV[!5/K=/V M^ID),DE.QSR>)=@9/M1=*]IF:V]P@M]Y1KI:[Y64,-+1NC@D+&N>UV2//ARY M_P :MY^AT'^Z_O*T;DT?!E6<#\2_J_DE5+R9 '5AR,_Y,_\ 6$<[[XO$;O:? M:*U)5:EM]3/50PQOBEV (@0", ]9*T=:ZPKM-5M+#204\C98R]QE#B0?H=!_NO[R?&K>?H5!_NO[RDW)K3PR:4VGPQN=X0_>YH)ZE+_!*;Z/%_N!%I M34M6)W('J36][L5?'&*.C=3SQ-EA>YK\D$;P?&X@_N4RLEVAO=GIZ^' $C?& M;\UPXCVKFZST^+]87QQ,!JH/PD&.L];?6/MPH)R;W\VZ[.M50[$%6?$S^;+U M>WAZ<(NZU-3%I\2MU<'5NHVZ;M'A#6L?4R.V(8W\">LG'4!^Y=XD 9)P%26I M[G/J[5;8*/,D0?S%,T<#OWN]9WY[,=B-ZU]M?'N4^T7J6[:E?42U5+314D0V M0^-K@7/[-Y/ @@WB-OC.Q\MW6?65T$;I$Q7S[%!M1\H] M-:ZB6CMT(JJF,[+I''$;3V;M[OL]*D^H*J2BT[<:F(D21T[RPCJ.-Q55O&]DS1@./8['$>?B/L1)T]2/,6R[]#74URHXZNDE;+!(,M-KMESF=1XX^U#,9PW$11ZNUQIZ@F=#+ M<&OD:<$1-+\>L#'VH3:(]RD*IW2-;52W118X)HZF".>%X?%(T/8X<"",@K(BM6XW&EM5#+65DHC MAC&2>WL [2JVN7*I6/G+;7111Q< ZH!<\^? ( ^U;/*Q5R!MMHP2(G;>UK6OLK.,(:.4;4L#@Z M5D!:=X$D! ^PA2W3?*)27>=E'71"DJGD-80[+'GLSU'S'VJ92PQ3Q.BFC9)& M[<6/:"#ZBH).&%O%\C@ CT,R*+OY0M-,DV/#W.WX+ MFPO(_4NQ;+[;+RPNM];%/CBT;G#TM.]&8O6?$2^=0NQQ:YM)*00<$' M8*@7)=5U-1]P:QM. M"YSC@ 9XE''4_P M5KHHU-K[34$QB-QVR#@NCB>YH]8&_P!2[%MN]OO$+I;? M51SL:<.V>+?2#O".T7K,XB6ZB+YDECAB=)*]K(VC+G.. !YRC3Z11JHU_ING MD,9N'.$'>8XW.'MQ@KH6O4EGO+MB@KHY9,9YLY:[V'!1F+UF<1+JHBT+E>K; M9^:^$*ME/SN=C;SXV,9_6$69B/,M]%S*K45HH[?%75%?$RFF&8W;R7CS ;S[ M%S:?7NFZF81-N 8XG ,L;FM/K(P/6B3>L>Y25%\&:(0\\9&0<$QQ/W@0B1:)G$2S(B(J%ZUUA7::K:6&D@I MY&RQE[C*'$@YQNP0HQ\:MY^AT'^Z_O+-RK_PK;_Z!W[2G&EJ:!VE;6YT$9)I MF9)8-^Y'E_';4FL3A ?C5O/T.@_W7]Y=&P\HETNM]HZ&:EHVQSR;+G,:[('F MRY6)X)3?1XO]P+UM- QPIG\S*BUZVMIK=2/JJN9L4#,;3W M6X_![*^(U8>8^:WY MVAQ'V(LS$>W41<^OOMJMC]BMKZ>!^,[#GC:QZ.*V:*MIKC2,JJ25LL$F=E[> M!P<'[04,QG#.BTKE>+?:(A)7U<4#3P#CO=Z -Y]2XC>4/33I-GPYP'SC _'Z MD2;UCQ,I0BUZ.NI;A3BHHZB.>(\'QNR%L(TI[5=;5Q3@*JN5/\J*?^IL_;>K4MG\%4?\ 0,_9"&G_ )+* MYY0OA\:BB-'X;X,(F\T:?;QM9.>'YV?LPK%M?A/P31^&9\*YAG/9^?LC/VK7 MN.H;3::AL%?71P2N:'AKLY(R1G["NBQ[9&->QP1Z<#=ZT)F(]NXBA];RB646JIFH*H25;&9BBDC*C-LU%KBL MKJ-[HJIU)+*S+FT(V"PD9.UL\,=>4&31U,Y\,;G; M=E-51FBJ'G#- MIVTQQ[-K=@^E2B:VT%1&6345/(P\6OB:1^I5AKW1L%HC;<[;&6TKG;,T6QPM&9O6)Q,I,BQP3Q5,+)H)62Q/&6O8X$$>8A9$:$ M7,NFH;39L"OK8X7$9#-[G$?ZHR5RX>4#34T@9X>6$G +XG@>W&[UHS-ZQ.)E M)T6.&>*IA9-!*R6)XRU[' @CS$+(C0N;?[A+:K%65T+6.D@CVFM?G!.>O"Z2 MX6LOR/N?]#^\(S:<5F7+T3JVMU+-6,JX((^8:TM,0(SG/')/8IBJOY)O\[NG M]''^MRM!&-&TVI$R(B(ZB+A7#65@MDSH:BX,,K3@LC:7D'L. <+XH=;:>N$H MBAN+&R.W!LK2S/K(PC.^N<92!$7*JM2V:BK74=3<(HJAI ,;LY!.\=7G"+,Q M'MU41$41O)9(=&5\D3W, M>.;PYIP1^$;UJ2*,\H/Y$7#_ -O_ (C434_)/\./R6U,]1;;AS\TDNS,W&VX MNQN\ZGRKWDH_@VX_TS?U*PD9T?\ ' B)P1U8*RLI[?22557*V*",9<]W4J[? MRD72X784MDM<4K7G9C;*'%[O.<$ #]7:N+JV_P!3JN^QVVW[3Z5DG-PL:?QK M^&V?W=@]:L72NEJ;3=!LC9DK)!^&FQQ_DCS#[4>??;4MBOB(=:WFM-#&;B(! M5$9>( =@>89*VD1'H@1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$ M0%$.4O\ )!_].S]ZEZB'*7^2#_Z=G[T<]7\DN3R85U)2V6L;454$+C49 DD# M21LCM4X-XM@&3<:3].W[U3FFM&5.I:.:IAJXH1%)S9#VDYW ]7I7;^*BO\I4 MW^XY'#3OJ16(BK-RD:EH*^B@ME#4,J'-E$LKXSEHP" ,\#QZNQ=[DUH)*/2W M.RL+75,QE;GB6X 'ZB?6N=:^2RF@G;+/(V)P&R3QR2#D^Q1G5_\ I)G_ *:#]ABNA&-.E;7MGM36L=$]'(HZRDGD MFI'.V#M@;3'=62-Q!]2GN@;Q+>-,L-0XNFIGF!SB4)@=HFO M)&]IC(_2-'[UQ.2@GX-N(SNYYOZD6M8IK8CU+H\H<-ZJ+-'%;&/? YV*EL62 M]PZA@<6]OJZES+/R74HI&27>>9U0X9,4+@&L\V<')4VNMWH;+1FJKYQ%'G Z MRX]@'65"ZCE7H6/(IK942M[9) S/LRC5XTXMF\N-K#045DMYN-OGED@8X"6. M7!+I=7E+NU1;[%%34[BP MU;RQ[Q\P#>/7D>K*X6D- 45UL\5RN,TI$V>;BB<&@ '&2<>8J5:[T_/?K&T4 M@#JFG?SC&?/&,%H\_P!RKVR:SN^EHS;IJ820QN/X"=I:Z,G>0#U>L(NIB-3- M_207WDPB92OGLLTKI6C/,3$';]!W8/I4LTA;KE:[!%3W2HYV4;VLX\TWJ;GK M_=P4>H>52WS/#:VAGI@?SV.$@'IX%3FDJZ>NI8ZFEF;+!(,M>TY!1TTXTYMN MH@W*1J::@BCM%'(62SLVYGM.\,X!H]._U#SKG:9Y-HZV@CK;O-*SG6A\<$1# M2 >&T2.OL"CVN*CG-;USI!MLC>QNSG&X-&[]:DGQM.\BCZS_ ($<=U)U)F[W M4?)K!36^2KM$LSGQ-+W02D.V@/FD#CYM^5FY-=2S5.W9:N0O,;-NG:(B/:U:BW M4=74T]344TF:^J!P\1%C#_*=XH^TY785=\JMQV*&AMS3OE>9G MCS-&!]I/L1TU;;:3+#R4V[=7W)P[(&'_ /)W_*K*7 T7;O@W2=#$1B21G//] M+M_ZL#U+OH:5=M(@1%#-9ZVBLD;Z&@(A':?/V#V^[&!Z@/M4VT/;I+;I.CBF;LRR RN'9M'(^S"@FB=(3 M7JL%WNC7&C#R]HDWF=V>)_DYX]OM5N(XZ,3:TZD_<1$1Z!4O4$ZOY1M@>-3O MGV1VS>?4JKT5?K9IZOJ*ROBJ) M)'1B.+F6M. 3EQ.2.P?:CS:]HFT5GTM35MK%VTQ64K6YD:SG(@/G-W@#TXQZ MU".2NZ[Q96\]&#\X;C[01_NKM_&G8_HUP_1L[ZKJDNU/;M7,N="V1 ME*RI+VL> '",G>W<3U$A&=34KOBU97XJJY5_X5M_] []I6HUS7M#FD%I&01U MA57RK_PK;_Z!W[2.GU'^.7;T_KC3]#I^@I:BL<9W49K.MB,1"&W.6OU_J824%)(V$-;$PN&Z-@.L 8_(\Q5I:;O3;_8X* M\-#'N!;(P?FO&X^KK]:&AXM,6]MVY?P75_T+_P!DJI>3'\K#_5G_ *PK:N7\ M%U?]"_\ 9*J7DQ_*P_U9_P"L(NK_ )*KC55?S'C@?^^K*&K3?7""7C7C:O0\,<4@%RJ@89PWBP#Y3O-M M C'I/8LO)EI[8C??*AGC.S'3 C@.#G?N]J@=FM+KIJ"GM;GAADEV'N[ ,EV/ M4"K_ *>GBI*:*G@8&11-#&-'4!N".&CG4MOM]F5$1'K:]=2LKK?4TCSAD\3H MR>P$8_>J2AENVA=1./-[,C,L(>#L3,\W:.!5ZK5K[;17.#F:ZEBJ(^($C_:3NNDY8ZQLVW"'@1U,)+2 MUW5D<04IMOI[D&T;HVDU+05%1454T3H MI=@",#!& >M6C8K-#8;5'002/D8PN=M/QDY.>I1/DI_@6N_K'_*%/D30I6*Q M;[J7O?\ I0/]>A_6U70J7O?^E _UZ'];5=")H>[?RBG*-^1M3_21_M!B: ME(K>N.T[Y1K5\(:8?.QN9:-PE';L\'?9O]2Y_);=.?M%1;7N\>F?ML'\AW_4 M'VJ=S0LJ()(96[4]O?JSE"\%B<3$9A3L(ZF-^41_^15I:FNGP/IVMK0<2-CV8_\ 7.X? M:<^I0'DLM?/5]7=9&Y;"WFHR?G.WD^H?M(:WXK11:4<;(HF1QM#6, :T#J X M+Z1$>A#>433]1>;3#4TC#)/1EQYMHR7M=C./., X]*AFE]>5.GJ<4%53FHI& MN.R,[+X\\0.T9ZOM5RKBW72=EO+G25=$SGG<9H_$?Z21Q]>4<+Z5MV^D^6A0 M\H6G:W9#JI],\_FSL(^T9'VJ30S15$398)62QNWM>QP<#ZPJZN/)3$6EUMN+ MVNZF5#00?]H8Q[%%+=<;MHB_F&8/8&N'/T^GT$*YD1NVA28\>'$N MTL\VB:^6I@YB=UOD,D60=EW-G(R%4.EK977RMEM=)/S$4S ZI?V,:>SKWD;E M-K9W-EC/WCV'T*]54'*DP-U3 0-[J1A/^\\?N1-;3K2N MZOA;P(O@6^1W1]/X2]FT=DOVL?;E1?E:XVC_ -[_ )%BY)I7"JN<6?%+(W8\X)^]9>5K MC:/_ 'O^1&[6FVAF?]\M/3.BY=36^"ONE9+'2-;S5/%%C:V6DC.3D 9SU;]Z MR:HY.H+9:I:^V5$[Q -N2*;!);UD$ <.*FVC/R/MG]#^\KHW9H?9JYCAD.IY M ?\ =*-1HUFG[J;L4MWU!30Z7@J=BE=(97N<2=E@XCSC._':5-?BKM'@^SX; M6\]CY>6XS_JXX>M1SDK_ "GJ?ZF[]MBMY&='3K:N;>5%,-;HC5P:YVTZG>-K M9W"6,_>/8?0KTSEN6X.[/-C+2#P;'VC]77O4BFY+K*Z LBJ*R.7&YY> MUV_SC'W+C#B\ Y +G%V/5E=E$=:Z45M-H^XB(CHJKE7_A6W_P! []I2'3NL M;!1Z=M]-47%D) MLA:UK< D(\>;QJVVI;TZTUY5C_1O^Y;EMU+9[O4FGH*YDTP:7EH:X;AU[QYU M%/BHM_E&J_W6KK:=T-2:=N1K8*N:5YC,>R\ #!(/5Z$=JSJY\Q&&3E!_(BX? M^W_Q&JM])6&MU,)J%M2:>WQ/$LY SM.(PT8ZSN/H5D"SQYW')P#ZC@Y[/2KL5+:M CY2)]C=^'A=ZRUA1-:D4Q:JZ50]=45- M+KJMFHFEU4VOE$0 R2XO(&[KWE7PJ6H0#RJ.R,_^9R?MN1KZCSM_EUJ;DON5 M:#47*YLBGD.T\!AE=D]IR-ZF$;8M#Z++9)O"!2-=LNV=CG'.>2!C)QO=A2-0 M7E4FIZFJJ2UC<&:9PSC/!K1^[ MJ4RDY*[.8"V.LK6RXW/9E24K&[&YK4MG\%4?] S] MD(Q6D6U+95?JWD^CLUN=<;=/++#'CG8Y<%P!.,@@#=ZE(.3&\S5UIJ*"=Q<: M,MYMQ.3L.SN]1!]H4FU*P/TM=@X;O!)3[&DJON2@GX5N SNYAO[2+MBFK&W[ MI/RA7V:SV)L-,XLGJW&,/!P6M \8CS[P/6HMHO0M+>K=\)W*20Q2.(BBC=C( M!P23Z<^Q=GE3H9)[/1UC&ES::4M?CJ#@-_M 'K7WR=ZAH'6"*V35,<-33N< MV1P;MM+B[(SQXX]2%HBVMBWIH:JY/*"CM$]?:W2QOIVE[XGNVFN:..#Q!PMG MDQOLU72SVFH=M>#-#X7'CL$X+?4<8]*[&LM16^AT_64XJHI*FHB=$R)C@YWC M#&3V 948Y*;?-X577%S2(>;$+7'\XD@G'HP/:AB*ZL11:"(B/4KWE7_@VW?T MSOU+K\G/Y&4O]))^T5R.5?\ @VW?TSOU+K\G/Y&4O]))^T4>>/\ //\ "5KE M:FA;4:7ND;QD>"R.'I#21]H"ZJYNH7!FFKHX\!22_L%'>WJ5:\E<[F:AJH,^ M))3%Q'G#FX_65+]>ZDDL5I9#2OV:RJ):QPXL:.+O3O 'I\RAG)=&7ZHF?CIH6\CM70IM\PJ30>H*JSWL6.N+A!+(8PQY_$RYZO2=V.TJR-0W"2U:?KJV M(9EBB)9D9PX[@?:54NN,T6O*N6(X1SLGB?0TGSC&?M4)I*V^Z#NDK##L;>Y[)6DQR@<"#U^D=JE-)RL1$@5 MEJ>T=;H90[["!^M'/3G2B,7]M_06G;W8YJOPZ41TI):VG!V@]P_/'8/U]?!= MO5]^Z/6&2ICP:F0\W #\X]?J&2MRS7ZWWZF,]!/MANY[",.8?.%!.5F9W.VN M#/BALCR.T^*$=K3&GI?A2VU24 MKA15%3#4 >*Z1PWNL>H95PM9?D?<_ MZ']X7=7"UE^1]S_H?WA'>_Y90SDF_P [NG]''^MRM!5?R3?YW=/Z./\ 6Y6@ MCG]/_C@4 Y2-334$4=HHY"R6=FW,]IWAG -'IW^H>=3]4=KBHYS6]&T2.OL"R:CY-8* M:WR5=HEF<^)I>Z"4AVT!\T@^,; =(X;.> +2,?:K4UG:_A;2U9"UN98V\]'_K-W_:,CUH4SJ:, MQTS:4NGPQIJBJG.S+L;$O;MMW'VXSZUM7JXMM%EJZ]V/P,93:.MH(ZV[S2LYUH?'!$0T@'AM$CK[ LFH^36"FM\E7:) M9G/B:7N@E(=M ?-(''S;\KSXVG>11]9_P+WXVG>11]:_P(?\&W#-R:ZEFJ=N MRU8V;=.YQW[(XM]7$>M2#E!_(BX?^W_Q&JLM%3;&MK>^,; =(X;.> +2, M?:K-Y0?R(N'_ +?_ !&HUIVF=&<_;+A\E'\&W'^F;^I6$J]Y*/X-N/\ 3-_4 MK"1UT/\ ' HQKVZNM6EI^;<6S5)$#".K.TA<;9IZ.>\5S735.>:I868VN'C.\PW@9]/%=D\K%3SF6VF(,[# M,2?;C]R^^3[2-%74/PO<86SASRV")^]N!N)(Z]^['F4[J-.V:J@,,MKI"PC& MZ%K2/01O'J1PTZ:FR,3AR]-ZWMVH9?!@UU-68R(9#D.[=D]?V*3JB]26J326 MJ VCE< W9J*=^=X&3@'T$$*Z;96"XVJDK0,<_"R3'82,X1UTM2;9K;W#;1$1 MV$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0%$.4O\ )!_].S]ZEZBO M*#25-;I9\-+3RSR\\P[$3"YV/0$8U?R2YG)3_ =;_6?^4*>J$\FE#5T%FK(Z MREGIWNJ,ALT982-D;]ZFR)H_D@1$1T4OJ_\ TDS_ --!^PQ70JDU39[I4CZ^"FADFF=S>S'&TN<<2-)P!YEQN3*WUM!;Z]M923TSGRM M+1-&6$[NK*+:)^:)_9&>4^JFEU-'3N)YJ&!NPWJRP.<\D9SDKB:_TC4WKFKC;V\Y51,YM\6<;;-Y&/."3Z<^91.@U5 MJNQTS*$TTCF,&S&VIIW;31V#@4<\Q34F;1[3W6T%%3:0N#^8A8XL#6D, .2X M<%'>27Y-W],/_.M>EL^I=;2F:]ODIJ)C'&)CF; +R"&D-X\=^3U;@N79Z35^ MFKBZ"EH:IC)9&"8LIN=:X G\[!W;SP*)-IWQ?'A;5QNM#:8&S5]3'!&YP:"\ M\3Y@ONHHJ*X1-\)IJ>IC(R.<8'C'FRHUK;1[M1Q1U-++L5L+=EK7GQ7MXX\Q M\_M\T&H[OJ_2K?!#3S\RSY,<\)>P?ZI'5Z#A'6^I-;8M'A*=:Z-L\5BJ;C1T M[:2> !_X,X:\9 P1P'J6'DHJ97T-RIG%QBBD8]@/ %P.K;AJ[6 91F MDEYAQ!V(X2R,GMC=G\'D>'U,KN$M1$1W$41UU6:@I(J'X"94N+B_GN8@YSAC&=QQQ*AGPQR@_P 5=/J/^!'& MVM%9QB6GHG_2!1_TDO[#U=JH6BMFIK?7,K:6UW*.I826R>".)&00>+>PE=GX M8Y0?XJZ?4?\ CAHZFRN)B5PJG=2N.I.4=M"PDQME93#'4T?+]AVE9=)7STF MDHJ^XAXJ(J02S![=EVT&Y((ZCGJ5>ULM:&M#6@ 8 '4O46M<1(;75B':YTPOV-CCG9.,>='H0O6FNVVX26VU2! M]9\F68;Q%YAVN_5Z5QM'Z%DN;VW6]-?X.X[;(7D[4QX[3O-^OT<8K%8K_#,R M9EFK]MCMH%U(YPSZ"W!7?^&.4'^*NGU'_ CP[]UMUXE<#&-C8UC&AK6C :!@ M =B]5/?#'*#_ !5T^H_X%+-#5NI*NIK!?65;6-8WFN?I^;WY.<;AE'HKK1:< M8E-41$=E7\JMTVZBCM3';F SR#SG^JEC$CSSKF MXSO P#U A1FILUVU'KATU5;:V*EGJ<%\D#FM;$WSD8^2/:KB & . 1YM. MN^\VM"*_%UIKZ%)^G?\ >H9K_2E'8HJ.JMT3HX)'&.0%Y=AW$'K1O4TJS6<0U=!W3X3TI3;3LRTWX!_^SP_ M_'"A_*O_ K;_P"@=^TMKDU@NMLN-52UENK(*>>,/#Y8'-:'M\Y'6"?8%[RF M6NX5]RH7T=#4U+6PN#C#$YX!SUX".=IFVBF6E/R3M7]69^I=A4Q2UVNZ*EBI MJ>GN;(8FAK&BB)P!Z6K*Z[;S&'Q <]> CIK3NTLPF6 ME/R3M7]69^I=A4Q2UVNZ*EBIJ>GN;(8FAK&BB)P!Z6K-\,L-];4M>U[1%S\/-G&#G&X9ZE#;M<- M<5K:NBEI:^2DD6"7GWG8E86NQNWX*E:&E^2!$1'126DO M](=+_3R_LN5VJH-+V:Z4^NZ>HFMM9' )I"9'P.#0"UV-Y&%;Z//]-$Q6<]B( MB/0U;A<:6U44E763-BA8-[CU^8#K/F7-T[JJ@U)%(:8NCFC)VH9"-K9ZG>C] M2Z5RMU+=J"6BK(Q)#(,$=8/41V$*I;KH>^Z?K?"K9SU1$P[4LYB,PN113E$JX*?2%3#*YO.5#F,B:>)(<"?8 5!6ZTUA SF7F0N&X& M2E&U^I88['JK5][:<&T?. GAQ+2K6TW/<*G3U)-=&O;6N#N=$D>P[Y1QEN!C=A$T+ M^-N/2J=5.\ Y1IYY/DLJ(I<^;#2KJ8]LC&O8X.:X9!' A037^CZB[N9<[=&' MU+&;,L6<&1HX$><;_2HC;]2:MLD+*!D=1LM&&13TY):.P9&<>9'.+?%>D9&.=ATLS&M':0<_J!6CR5?P#6_UG_E:HW<;+JB^VJ:[W1E5)(S9; M34S8_&.2,D, W#'FR?4I9R:4-7066KCK*6>G>ZHV@V:,L)&R-^"BUF;:L6PA MG*+324FLI:C! G9'*P^@!OZVJW[=70W.W4];3N#HIF!P(^T>H[EQ-8Z7;J2W M-$3FLK8,F%[N!SQ:?,56=+5:JTA*^"..I@83OC?%MQD]HXCUA#,Z5YF8\2NZ M21D4;I)'!K&@NNG3NUAK1[:2I=)36\G M\,_FN;:1^MQ\W!8='V*Y4.N::26W5D5-&^4<[)"X-QL. WD8[$2]YO:LQ'C* MWE5'*A;#37>FND0(%0S8>1U/;P/LQ[%:ZCNN+7\*Z5JF-;F6 <_'Z6\?LR$= MM:NZDP@NM]2_"UALL#'#:FB%1.!\X9;CVA_V*?Z.M7P1IBC@=245(X%T0?MR \-AN\CU\/6K\1RT,VF;R(B(]2/ZAUA;=. MR10U!=+.\C,46\L;\X_=UKM4M7!74L=332MEAD&TU[3D$*.ZNT;!J2(3Q.;! M7QC#9"-SQ\UWW]2KJ*GU?I&9S8(JN%A.3L-YR)WGZQ^]'"VI:EO,>%VJG.4V MK@J=4,CAV&*%KN2C^%;A_0-_:4^N=O93Z0K;?10DM; M12111L&2?$( ':2H9R9VNX4%RKGUE#4TS70@-,T+F G/5D(7B?DJLI5#RJ?E M/3?U-O[;U;RJWE)M-RK]14\M';ZJHC%(UI?#"YX!VW[L@<=X1?J(S18UN:'V M:D8[@ZG8#_NA4[I:1EAUS'!7X:QLCZ>0O&X$Y /HSA7+;F.CME(Q[2US86 @ MC>#@*%ZXT/)=IC<[8UIJ\8EA)QSF.!![>KS_ *R:M)F(M'N$X\&@_B8_]T+4 MN=5;[1;Y:VK9&R&,9.& DGJ \ZJFEU/J^Q1MHY(YRUFYK*FG)(]?$^U'TFKM M:U48J8YA"T[G2,YJ)GGQU_:42=>)C%8\K9ME;07&D;5V^2*2)_YS!@CS$=1\ MQ4!Y6N-H_P#>_P"13;3UCI]/6F.A@.V0=J20C!>X\3^[U*)TM>H@)$K*(;)'$>*!GU<5"N4BTW*NU'#+26^JJ(Q2 MM:7PPN> =IV[(''>K%;1LJK$VBJ6N#):812-X$ MP?6C-(G?=57)U9*&\7:I M?71MF;3QAS8G<'$GB1UX_>K99;*"-NS'0TS1V-B:/W*GYK)J31MW-111S.:, MAD\+-MKV=CAOQZ#ZNU=!NK]:7<>"T=*6O=NVX:<@CUG('I1C2O%(VVCRY>OS M -8U#(&L:UC6-(8, '9&?UJ[E3M\T!=J*DI:J%DE;4/:35"/QW!Y).1UD8./ M2/.ISHFNOU=2U9OL<[)&O;S7/4_-$C&_ P,HUI3,7F)CVD-174=&6BIJH("[ MY(ED#<^C*S@AS0YI!!&01UJF^4.AKW:NGF,$SX9&,YEP:2,!H! ]>=WG5C:* MIZJETC00UC'LF#7'9?Q:TN):#ZL(ZTU)M>:X].^B(CJJKE7_ (5M_P#0._:4 M]TI^2=J_JS/U*&\IEKN%?YL MAB:&L:*(G 'I:CR;]FK,S"YT5/?#'*#_ !5T^H_X%TM/7/6LU_HH[A'9<;DSH*R@M]>VLI)Z9SI6EHFC+"1CJR$2T?\ M-$_LG2I?6/\ I)G_ *:#]ABNA5)JJSW2IY0)JF"W5,#MC9+G8. M<8QYT37C,U_E;:AO*91/JM+"9@)--,V1V/FD%I_6%,ECJ((JJGDIYV!\4C2Q M[3P(/$([7KNK,(-R67"*6RU- 7CGH9C(&_R' ;_:#]BGJIZZZ0ONE[F:VS&> M6!IS'+ ,O:.QS1Q_45X[6VL)X_!V->)#NVF4OC_J_V(.V^:F.9)7?RL\!Z=Y5J(UI5F;3>?NI?5_P#I)G_IH/V&*Z%5>N]- M78ZE==J"EEJ(Y0QV86;;F.: -[>/4"I'HBX:DKI:T7Z.H8QC6'8LVB:_5,UU%-=X:J.ACIR&\[2\E'\+7#^@'[2L2_QR3:=N<43'/D?2 M2M:QHR7$L. !UE07DSM=PH+G7/K*&IIFNA :9HG,!.UU9"%XGY:I=JV]TEDL M'KRI=RDQ M4,^GV,J:R.GJ&/YR!K@29" 06X&_KX^A0"TLU?%0L=:VW(4KM[.;#M@^<#@C M&K,3J8M&82RAY*863-?77)TL8.^.*/9SZR3^I3ZBHJ:W4<=)20MB@C&&L;U* MI#/R@1C:Q=CC_P#ED_9A;5CY0[K0W%E+?#SL&UL2.?'LR1>?0,=>%#K?/K>UTC:2BI+G# TDA@HB<9WGBU'DM;9JS,PNM03E'U%%1VMUH@ MD:ZIJ=TH!WQLX[_.?U947?7XUM4*B]N,$.U MM.9M[4DGK'#T\46VI:\;:0Z_);:GP6^JN;EAYO/\II)_4X*U(((J6GC@@8(XHVAK&-X #@%SM0V*GU#:9**<[) MSM1R 9+'#@?^^U&[:7_'LA\:6N$5RTS03QO#B(6QR>9[0 1[0NPJ6;1ZLT55 M2>#LG$3CO=$SG(G^?AN/IP5]U.H]8:@C-'''/L/W.;30%N1YSQQZ\(S&OB,3 M'EK7IS=21L<3!M.>\X 'G*AF MB-$OLCOA&XAIKG-V61@Y$0/'?VGS?O4BU%8XM0VB2AED=&20]CV_FN'#(ZQY MD:TJVK$VGW+9I:J@O= V>!T552R<"6Y!](/[URKEHFP7&%[/ (J>0CQ9*=NP M6GMP-Q]85<,HM6Z+K'FFCFYHG>Z)G.12>"MBHUAJ^[0.I8:5[-L;+C3 M4SMH@^??CU(Q.M68Q>OEAY/Y9:+6[*5CRYD@DB?L\'!H)!]K5(>5>B>^DMU: MT$MC>^)Y[-H C]DK9T%HVILTS[G<'>BTTYG2FLH]H"JI+AI6GCV(W3TV8I06C(WDC[,?:I1X-!_ M$Q_[H5.U%AU-HVXNJ* 3/C&X3T[=IKF_RF[\>OU+,_66L:Z+P>&*0/.XN@I3 MMG[#CU(E=;;&VT>5C_#=C%\=9W20MK !XKF@ D_F@]O#=YUVN P%6VCM"5<= MP9=KVW9>QVW' X[3G.X[3C]N..>*LE';3FTQFT8%PM9?D?<_Z']X7=7&U9!+ M4Z5N,,$3Y97Q8:QC2YSCD< $:O\ EE".2;_.[I_1Q_KRW9Z\G9W*8:MTO%J6W-8US8Z MN'+H9"-WG:?,=R-W_P"6GB/3JT3Z*X44-73,B?#,P/8=D<"LY@IVM+G11 9 M)+1N5-4\VKM'2/@9%41Q$Y+71\Y$?.#O'L66JO&L=4,\";!/S3]SF0PEC7?Z MSCU>DX1(UXQYCRLVS7NS7ITGP?)$Z2)Q!;LAKL9QM =8\Z["B6BM']'87U-4 MYKZ^9N';.\1M^:#U^<^92U':DVFOXO:EFMZ(\HX'R((ZCU!P #]K2KG4>U;I>+4MN:QKFQU<.70R$;O.T^ M8[D>G6I-ZXAU:)]%<**&KIF1/AF8'L.R.!6;5VCI M'P,BJ(XB!-@GYI^YS(82QKO\ 6<>KTG".<:\8 M\QY6;9KW9KTZ3X/DB=)$X@MV0UV,XV@.L>=:/*#^1%P_]O\ XC5@T5H_H["^ MIJG-?7S-P[9WB-OS0>OSGS+K:GME&="WX=N/3[5>\JU&^2VV^L:"6PRN8['5M =W[582U+G;J>[6Z>AJF[44 MS<''$'J(\X.]'34KNK,(WR;UT53I.*G8X<[2O>Q[>L9<7 _;]BEZIBIT]J;1 M]Q=46_GWQCA/3MVFN;_*;O\ MW+V36&L:V,TT9F#G#9/,TV'GT8&1ZD<*ZVR M-MH\P^^4RNBJM3MBB<'>#0"-Y'4[))'L(5HZ?IGT>G;=3R#$D=.P.'8<#(5? MZ3T#635S+E>V&.-CN<;"\Y?([CEW8,]N\JTD:T:SF;S]Q$1'H$1$!$1 1$0$ M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$ M1$!$1 1$0$1$!$1!#N4JX^!Z7-,TX?5RMC_V1XQ_4!ZTY-;=X'I<5#FX?5R. MD_V1XH_43ZU+I(8I@!)&QX'#::"OIK6L:&M:&M' 8 1SV?CWR]1$1T$1$!$ M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$ M1 1$0$1$!$1 1$0$1$!$1 4,U7K&ULT_704-?%+5R-,+6L)R,[B?4,J9J"#D MMM;JATDM;5N#G;1:-D?N1SU-^,5:G)7:MBGJ[K(W?(>9B)[!OH[-<*.*2FK:=@+1^"<\-MVH*9L-=$269V)&'#V>@_N.Y0V?DFB+B:>[O8WJ$D M.WB!ZE(X^24;69;R2.QM/C[=I2>PZ)M%AE%1"Q\]2.$TQ!+?0!N'ZT2U=34\ M3&(=^GC,--%&XY+&!I/;@+(B(](B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(JGP]>/*U=]8?]Z[\*W;MQ9[7BBH[X M>O'E:N^L/^]/AZ\>5J[ZP_[TX5NSBSVO%%1WP]>/*U=]8?\ >GP]>/*U=]8? M]Z<*W9Q9[7BBH[X>O'E:N^L/^]=S1]VN55JJBAJ+A5RQ.V]IDDSG-/B..\$K M-OI+5K,Y],V^FF(F81$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0:VT[YQ]J;3OG'VKQ$'NT[Y MQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'V MKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ M]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VK MQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ] MJ;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ M$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J M;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$ M'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J; M3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$' MNT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3 MOG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'N MT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3O MG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT M[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG M'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[ MYQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG' MVKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[Y MQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'V MKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ M]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VK MQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ] MJ;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ M$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J M;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$ M'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J; M3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$' MNT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3 MOG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'N MT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3O MG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT M[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG'VKQ$'NT[YQ]J;3OG M'VKQ$'NT[YQ]J+Q$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1%H5E[ME X MMJ:Z&-XXLVLN'J&]6(F?$+$3/IOHN$=96 ?_ '_N9.ZO.F=@^G^YD[JW\6I^ MF?Z:^._4N\BX/3.P?3_D=2V5B8F/;$QCV(B* B(@(B("(B B(@(B M("(B B(@(B("(B B(@(B((!:-:5K[XRFKWQFF>\QY# -DYW'*ZNK]2S67#.RW@/:?U*$TEJ=ZU^A#=BYGA>RXYV=VZ0MX M>A<*DU#JRKIC54].V>%I();$#O'F&];L'^BMW^H[_BE;^@OR<_\ ?=^H+C^& ME;3B)\N7X:UM./NSZ8U,+[')%-&V*KB +FM.YP[1V*/MUK74VH9(:IS'43)W M1N 9@AN2,Y\R^-*G;US7.A(YK\,=W#9VQC]RY<=J==[U>H8P3-'SLL8[2)!N M]8)72-/3B]LQXQ'_ $W&G2+3GTEFL+_6V@T1H9(PV8/)):'9QLXQ[5*)9604 M[YI#AC&ESCV #)5.UMSDK;90TLN2^DVV@GYIV<#U8(]BL+6M?X'IU\33B2I< M(AZ.)^P8]:Y:FCC93[^7.^EC;7^4=H-;W*2ZP"I=&*2279< P# )[?-D*P*J MJAHJ62IJ'AD4;=ISBJ@J*NBDL-'21QRBKAD>^1Y V7!W9OSU-^U6;:I(-0:9 MIS5,;*V2,-E:[YPW$^;>,J_4:=8Q;&(77I$8G&(0RJUO>7/=40-9%2O>6QAT M8/#&[/6=X]JL!U;'36L5M4\,8V(/>[U*$Z[HX+?06FEIF!D4?. #_=W^E31M M)!76B*FJ8FR1/B:'-/H"SJ[)K6T1B&=39-:S$80&JUO>7/=40-9%2O>6QAT8 M/#&[/6=X]JL:F>Z6EAD=\IS X^DA0/7='!;Z"TTM,P,BCYP ?[N_TJ=47^8T M_P#1-_4IK;9I6U8Q[-7;-(FL89T1%YGG$1$!$1 1$0$1$!$1 1$0$1$!$1 1 M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1 M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1 M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$7CG MM9C:^GI!NRTX>_TGJ'F461%]>E*TC% M7TZTBL8@1$6FA$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$7I!:<$$'L*#Q%Z 2 M< $^A>("(B B(@(LG@\_-,EYF3FWNV6OV3AQ[ >LKR:&6GE=%/$^*1O%CVEI M'J*9,OA$1 1;4=MK)F1/CIW.;*U[F$?G!GRCZEJIF),B(B B(@(B("(B B(@ M(B("(B B(@(B(/N*62"5LL,CHY&G(;>3Q=V'V?J*[Z^1>LUM M-9?,M6:SB1$199$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$$8TSIRKLM=635 M,D#V3##1&XD\<[\@+=N]B%3IV6UV]L4.TX.:'$AH\;:/#/G7:1=)U;3;&ACB7#:>'#.1V!2=%GY;3G/W9^2TYS]T&OFAJBMNLM302T\<4OC.9 M(2,.Z\8!W=?K71U/IROOM92F*:!E+"W!#W':R3O( &. "E"+7SW\3TU\UO'[ M.57V&BJK9/2Q4M/&]\9:QXC V3C<U7VCI MJR.MN$/YOF4BT[;;Q;W3"YUK*B,M:(FL>3LX]('F7>1+:]K5VR6U;6C$B( MBXN0B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B( M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B( M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B( M"(B B(@(B("(B B(@(B("(B L<\S*>!\TFUL,&7;+2XX] WK(M"^?P!F_BJWZC-W%CGN%!4Q.BGIJN2-W%KJ"8C]A=-8JE\[(O\ M)XFR2$X >[9 \Y5C&5C#A2786J,RL-9/2-WNCGI9@Y@\SRW!]#O:N[2U#*NF MCGC#PR09 >TM/L*UHK<'2MGK9/"9VG+DY/G6\K>:SZ6TQ/H5.: MDF=/J2X/<M#K>VXQNN@E=2MR7-C&]Q' M>@J4:CN7PMHJDJA R!GAI8R-@W-:&N "B-#13W&MCI*9H=-(2&@D#.!GB?0I MQ/I:[2:,I;<=:\^K-8M69GRX:DUBT3,HO8KU%9&U4 MS:1LM:Y@;3RNWB(]9Q_WP7?N%9->M R7"Z1Q^$QU 93RA@:7C=G_ )O9YES] M+Z7^%;E4MK'8BHG;,L;#XSW9/B@]FX[_ /Y6]JJW7^JA,TM%'36RD;^"A9*T MAC>&2 =Y4O-)U(B/?^^$M-)O&/;R:Y3:6T[:66T1LJ*R,SS3%@<2-V!O]/V+ M2U:R*IIK5>(XF125T)YYK!@%[<9/V_8MV>VSZHT[:9+:625%'&:>:$O ( Q@ M[_1]JT]6OBI:6U6=DK9)**$\\6'(#W8R/L^U2F-T8]YG/^_TE,;H[\YL#JZ_:%W]-T7AVC!'/1LN$?A1,<+I>:V-V\[7[O.M:XVVZ7+55 MKBKZ!M-2DMCB9&\/:(V^,1D=>/0LQJ3\DYGUG_>V?DG?.9]9:MZ_R&+3]G&Y MT+&S2C^6]V<'T;_:MF]V&2[:MNL\DS:6B@##+4O;D#\&WA2=U,3'7G^ MXRD[JX_A"[588:^&LK9Z\4UNIG;)G=&279.[#0?1[>M;MWLELM]KMTE),ZH? M5O\ %JWG8BP#O!;Q'$>PKJ:4MTPMEZH:NF;4-9(UCZ1SMC+P>.WU1P:Q@+B0UF=D;^ SU+:FNU;/'-')/M-F;&V0;(&0P8 M:.&["TEUTM.:9RWITFN.:'-+7 $$8(/6 MMZ=YI:+0W2\TMF%$HIQJ#0TC9'U-I:',.]U.3O;_ *O:/,H7-!-3R&.>)\4@ MXM>T@CU%?7T]6MXS67TJ:E;QF&-$1;;$1$!$1 1$0$1$!$1 1$0$1$!$1 1$ M0$1$'H):<@D'S+Q$0=2R7Z2R3R[49EHZAACJ(V@;6#NVFGM&3NX'[1Z;\QQ\ M&?1_^38V1#@<\/\ ^;M?/\W#&[SKE(O-?Z;=>;;IC_\ O?\ \=*VI'NL3/\ MO_G]_;N=)8Y&1TD]$7V2,;#*; YUHX\[M?/R3NX8./.MBEUI+15364]*8[.Q MICCIQ@RQ@YS(''\_>=W#?CSJ-HL<./U3_P#>_P#YZ)MIS[I'_P __O[^VU65 MPJRR."'F*.'(AC.-LYXN>>MQP/,, !:J(O3ITV5BNS^$ MC=\@GK):1Z\=J[W*IKNIT=9X(;2UDMXJRYT3'-V@R)@VI'D=@ Q[3U*"V?2T MFI]*ZR%$2R[4.HZBKH)6[G-E;@X!\_#TX/4LMNI[CJO2>K=?WZ$1U$EHGHJ" M'!Q%&V-PD<,\,NVO_P NU!;.C;K4WO1MHNE86&IJJ9DLA8W VB-^ MNGU!9: MJN-#3W>@FJQN,$=2QT@_V0="T[?>[3=G/;;;I15CH_E MBFJ&2%OIV2<*NM>O=J34VB-,5;GMMMS+ZJLC8XM$VPP.#"1U<=WG'8%JJ=.4,5NKZ*NB8?!ALB:-V=ICFCCG'ZT$PUMKFFTF^U0MDI)*FLKXJ M>6&2<-=%$_.9<<<# WG=O7-Y2]15%'I^Q5MCN8:RIO,$#IJ:0.;)&0_:;D;B M,C[%Q^6.QVN>MTO62T,+ZFIO-/2S2EOC21':RP^9.5RRT%MT3I^U6Z!M'2?# MD#6L@\78VA(21V'))065!?+14U[J"GNE%+6LSM4\=0QT@QVM!RMR66.")\LT MC(XV#:<]YP&CM)/!4]RHZ1L6E-.VV]V&W16^OH*^'FYH,AS@2=SC^=O .3O] MI6URO5QGU#I:P5%'7UMLJ99*BKHZ%NU+4\V 6L R,CB2,\-_$!!9=OO=INSG MMMMSHJQT?RQ35#9"WT[).%L/KJ2.J%*^J@;4%G.)K;Q M8[GH_D_U!9KA1U;.>?\ !XBBE@.Y[7!KCD\-Y'#._@NUJZP46IN76V6VYMIXI1&93')*UK@P<78)X>=8[?=[9=F/=;;C25C6'#S33MD M#3Y]DG"K+5%DH;_R]VFBN41FI/@0R/AVB&R8ED(#L<1G!QY@OG4=CMVB.4C1 M]RT]3-H?A*J=0U<$ Q'*QVR =GANVL^H'J06K!6TM3+-%!4PRR0.V961R!QC M/8X#@=W6CJRE96,HW5,(JGMVVPEXVW-[0WB1YU7$ MQ,C:#21D*"6:KY5[K8*.]TE=IR:.I@;.RFEBD:2",@$CK]>/.I? MRB?Z.=1?^GS?LE.3K_1QIW^H1?LA!BT+K(ZMH:N.KHS07>W3>#UU(79V']H_ MDG!QZ#QXGMUU]L]KF9#<+K0TDK_D,J*AD;G>@$C*KS2\W,\L/*%40#:IXH:< MO:WK>(Q^\/6KR9:2LNK=*2:EU%0PW.YW6>9\TM0-K8 >6AK?F@8ZM^_S!!;; M'MD8U['!S'#+7-.01VA<]FHK'+7F@CO-O?6 [)IVU3#)GLV\X#1VDG@M.WWNTW9SVVVYT58Z/ MY8IJALA;Z=DG"K#E6N$=3>-(V(T]?<+-5.?4STU!F22K:QH+&@Y&T.)._AOX M@+C7>)K;Q8[GH_D_U!9KA1U;.>?\'B**6 [GM<&N.3PWD<,[^""]U5 M^4#4-DL%=:::FM9BQX7"XDA[0>(SG?E6HJ3I*?54_+!K4:7K;=2O!I^?-;&Y MP<-CQ=G /G06!IJDUS!:=P\;(V,;SN.=_#<@O\$.:'-(((R".M*"R\@[Y](UFJ-MSGM: MY^R[>=X/RAU8/#&%U!R/Z1FTU3V]M#S%0QC"+A <5&V,$NVCGB>KAOW ()S6 MW"BMM.:BNJX*6$<9)Y QH]9.%\T-RH;I3^$6^MIZN'..*^TUTOMSAIG-I[9!&:@O;G?*^,8!=N._K[#@8X&A9J6FY::V"TV:XV M.@K+5SLE!6T_,>.UX >U@)&..#YW()=8;O<*GE@U9:YJN1]#2T],Z" GQ8RY MC2XCTDE2VX7RT6E[&7&ZT-&Y_P D5%0R,N]&T0H+IK_3KK;^JTG_ V+D7"3 M03M5WL]&[SJJXOFQ5O@HS5,IG8QS;22 W&.KAPSNP MB6OHX:+PV6K@CI-D. MY]\@$>#P.UPPRVKE6N5+_G%-Z@LV66.")\LKV MQQL:7/>\X#0-Y)/4%SY=1V.!\#)KS;HW3@&$/JF R \"W)W^I5II&Y5==R%Z MEIJR9T[K=#743)7[RYC(B6[^O =CU+#I[D_TW<>1F.LJK;'+7SVY\QK'Y,K7 MAIV<.Z@, #=@(+D10[DJK)Z_DQL4]1(Z23F#'M..20Q[FC[&A3% 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$! M$1 1$0$1$!$1 1$0$1$!$1 7S)&R:)\4C0^-[2US2,@@\0OI$!$1 1$0$1$! M8YJ>&H;LSPQRM['M#A]JR(@T#9+2>-KHOJ[/N3X#M/DNB^KL^Y;Z+6^W:[I[ M:'P':?)=%]79]R? =I\ET7U=GW+?1-]NUW3VT/@.T^2Z+ZNS[D^ [3Y+HOJ[ M/N6^B;[=FZ>VA\!VGR71?5V?VA\!VGR71?5V?VA\!VGR71?5V?VA\!VGR71?5V?VA\!V MGR71?5V?VA\!VGR71?5V?VA\!VGR71?5V?VA\!VGR71?5V?VA\!VGR71?5V?VA\!VGR71? M5V?VA\!VGR71?5V?VA\!VGR71?5V?T0-'[EO(FZW:;I[>,8V-H M:QH:T< !@!>HBR@B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B"(Z#TK M7:7;?A6RT\GPA=):R+F7..RQV,!V0-^[JR/.NQJ.TR7;2=VM-'S44M71RP1E M_BL#GM(!. =V3V+K(@A#M "X\EE)I&YSL9404\;!409<(Y6;PYN<$C/HW$\% MQ*W37*7?[7T>O%VLD-L>!'4UM*R0U,T?6,'#OKM)$$)UQHB:^$.<&AD>-Q(!.<#L6_RA:*?PF.;:J'.:W#3OX G/J7NN-(5. MI&6ZOM5:VAO=JF,U'4/;EF_&TQP^:<#J/#AO4M1!7]!:>4.ZWR@J-0W6VV^W MT4G.N@M!DVJIP& 'E_YOF^S.".E4Z6KIN56BU2V6G%#!;#1NC+GH9K+=;'5T\%VL]09H!4@\U(';.T'8R?S1]O#BN%>=' MZ_U'+;+O77"Q4]TM52V:CI(FR^#GYQD<:CEQM/ MP364]-=([%ML=,PNA>1))EK@-^R-XW%=BVZ1U3>M84&H-9U=MYNV;1HJ& MW!^P'G<7N+M_4#Q/ <.!F4FGK;+J6'4+X'&YQ4YI62[9P(R2<;.<<2=ZZB"M M^6V!K="-NL<_@]?;*R&HHY&_*YS:#<#U'/\ LJ2:!T]T8T1:[6YNS.R(/G[> M==XSO83CT ++>-%6"_7NCN]TH?":NC $)=(X-&'%PRT'!WGK"[Z#CZJM4]\T MG=;53/C9/5TLD,;I20T.<,#) )QZE!+5IWE6MEDI+-3W73-/34T+863,9*^5 MK0, ^,W!*M-$$8T3HV#1]KJ(C4R5U?62F>MK)1XTTA_=QW;^)[5%Z/26N-'/ MJJ#1];9I[+/,Z6&&Y"0/I"[B&EO%H\^?1QS9Z((7IO0]58],W2F?>)?ARZO? M/57.)@RV5WS0>H;^SB>&[$/.N,=/\JDMLBT_)>[-#0M:(G7. M 2BK,8W>@.P.(QZ>M6DB"N;YHS4M%K&EU1I6MHIJMM"VAJ8KH7?A6@CQMIHX MG )X;QY\+XI-':Q9KJ@U;5W.TRU3XO!:ZG:R1L<4&UG$)XD^=W62K)1!!F:4 MOM!RI5FI+?4V]UMN4<4=;%.'\ZT,8&CF\#'4#O*X]MTCKG25TNT&FJNQRVFX MU3ZIIKQ)SD#G<=S>.X >?'4K11!!=":/O>D;M>&5-PI*ZV5TKJH2[+FU!G=C M:+AC9#=QX=:Q:$TIJ;2%?54$M5:I]/R3RU#"T2>$[3B,9W;.-RGZ((3IO1,U MO=J^&[.IYZ2^UTTS60N<2(I,C#L@8.#U9]*X=%IGE+T];.CUENUDFM; 64U; M5LD%1 P\!@ M)&=W'U=5I(@A]OT.RR\FM;I:@G$D]123QNJ)L@232-(+W8R0 M,D=NX=:VK%IVKM?)U3Z>GD@=5QT+J8O8XF/:+2,Y(!QO[%)D01S05@J]+:)M MMEKI(9*FE:\/= XEAR]SA@D \".I2-$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1 M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1 M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1 M>$AK2YQ &23U*L=5:^FGE?16:0Q0-\5U0WY3_\ 5[!Y^*,7U(I&96#77FVV MW=65T$+OFN>-KV<5RSKO30.#]Q2?JK?:% MT]/-->4O<2=U.GFFO*7N).ZJ61#E7ZA=/3S37E+W$G=3IYIKRE[B3NJED0Y5 M^H73T\TUY2]Q)W4Z>::\I>XD[JI9$.5?J%T]/-->4O<2=U.GFFO*7N).ZJ61 M#E7ZA=/3S37E+W$G=3IYIKRE[B3NJED0Y5^H73T\TUY2]Q)W4Z>::\I>XD[J MI9$.5?J%T]/-->4O<2=U.GFFO*7N).ZJ61#E7ZA=/3S37E+W$G=3IYIKRE[B M3NJED0Y5^H73T\TUY2]Q)W4Z>::\I>XD[JI9$.5?J%T]/-->4O<2=U.GFFO* M7N).ZJ61#E7ZA=/3S37E+W$G=3IYIKRE[B3NJED0Y5^H73T\TUY2]Q)W4Z>: M:\I>XD[JI9$.5?J%T]/-->4O<2=U.GFFO*7N).ZJ61#E7ZA=/3S37E+W$G=3 MIYIKRE[B3NJED0Y5^H73T\TUY2]Q)W4Z>::\I>XD[JI9$.5?J%T]/-->4O<2 M=U.GFFO*7N).ZJ61#E7ZA=/3S37E+W$G=3IYIKRE[B3NJED0Y5^H73T\TUY2 M]Q)W4Z>::\I>XD[JI9$.5?J%T]/-->4O<2=U.GFFO*7N).ZJ61#E7ZA=/3S3 M7E+W$G=3IYIKRE[B3NJED0Y5^H73T\TUY2]Q)W4Z>::\I>XD[JI9$.5?J%T] M/-->4O<2=U.GFFO*7N).ZJ61#E7ZA=/3S37E+W$G=3IYIKRE[B3NJED0Y5^H M73T\TUY2]Q)W4Z>::\I>XD[JI9$.5?J%T]/-->4O<2=U.GFFO*7N).ZJ61#E M7ZA=3=[ N0SYX9!^MJZ]%'Z)15]I'7CJJ:.W7=XYUQV8JCAM'L=Y_.K!1ZJ7B\ M9@1$1L1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$ M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$ M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$ M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$ M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$6C5.N%/.9H&,J8"/&@W-D;YVG@ M?0<>GJ1)G#>1:U'7T]C9VO\ F461\W6MNO(B(CD(B("( MB B(@(B("(B B(@(B("(B B(@+TM( )! /#SJ3Z HJ:NU1&VIC;*(XGR,C?P M2#"&^#O'#!QQ]._W/-DXR1[?L6:LKI-4Z%K*^O9&ZX6Z=F M)VL#2]CB!@X]/V!"*>/?E!T6S;Z7P^Y4M'M['/S,BV\9V=H@9QU\5U8=-F76 M)T_X7@B5T?/\WV-)SLY\W:C$5F?3@HI!:-,BXU%Q=/7,I:*WD\]4.87=9 PW M/7@K>O5ALUMTK3U]%/-7NJ92QE4/$8W!^26'?P!]B-12<916.GFF9(^*&1[8 MV[3RUI(:.T]@7LM-/3MC=-#)&V1NW&7L(#V]HSQ"D]'_ .5\G5;4\)KG4-@9 MV\VS>3[/: HN]2:;;;< \R%Z16(G+ B(C B(@( MB("(B B(@(B("(B B(@(B("(B KGT1>W7FPMYYVU4TQYJ0GBX=3O6/M!5,*= M\E\[FW>MI\^*^ /(\[7 ?\Q1W^GMB^.UHHB(^@(B("(B B(@(B("(B B(@(B M("(B B(@(B("(B B(@(B("(B B(@J71?*C7W'7]RT_?&Q-IWU4U/;IV1[ +X MW',9/62T@^G':%)]8:EN-DU7I&W49B%/=*M\-3MLR2T;.,'JXE5S9=)OU5I? M6+*-QCNU%J.HJJ"9IP6RMP0,]6>'IP>I9ZC5;=7W7DUKI&\W717&6"MAQ@QS M-$>UNZ@=Q'IQU(+R1%!KK?K".@H(C7:AK?$HJ&,;3B3 MNVW <&C[<>DC#H:P#D_T14S7FI::I[I+A<9N(:XC+@.W 'K.>U!YRBZPK=/4 MU';;'''-?K@\\PQXVFQQMWOD<.P ?K/4M_DYO];J?05LO%Q,9JZCG><,;=EO MBRO:,#T-"@FE+E;[T;]KB]7*AAKJ^"2GM]++4L#J:F:" ,9W.<>/M_.4@Y%* MVEDY,+121U,+ZF(3&2%L@+V SR8);Q'$()W17&AN3)'T-;3U38WF-Y@E:\-< M.+3@[CYEQ-=ZJ;HW2-9>>9$\L>RR&(G <]QP,^8<3Z%FTOH^SZ/IZJ"SPR1L MJ9N>DVY"[?U 9Z@L^I].4.J]/U5FN&V()P/&C.',<#D.'G!""#%O+!34)NAJ M+#52!O.&UMB<#CCLM=NR[J^5CSE6':JNHK;135=;1/H*B2(/EII'AQB/6"1N M_P"^I5G54/*7H.URU5)>J+4-JH8R]T%7"63B-HR<$;R0!UN/#@>"UN4/6#K_ M ,FFGJBACJXZ>_5D4-1%3^-*6;]N)O#+BYN!PSCSH+1H[_9KC5.I:*[T%34- M^5%#4L>\>D Y44Y0[O<+7>-&Q4-7)!'67F*"H:PX$D9(RT^95]J6AH)['"-* M\G.I+3>J.2.2CK&V\,((<,[;@XEV[/'._'G4KY0IIJBLY.)JB(Q3R7FF?)&1 M@L<=DD8\Q06955=-0T[JBKJ(J>!GRI)7AC1Z2=RQ6^ZVZ[0F:VU]+61-."^F MF;( ?2TE5)R@5T=PY6;?:;G:+G>+504'A8M]#%SADEW(RT# ].[@2L5 MOBD@Y2[':XX^5G''H=B#XT+KJEU?13O?+1PU+*J6&.".<.<^-N,/ XX(4GK:ZDMU M,ZIKJJ&F@;\J6:0,:/655O(C8+2VQ5-V%! +A%<*B%E1L^.UFX;(/9O*LF^V MJ@O-GJ*2XTL553ENT8Y!D9&\%!P] :V@UGIZGK9'4L%?)SA?1QS!SF-:\M!( MXX.[JZU)Z:LI:V-TE+4PSL:XL8Y.;>';#AQ M:<<#YEHRZEL,$<,DU[ML;)B6Q.?5L >1N(:<[_4H5R1_*UE_^T-3^Y1SDCT) MIR_\GSZJ[6R*KJ*B:6+G9V-A=7W6AI!,,Q&>H M9'MC^3D[_4MZ.1DL;9(WM>QP#FN:<@@\""J8Y)M%V+4.B)9KY1-N,[9Y:2.2 MH)<8HF\&LW^(,EQW=96'3-\K['R WZ:GGD,UNJ)Z2FDSES&E[0"/1MD^9!;S M]066.X?![[O0-K2=GP=U2P29[-G.5NSSPTL#YZB6.*%@R^21P:UH[23P5<6C MDKTI5Z I89[;%)655&V62O<29N=;>VM!V?!S5,$F>S9SE0K0^@K/2:3MMZHH7_ ]56N,MKYIGNTZ;+K[1%QIJH/<)KTR R-<2XX>)0CX$I/XZX?VA/WUI5=-;J600B2Y3U+AEL$5?.7D=I\ M?#1YS@+O+Y#&-+/$QX/H&S_P JB:M_7UA?=[0VIIV% MU329<&CBYA^4/3N!]7G50(^?KUVWG]Q$1'$1$0$1$!$1 1$0$1$!$1 1$0$1 M$!$1!FI*FHHZN.HI)'QSL=ECF'>"K(J[_=[)IJ:2^5W.72LCV*:E#6M,+3Q> M[ &_[L=N*Q1&Z7FN<)EIB-MZTI=-/Q2L96NE;4T[7NP)",9 ]3?M6:KH9-+: M%K*"O=&RX7&=F(&O#BQC2#DX]!]H4'7I)<I'0MMQE<\2NE:,N 0 MX=87;N&KHWULT]KH@UM4[G*P50#^=SQC'8ST8)._=@8Q:^)QAZ_IM"+TW3:( MB)^\XQU_?[)-I>VU$=RU3154#)F'&W2.?@2%Q);XXW#"Y,>JJ>WTAHK32.;12.,M1'4ALAE)&.:SN M\0#KXYW[ED.KZ>VQQT^GJ P4KG"2J95.YPS'YF_@T=NX\."GRQ]H=Y^BF*XM M>L8]^?743_/[?]X\OO6G^11VFQM_^QI090/XQ^]W[CZU*^D-/;J#3]JK8F> MU]M8R>7)#F@M#1O[..?3YE!K_J*&[33OHZ=\7A3A)5238<]Q&,1M/4QN!YSC M?V#@K=;1:,P\FM%M"\UG&?[Q^W])]INR5=BY2&T!E :&/ 58K:NW'K_?X1!$1 M'G$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!3[DNI7.N-?5X\5D(CSYW'/\ MRJ!L8Z1[6,:7/<<-:!DD]BNW25D^ K%%3R >$2'G)O\ 6/5ZA@([_3US?/3N MHB(^@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@B.@]* MUVEVWX5LM/)\(726LBYESCLL=C =D#?NZLCSJ.77DKJ'\JE!JJU5%-#0BH;4 MUE-(YP<9!Q4JQ7 M>MO#*W2]9=*PYEK*QT\D@'S6X8 UOF [!P 5@6&@U164=QH];? M33SL;''' M0"3#FD.#P_; X^+C'G4H1!#:KDNT=)23,@T[;V3.C<&.+#XKL;C[5\\F^A(= M%Z>IXJBGHS>2U[*JJI\GG09'.:,D G +1PZE-$01C15#JRAI*YNK+E35TSZD MNIW0-P&QXX'Q1U]6_':MO5UAJ-1V"6@I+K56RIVFR15%.\M( [&\MSU>A M=Q$%6U-EY6;K:Y;)7733T5+,PQ35\3)#,Z,C!P,!N2/,./$+MW7DXHZSD^H= M,4E5)3R6XLEHZO&7,F;D[9 [279]/F4W1!6QLW*A>'4U!=KS:;?0Q2,=/5VO MG!43!IS@9&!G&_=3)$$"U#I#4%;<+/J>T5U#2ZHHZ805+7M<:6H:=[F?.#0XNQNSO' @%9K!: M=;U6HX[OJBZT=/3T\;F16VUE_-2%W%TFUQQU?NW@S=$%>7/26I[+JRX:@T95 MVW%S#36T%Q#]@O;N#VEN_.\]G$\>KLZ.LVHZ%]?<-3W=M76UKVD4U.3X/3M: M, ,!WY/6?-U\5*D00#0FE-3:0KZJ@EJK5/I^2>6H86B3PG:<1C.[9QN4]D8) M(WQG.' @X\Z^D00+DYTOJ?1],;-<*FTU%D@;(:9].)!4%[G[7CY&SC!=P\RY ME%I'7.D[M=(=+5EEDL]QJG50;<&R;=,]WRL!O'=CK.<#<%:"((7RD** M[PW2L@JYJVX/JFS19RX. &7 @8<2"2!D;^*S6H;-)(74 M[G.;AQR-Y /V*7(@B7)SI:MTAIF2VW"6GEF=5RSAU.YQ;LN(QQ .=W8M#2V@ M)*#1%XTY>Y()H[C53R$TSB=ECP,;R!XPQGV*>(@JV'37*=168::I;Q8W6QL? M@\=Q>R05+(> &R/%V@W<./IZU(*G0S:;DLGT?:)&!QI70LEG) <\G+G.P"1D MDG=GBIDB#CVFTU-#HV@LSJKF:J"WQTIJ(,.V'MC#=INT-^",C(]2@==IOE0K M+'-IJHNMAJ[?/&8'W"9DGA!C.XY'R=K'I].=ZM1$'.L-ICL-@H+3#(Z2.C@9 M"'NXNV1C/KXKHHB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@( MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@( MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("YTWY2T/ M]3J/VX5T5@?2M?7PU9<=N*)\0'40XL)_8'M1)C+.B(BB(B H#JK0'ADKZZT! MK)G>-)3DX:X]K3U'S6"0?FR-(SZ.U:Z_1, ML,4["R:-DC#^:]H(^U:)L%F<U"(K[Z/V7R M/;_JS/N3H_9?(]O^K,^Y#BSVH1%??1^R^1[?]69]R='[+Y'M_P!69]R'%GM0 MB*^^C]E\CV_ZLS[DZ/V7R/;_ *LS[D.+/:A$5]]'[+Y'M_U9GW)T?LOD>W_5 MF?U"(K[Z/V7R/;_ *LS[DZ/V7R/;_JS/N0XL]J$17WT?LOD M>W_5F?W_5F?U"(K[Z/V7R/;_JS/N3H_ M9?(]O^K,^Y#BSVH1%??1^R^1[?\ 5F?W_5F?W_ %9G MW(<6>U"(K[Z/V7R/;_JS/N3H_9?(]O\ JS/N0XL]J$17WT?LOD>W_5F?W_ M %9GW)T?LOD>W_5F?VMKBV:N_- WMB]':?.I@B(]5:16,0(B(T(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@ M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@+PG#2<9QU+ MU$%;4G*Q4U6H!9!HR],K@ULDD3MG:CC) VR.S>%);7K"FN.L[MI=U++3UEOC M;+M/(+9F.QXS?]YOM47MO_U%WC_T)G[<:PZZ'1GE2TIJMOBT]6XVNM/ 8=\@ MG_>)_P!@()CK+5U+HRR,N-33RU)DG93Q01$;4CW9W#/F!/J7?82YC2YNRX@$ MMSG![%6.J!THY9=.6 >-26>)UTJAU;>1L ^@AGJ>5:""N;IRJ5%LU)\!G1]X MEJWOD%.&;/\ E#6$Y>P=8P"?0K"@D=-3Q2NC=&Y[ XL=Q:2.!\X5;ZD_T^:, M_J=5_P .19^5.Y7FAJM*4]EN#Z*>MNK*=SAO:X.P!M-_.;D\$%BJ+ZZU7-I2 MUT_8:7OSO)[-WVJ$WVEU!R>WVP71NJ[G=:*ON$=%64U< M\.;X_P"F93L<-B%QS^%9_+06A M8YKK46>"6]TL%+<#M<[#!)ML;XQQ@]>[!]:Z*K'4K[MI>KT':X[Y7U7/77FJ MF>9_CU#"X'9?CB #CT!='E.NM?:FZ7-!5S4WA%\IX9N;=CG(SG+3V@]B">HJ MMY4;[64FI]/V:6^5%ALE:V1U3<*?Q7[31N;M_F]7^]OX+O:'MU925%5-!K0Z MBLCV 0\Z]LTL,=7GZL;P[-AN-YKZJZLNMH%!%3U3HZ202A_A$0SA M^.KJ]OF7;58Z8U764E/RAW&XU,U7#:+E4\Q$]^=EC-HAC>P;@%J633&K=5Z= M@U)5:WN=%OB0ME%7-DUA<+_P C]YND[N8N M]#2U<$TD7BXFCC)#AC@=[3Z5';?8]5WSDWI]3.UO=8;@RB-1!!"_9A(:"0'] M;R[&\GK/#<@NA%'-!7VHU+H:TW>JV?":B'\*6C +FN+2<=62W/K4C0<+5>KK M5HZU"ONDC_'=L0PQ-VI)G_-:/WG_:0OEIMLC@T5LT6TUF>!>, M9;Z-Y6*_-;<+GC: [1LM/^R%8=VH:>YV>LH:I MC7P5$+XWM<,C!&$'D]WH*:S/O$M5&+>V'P@S@Y;S>,[0[=RKQW+&12?"HT?> MS8<_PCL#&SG&UL]GGRLO) R*_E^D>3BRAVVZZU$3ZH<=J.G' MX7/K&?4@L[2FHZ;5NFZ2]TD;XXJD._!O(+F%KBT@X\X6MH[5M/K*VU5?24LL M-/#5/IF.D(/.[('C#'5O5>V:[=#M./:IOR9 M6?X#Y.;)2.;LR.IQ/(.O:D.V0?1M8]2"6HB("(B B(@(B("(B B(@(B("(B MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B MB(@(B("(B B(@(B("(M*[7.&SVN>NG^1$W(;UN/4!Z2B3.(S+!>[_06&EYZL MD\9WR(F[WO/F'[U6]TY1;O6/WNR;O7 _R9W#]17ST@O7EBX?67_>NW1Z07KRQO+%P^LO\ O7.1#=/;H](+UY8N'UE_WIT@O7EBX?67 M_>NW1Z07KRQO+%P^LO^]G2"]> M6+A]9?\ >NW1Z07KRQNW1Z07KRQO+%P^LO^]NW1Z07KRQO+%P^LO\ O7.1 M#=/;H](+UY8N'UE_WIT@O7EBX?67_>NW1Z07KRQO+%P^L MO^]G2"]>6+A]9?\ >NW1Z07KRQNW1Z07KRQO+%P^LO^]NW1Z M07KRQO+%P^LO\ O7.1#=/;H](+UY8N'UE_WIT@O7EBX?67_>N< MB&Z>W1Z07KRQO+%P^LO^]G2"]>6+A] M9?\ >NW1Z07KRQNW1Z07KRQO+%P^LO^]NW1Z07KRQBJHZFFD='-&[::]O$%'73U[5GSYA^AD7'TU?&7^SQU8 ;,/$F8/S7C] MQX^M=A'T(F)C,"(B*(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B( M"(B B(@(B("(B B(@+PG#2<$XZ@O404I;-0W+XWJK4C]&:H915E RA:'VYP< MQVVP[3NH-\4[\J>, WSD9;ZU+T05IR3 MVV[SS7S5.HJ*>DNESF9$(JB)S'MBC: #AP! )_9"LM$04OJ.^W)W*W:+W%H_ M4TU'9VU%-*Z.WN=SQ(>T.C/ M.0 MRW%E6^EC&7R,''9'$G<.&_>HQJN^W77%3IGX.TE?:>CI+Q3S5$U72EI:0>IH MSXH&6.3J_!$8(QU^?B,;XO MR?6ITW*17WZS:>K;!I]]"(3!51<-W-=S@.X8QG /[A;2(*UL.DKC8.1N]V^JB,EVKZ6KJ)H81MGG9(R MP8SDX#1NZ^"ZNEJ&KI^1ZDH9Z6>*K;:WQF!\9;(';+O%V3OSYE-405?IZZ7# M0G(-27">T5#ZRAB<7TWKQ@\2X M M+I135$D4E534\P;#4&/< X8R01Q&>L]J##06VKY.N2QM);:)]SN%#3EPAB:Y MQFF<[+L #)&7$]N JYTG=JZVW:;4>H]%:NNNHYR1S_P:[FZ=G4V('ANZ_5VY MOM$'(L%W.HK/X7-::ZW;;G1FFN$/-R8'66]A55DKS;==5C;I1U,5NL<<] M-;I)HG-;)SDI.VQQW.RT'>.T*[$04GRH:3O-QU]2LM='4RVV^Q04UQDBB?:T.,9.#CM ZPLRXU7*^NC#*C3]>[9.6.$D

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end GRAPHIC 9 noevidence.jpg GRAPHIC begin 644 noevidence.jpg M_]C_X 02D9)1@ ! 0$ > !X #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" %3 G$# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]3I/W;A_X M>C?XU+25$J21O@'?&3WZK_\ 6H$>5?";X_6_Q(\:>*?#%UIATC4-)NIH[4F7 M>M]#'(8WD4[1@JV,KSC<.:Z:P^(CWGQ>U7P2;!4CL=)AU,7OFY+F21DV;,<8 MVYSGOTKP#POX/U/5/ _B;Q3X:3=XN\*^-=5O[!!Q]JCW@3VK?[,B9'^\%KJ? M ?CNR\6?'#7_ !;I/[^TNO ]I>11G[P(FD)C;T8,"I'J*>ED_+]+GBT\35]V M,WJW]ZN_R_*Q]"27MO#<1P23Q)/)RD;. S?0=ZGKYO\ A+\&?"WQ6^$EAXN\ M4V+:KXJU^"2^GUF29QC?LY^*M2\9_!KPYJ>K3-< MZ@8Y+>6Y?[T_E2-&)#[L$!/OFBQVT<1*HX\T;*2NM>FF^GFNYE:U\6O&4WQ, M\0^$_"O@_3]9&BPVTT]U>:L;4GSD+ !?*;I@]Z[/P-K7BW4HKQO%WA^P\/,C M(+<6>I?:Q*#G=D[$VX./7.:\=CM_&MQ^TE\2O^$.OM$LG%EI?VG^V;:68-^Z M?;L\MUQWSG/:NY\0^!?&/CCX5^*=!\6:AI,^J7<).GSZ)!+ (I% :,G>['<) M%4Y!'%'2YSTJE64I/5V+C)QDE[NGXQO\ Q$\6-X7\$^)=2L9+>74],TZ>\C@D.[YDC+#< MH.<9 JUX&UV;Q%X'T'6+P1QW%]I\%U-LX0,\89L9Z#)-> W?P-\)V/[.-]XB M^QR3>*I_#DFHSZ^TSF\FFDMR[EGSRI+$;3\N.,53\>:I?WWA/X)^$XM'OM?T MK5=.%S?:1I]TML]\L%K&RQ-(S*-F6W,N1D+BG;=>GZF+Q52+52<='&Z2=]VD MNGGTN?45M=P7L?F6\T<\><;XV##/ID4DU];6P4S7$409M@+N!EO3GO7SG\._ M"NO>'?BWH5]X<^&=]X \-SPSV^MP-?V[VLPV;H9!$DAPZN,;@.0W-.^%?PA\ M*_$RR\?3>)],&LR+XHU."#[5(Q%LN\GI2-HXJI.T5#5NVMTMK MWU5_+;<^D:@M;ZWO0QMYXIPIPWE.&P?0XKY-TGQ%JOB;X&_"7PS>ZC>-:Z_K M[:+J%VLS+/+:0O-B,R#G++$JD]2 :]V\-_ ?PAX)\46>N^&K!_#T\$+P36VG M2%(+Q& QYR#GN:;5MRZ.*G7LZ<=+)O7OVTUM\CO)KZWMY(XY9XHI) M#A$=P"WT!ZU/7QGX-L7^*.EZIXD\0_"/4_'FH:G?72KK']IV\:P1I*R)%;J\ MJM$$"@< '()S7T1\ [?Q58_#'3;/QC;7%MK%J\L ^US)-,T"N?)9W0D%MFT$ MYYQFBV@L/BW7E;ET>J>OXZ):^39WUU>064?F7$T<$><;I7"C/IDU7UK5H]'T M6]U%L/';0//C M!#"LCR"/."[LWWCS@ "LS0_#&G3VGQD^'-[;R:CX5\/F&\TRVNIG?[-YML9O M*5L[MJ.N5!/ .*E[?*X_K,V](Z-M+7JK[Z;:/OZ'I?P+\5>*/'?@^#Q)XBFT MGR-5ABN[&TTR*16MHV!)25F8[FZ&_B!H7A+PUX:M->U#4[ M*>]W7FH?9%18F4$9\ML_>%9W[*?@[1O#GP:\-ZEIM@EI>ZOI]O<7TRLQ,\@7 M[QR2!U/3'6L#XM0^(Y_VDO Z^%KG3;35O["OR)-5A>6'9YD>X;493GI@YJY+ MW[',JE6."A-M\SY=M7JUW]?D>C^"?$'C_4]7>'Q/X1TS0].$19;FSU?[4YDR M,+L\I>,9YSVKLY+VWAGC@DGBCFD^Y&S@,WT'>N*\*K\0]+;4;GQ=?>'M0LX[ M9G@AT:TGAD\P<_,7=@1@$8 SFO+?@_\ !WPM\7OA;9^+_%M@=8\3^(%ENY]5 MFE<3VS&1@BP,#^Z" +CI4G3&I4CRPBFY.[]ZRT5NR\SZ,DD2&-GD9411DL MQP />'= M2C:!!'\P6>*/@S0UN33QGM)Q25E)+?S[:6_$]4\%RZ\?"]BWBIM. M_MQMPN#I;,;8G<=NPMS]W;U[YK8AO(+B22.*:.22,X=4<$H?0CM7R3"LEY^R M'\-(C<3Q--KUE&TT4A60 W[@D-U!Q7:^-_A_H'PG^*GPOU7PEIZZ'=:IK#Z9 MJ'V9VQ>0O"[$2@D[V#*"&/.>]5RW^^QE'%R48M1NK1;N]?>T[:_@?0-U>V]D MJM<3QP*QP#*X4$^G-2,ZJI8D!>N2>*^?_!?@?0_C=XW^(FK>-=.37CI6MR:+ MI]G>,S06D$2)RB9P'F#7(:M?7.E?!/X\>$8KBXDTSPS3DA"Q RVNNE]].MF?58O(&N3;B>,W &XQ M;QO ]<=<5PFN^/K_ $OXU>&O"B+;C2M0TJ\OIY'!\Q7B:,+@YP!ACGBO*_B[ M\)?#?@OX+WGCC1;22P\8Z/9Q:G!KB3.;J29=I(D--'LOB M#\>/AO;ZS TUE>^&;Z:XM [(LF3"=CX.2N3]WH<#-5:SM_6Q-3$5+CDEV/?X;J.\M_-MI8YE(.UT8,I/U%>5^-_'7C'X>_!:;7M671Y?$T-S%&XL M1(]KLDNEC&-Q#9V-^=8?PY\-V'PY_:&\4^&?#T/]F^'KK0+?5#ID3'R(KCSG MC+HO\.Y0,@>E>>[VD_8DB9F9V_M%>6))_P"0I22OJO+\[$5L3/DEI:2C/9]5 M;R\_D?3.K2>(AXJT)=/.FC0&6;^TQ((5#1VLR#:8[>621=JQD?P# /K4]#>>(=-RMO>VK?\J> MEDW_ %<^J:Y/XI>/$^&W@B_UW[+_ &A;6XBIKA;KPGHW@E=;D^*GP_UR_O?M\UW)X_TMS<;8FE+12>8CB2 (I4;0N!M MIV.:.,DJ2:]ZS:;Z:=79.UUKM8^O;BZALXC+/+'!&.KR,% _$T^.1)HU=&5T M89#*<@CUKP'XT>%[CQ!XJ\*^(9?"US\2? L.FO&=(M)U9EG?2T=[;S7#P1SQ//']^-7!9?J.U/N+B*UB: M6>5(8UZO(P4#\37SK\6/@UX6^%/PFOO%OA:Q;2O%/A^&.^@UB*9S^LF$FR?4&;[*7[ M%RG..O2M*WN)+?389=0D@BF6)3.Z-B(-@;L$]L],UX?\6/AGI'PO^ 'Q-A\/ MO=6FG7ED]Q'IYG+06C;0&$ /*!B,D9QGIBG_ !3N_"%Y8^!=(\0Z-K'C#4I+ M3[1:>&M+!D2X C4-+.A95*KG@N<9/>@)MK,N"?E)Z5X;\#] M.L;KXD_$'PHGA;4?"OA6\TJUG;PUJ; *CN9(Y'C5'8(K@#@'J#TI_P"SGX,\ M/^#_ GXZ\4Z;H\4>L:=JFKVD$JLY/D1/E(L$XQ\H'K[TM%J^Q%/%5*CA9*S M;3WZ=M/\CZ.>^MX[A;=IXEN&&5B9P&(]AUJ621(8V>1E1%&2S' ]2:^+?"? MA6Y\(O$VL6YO/\ A+EU>V2X,S@LDL+&4-&JDC:H P% (KN] M2L]=\?:Q\'? OQ"CF076FW6H:Y8B8 7EQ BJB2,APRY;>0#@DT^7H1#'N<>; MDWM;?JTE=M>?2_7Y^JZY\0[RS^,'@OPU9_99](UJQOKF:8?,^Z$)MV,#C'S' M->A,ZKC<0N3@9/>OGR;X?Z%\/_VE_AW;^'K%=*L9],U1FLX&/D*P6/YD0G"D M@\XP#@5V_P"T?I-Q?_"35KZRW?VAHKQ:S;;#SOMW$I'XJK#\:6FG]=3>%6HH MU925W%[?]NIV1Z:6"L 2 3T'K4-Y)*+>9;=H_M7EL8A*?EW8XSCG&<9KYE^+ M7BRZU[QUIGC72KF4:/X$M=/U*>)&^687L@$H/KMM\-^-=YH;'Q/\6_B7KHD9 M[32-.@T&U(8[=WEFXG(]\R1C/M0U9:^81QBG/DBNJ2\]'=_*S.HU#QW?_#OX M4?\ "1^-4M+C5+.%6O8]%8F)W,@4>5O()^\.OO3/BMX_O?!NF^%[G2UMYCJF MO66F2^<"P$4S$,1@_>XXKP#Q#X7TOQ!^PQX>U+4K1;R^TVPADM)Y';=$SW"( MQ'/.5XYS7>?&KP%HGA7X>>!M!T2S.DZ;-XNTXF.UE<,I=FW%6))!/KGBKLN: MWG^IPO$UG2DXZ+D36NMW?R/?8;R"Y>1(9HY6C.UU1P2I]#CH:YGXJ>,KSX>_ M#_6?$ECI@UB73(?M#69E,9>,$;R&"GD+D].<5Y-XF\!Z%\)?C1\,+SPCIZ:& M^M7EUI^I1VK,$NXO(9QYBD_,P900QYKWW4+-/N;*Y02VUQ$T,J'HRL""/ MR-0]KH].%2=53@_=DM--=U=/;S*=EXCL;[PS!KR3*--EM!>B7/ B*;\_E7EN MD_'Z\U#PG\/= M=1^&,3))N63Z?9R>?:O1/C3H]MX>N/@II=FGEVEEXHL[ M:)1V1(9% _(56E_*Z_K\C@EB:DX>V7UY#IME<7=P_EP01 MM+(WHJ@DG\A7C&C_ !:^)7C+0HO%/AKP%IMQX:N%,UI;WNK&+4+N'/#JHC*( M6 R%9O2O:+RUBOK6:VG0203(T _$UAKOAZ MS#-:>'_$5L1)''R1#'/)?EUO:U^EM^F^VI[!X9UF3 MQ%X?L-2ETZ[TB6ZA61[&^0)/ 3U1P"<$5IURGPM\?0?$_P :-XGM[9[-=0B M+-;R')B=6*.N>^&4C/>NKIO1G53DIPC).Z:W"BBBD:!1110 4444 %%%% !1 M110 4444 %%%% !1110 5")B\FU$+*.K]O\ Z].D)8A!WZ^PIX 4 #@4".2^ M&_P\A^'-CK-M!>R7HU+5KG56:1 I1IF#%!CJ!CK7/^ _@/I'P]^)7B?Q;IEW M,L>N1A&TMD'DV[%][E#Z,Q)V]!N->G4SS%\PI_$!F@Q]A3]W3X7='CW_ H7 M6M(M;S1?#7Q!U'P]X1NI)'.DQV44TMLLA)=+>=OFC4DM@8;;GBO3_"OAG3O! MGAW3M#TF#[-IMA"L$$6Y/4GN2:U:*84Z%.D[Q7Y_AV^1Y1KWP6UJX^ M(.M^*_#WCR]\,7&KPV\-S;PZ?;W"D0J54YD!QU/3UKK? GACQ!X;CO5U[Q?< M^+&F93"UQ90VWD Y \H#=G(Z^E=0&!8KW%.H\A1H0C+GC>_J[?=>QYKX!^! MNF> ?'WB/Q1;7UQ=/JI?R+*50(K!9)/,E6/V>3YC6O8?#&QMO%GC+6;B=KV+ MQ/!;V]S92( B)%$T9 /4[@QS78JP==%R., D#!.*Z?Q%\%[37?!OAG2 M8=5N],U?PVL1TO7+55\Z"1(Q&6*GY65ER&0\$&O168*I)X I(W$B!AP#ZT[L MA86C%62Z6W>WEV\K;'G_ (/^&NN:9XF37_$_C2]\47\-NUM;01VZ65I"K$%F M,*$AW.T?,Q.,< 5K_#_P!#X M=;AAO)+P:IJMSJK&1 OEM,02@QU QUKJZ1F MVJ3Z4C2-&$+-+;S;_,\IM?V>]+@^%=EX,?5;S?I]XVH6.L0!8[FUN?.:5)$Z MC*ER,'@C.>M7O#/PO\0V_BBRUOQ3X\OO$KZ>CK9V<-HEC;JS#:7D2,GS6QTR M<#J!7I .1D=*1F"XSW.!3NR%AJ2M9;6ZOIMZV\SR6;X(ZWHNI:LW@SQY>>$] M(U6X>ZN=,%A%=)%,YS(]NSD&(L>B>$?#,'@WPWI^BVUQ=7D-G'Y8 MN+Z8S32'))9W/4DDG^5;%%'2Q<*%.G+FBOQ?X+I\CS7Q/\(]1G\77GB;PAXK MG\(ZKJ$21:BOV..[MKO8,([1N1B10<;@>G!!J_X/^$]KX3\,:YI[ZE=:IJNN MF274]9NPOG7$KILW8 "JJK@*HX %=PT@5E4]6Z4^ETL)4*:GSI:_/KY;7.>^ M'O@^+X?^"-$\-PW+WD6EVJ6JW$BA6D"C&2!P*Y;XB?"*_P#&'C31O%&D>++K MPOJNFVDUFDEO:17 =)&4MD2 C^$=J]*INX!@O<]*=VW<;HTW35)KW5;\-O,X MCP7X)\5^']6>YUOQ_>>*+-HB@LKC3;:W4,2,/NC4'@ C'3FN6/P'UK1X[_2_ M"OQ U#PUX5O99)6TF.RBF>V\PEI%MYF^:)222!AMN>*]BIJL&8@=J"7AZ;23 MOIYN_P!][_(\\U;X.I#X3\.Z/X3U_4?![Z!Q8SV9$J,,883Q-\LH;))SSDD@ MBE\$_"J]T/Q)J7B7Q%XEG\4>(KRS73UNFM4M8;>W#%MD<2DXRQR222:]$HH' M]7IJ2DEMYNVFVFQY7;_ 6SM_A;X:\%#5[@V^B7\%^EWY2[Y3'.9@I7. "3CB MNF\6R;&ST'S9R/2NKCD$F[&?E..: M?1=@L/2M9+2R7R6WW'F&O?!_58_%>IZ_X-\87'A"YU;:VI6WV&.\M[B15VB4 M(Y&R3: "0<' R*Y7XK?#NS^'?[,WC^QM[BYU2]O+::\O]1O"&GO+ARNZ1\#V M ' %>\U&RI<1E74.AX*L,CZ$4NEC.>%IR4K:-W[Z7W=MCQA_@?JWC#1]* MTW6O'6H7O@H)!,V@FTB6295"LL4MR/F>,$#C&2!R3UKO-0^'=O??$K0O%XNY M(9=)L+BPCLU0;'64H=Q/48V#CWKK681ID\*!2BJ;NRH8:G!6M?;OTU7X]-CD MX/A[#!\4+WQH+R0W%SI4>E&TV#8JK*9-^>N><8KF1\!+'_A2[_#QM7NOLY=I M4U%8U$J/]H\]3M.5.&P,=P*]3IDD@B7<. M;[2_".I7DM[<:(EE$\BM*VZ5(K@_-&K$GL2,G!'6O7J*8GAZ;Z?B[[6WOV1Q M_P *_AZ?A=X3B\.QZM<:K86LC_8OM,:*UO"3E8LJ/FV\_,>3FCPW\.H- \>> M*?%YKKF8+C/3.*=1?J7&C3BHQ2TCMY M''>+OAQ!XH\8^$_$L=]+I^H^'YIF5HD#?:(94V20MGH#P+[_PE/IUFM@MN(EN[.6%?NAH'(&X8^^"#VYJ+P_\ M [3;7PWXIT[Q%?S^*+SQ2V_6+^X183-A B!$3B,(H&T#)!&ES< MUOSMM;;;;0\;_P"%"ZUJUO9:-XF^(.H>(O"5I)&XTF2RBADN5C(,:7$Z_-(H M(&1A=V.:Z+QQ\*;C7_$UGXH\.^(9_"?B6WMC9/=PVZ7$-S;[MPCEB; ;#<@@ M@C)KT*BBXEA:23C;MU=]-M;W5NECRMO@?/J7@7Q;HFN>+=2UK4_$T?EW>J3( MJK$ ,*L, .R-0.PY.>2:L^,?@[BVC6$=\MJES'/;L% MW1R1,0#RH(((P:]+HHNP^JTK6M^+OO????6^YYGX5^#MYX;\>+XMG\6W^IZG M)+J\\/:IG&UEL[[O?[_O[GC$/P!UO1;&YT'P M]\1=3T+P=.[E=)CLXI)K:-R2\4%RWS1KR<<$KG@UT?C;X.6WB;2_#BZ7K%[X M?UOPYC^R]8B(GEC&P(RR!_\ 6JZ@;@QYZYKT2BB[$L+22<;:/S?X=OE8\NT/ MX-:A#X^T/QCK_B^Z\0:SIEO<6H7[)';VY24*,+&I^3&,YR2<]> *]*OK.+4; M*XM)T$D$\;12*>A5A@C\C4]%)ZFM.E&FFH]?GY=3R[P#\!-,\$_#S7?"DVH7 M&LPZP)([B[ND42>48A$B8'&$10!]*U_AC\+(?AOX%E\/#5+C5IKB266YU*Z4 M"6:1QC<0.,A0H_X#7=44]R(8>E3Y>6.VWS/-/^%'V+_ V/X:2:G1]X#BI=0^$][X@\+^'M+UWQ3=:O>:1J\&K#4&M(HGF,3%EC*( M H&#C(YXKT:BB[O,/%'A#6I;V2VD\.7DEY'"B MB2PDT^WM<[QC<)(E# M@9Z'O7.P_ WQ?IVDOH&G?%;5K?PT5,*036$,U[%">/+6Z;YN!P&*DCUKV:BF M3]6IM)._WN_WWO\ (QO!_A/3? OA?3= TB$P:;I\(@A1FW-@=23W).23W)-; M-%%+;GZ>U24R-]V<@J1P0:5F"#+' H )&V*3U]!ZU'Y96,$3[>]2*P9GK2NY7 "[F/2HT0V^3]Y3R?]GZ>U B;IP*6BHWDP=J_,_I_C0,1_WD M@3L.6_H*7_5R?[+_ ,Z=&FQ>N2>2?6AU$BD&@0ZBHUDVD*_#>O8U)0,BC_=L M8^W5?\*(_P!XYDZJ.%_J:;(IN!A?E4'[W?\ "GQL?N,-I [=#]*!$E(3CD\" M@D*,G@5'_K^!_J^Y_O4#$6/S59F_BZ>P[4^-]RX/WEX-/J-E*MO7D]"/44") M*9*I9>/O#D?6E219!\ISZT.P1IE;E>14Z]3T ZFDC4Y+-]X]O0>E M",OE;6'"CY3]*EI*C5O)^5C\O9O3V- $M1']W)G^%N#]:EJ.3+Y0+G/4GH* M$/[R3;_"O)^O85+4,8,.$;D9X;U^OO4U !42_O)"W55X'U[T-)YAVQG/JW8? M_7J15"J . * (X_D)C/;E?I4M,D3=@CAEZ&A9 QQT;NIH&.90ZE2,@TR-B05 M/WEX/^-24R1"<,IPX]>A]J 'T4U'W9XP1U%.H **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@"L-/@7.$(SU^8_XT];5(^4RC>N<_SJ2-MRY/ M!Z$>].H%9#$D)8JPPP_7WI],D4L 5^\O(_PH,H\O>.?0?TH 1G.[8GWN^>@I MC6<;\N"S=SG'\JDC7:O/+'DFGT 4Y=/ARK>66V]MYS_.O//B%\38? ^HK91^ M$-?UX-!YQFTV%G0^OK73AZE*G/F MK0YUVNU^*(E&^VA^3VF?%[XL?&C2[CXF)\5M>\(WES)<7&FZ+IFQ1NP M2&:$K^]("?.7.>M?:/[,W[56J?&#X=>!=3U/P3K,&H:U;1BZO+:U_P!"\S)5 MYD)Z1DJ6'/ /?%0>,/\ @G7\(/&7C#4=X^SS7?AZTDO+*U.<,9;I!Y* 9Y&_/M7H;J0648 D!QD9 /TKY_\ M-_LNZIX?\=:;KUMXMTW21;72W-W:>&]!;2DOE#9:.98[HQN&[EHR:\'J;]#K MOVA/B!X@^'OAK0=2T,V*1W?B'2]+N1=PM(S0W%W'"^S# *=KD@G/TKB?'_QJ MUJPD^.=UHJV\-O\ ##3(+M+>5-XU"A?';X9 M:Q\5O#^C:7I>I66EI9:Q8ZO)+=P/*9#:SI,L8"L,!BF"V> > :P_&7[//_"4 MR?$%(=573[3XA:?;V'B&)8BY7RXFA>2W.1@O"WEG<#C:K#N"M>5]_P#@+_@C MTNKG4WGQ+\,Z1X<\&:QJ'G6L/BRZL[+3T57(H/B+IVJ^!]1\(^*O!L-K]HT_4+B*YC MGFN48VXADB8AU8A1NP.6QC(-B\#>+=BD!42SMWS\C CJ"Y_Q MIZZ? N $('^\?\:DD7&'4?,OZCTIZL&4$'(- 61$MOY7,7RGT;D&I$<.#V(X M(]*=4%7AFX'M[T]5"J . * ..\8 M>+D\)WMK;C0-4U7SU+F6QC+(G.,$YZU^9'P?TGX@?&GPM<>+=2^-7Q(TN[O- M5OHC::?JQCAC6.X=%55(., =.@K]::^/9?\ @F/\-X[Z[;3?&/Q#T6WN+B6[ M^Q:;XA,4$32.68*NS@9)ZY/J:];"XG"4I)UJ/-H[Z[OH_*QZ&'K8>FTZM*_S MW,[]@7XQ:]K?P1TZ'Q*GB7QAJ4>N7]E_;=TS7#&-;@HFYR><#\N:^S_L\?\ M=S]3FN ^ _P-\/?L[_#NV\&>&);^XTN">:Y\[4IQ-.\DKEW+, .Y]*]#KAJS MIS2]G#EMOK>_^1RSE"5N2-OU/GO7OBMK_@/X^Z-H&J^,=)O-.U'3M0OKGPZ^ MFM;20QP1>9$;2X)_?R'!WH23M#, NW!J^!_C]XAOX?@5J^JBWEL?BA',7LXH M]O\ 9[M:/>6XC;JP$<;(^[.20PQTKN(OA'KGBJ\T5OB%KVG^)H-"U&;4-/%E MIGV-Y':*6)#,?,<92.:1<)M#'!/3%9_@O]G.#PS/\.;>[U4ZAI/P\AGAT&'R MMLC>9%Y"-,.?#']GW7VGPGI%KK%Q M/E=DZ3B%?AEKWBW1]+T*TU[7I[:ZM MH7TY+BV%RD"([CSYEB(9E0X (Y).*Z?XD?L\^(_$GQ(UWQ1X4\>GPG%XFT6+ M0]=M9-+2\:2.(S>5+;NSKY4@$[J?2?"RZI::Q/0?#$UI-%&GB.[( M>O+?3-2U+2M+T@S(/M,<,%G% H3&1N#.DQZ_\M*Y7 MXR? ._\ AKIU[K7@Q]8.D6_B*U\1Z/I7AW2TO9O#U\4DBNIHK8L//M94D.^V M3# R.R>E4[)V_K^K$K5?U_6YZ_\ !7XX7'Q0\0^,?#>J^#=2\%^(?"LEK'J% MG?W$,Z.9XVD1HI(F(=-J@[N.N,9!KUBOF;]C_0/&=QXM^*GCGQ?_ &K)_P ) M+=Z>EE/K&D?V1-+';VQ1BMF69X8@SE5$AWMM+'K7TS0P04444AA1110 4444 M %>3_%SX]3?"K7K/38_ OB;Q2+BV^T?:M%M/-BC^8KL8_P![C./0BO6*KZA: MO?:?+?CIIWC;P:FK:'X3^'4PAN_#DTQ3^UY2W^G),BMM.V+Y5#9 MVL"1@U]L?#G]LRW^)ESX=.F?#CQ@-+UQH?L^K-9AK98Y,8D+@XVC.2?8UX9I M_P#P2<72K5K:U^-/B".!G>1E;2;5RS.Q9F9FR6)).2>M?5O[-/P*C_9O^$>F M> X/$5_XFM=/EF>&[U!51D61R_EJJ\*@).!D]3]!PPI8QR?/425]+*]UYZ*W M?3N_(\Z%''N3]I525]+*[:\[I6VOIW?D>IU\QZ?^V!IM[8ZWXHOKE](T"./5 M7\.Z?)92*=<6P20RL+IE\O>YAD9(D^;8 V3R!].5X$W[)NE:AX1\/>!]6OQ? M>!?#^HW6H6%D(MMPPE2X18)),XV1BYD (&6PN>AW>D[]#V5;J2>$?C%XAM_& M'P@TO7)+>^3XA:!=:BZPQ",6-U###/MC/4Q%)67YLG* YY(KJ=4^/6F:7)\6 MD?2[QS\.K-+R]VE/]+5K,W06+G@[1M^;'/M57P=\"FT7Q%X(U76-6&K/X*T> M71='VP^66618D>>7DYD,<*I@8'+'O@^&NO>+="\-Z9;ZEXAO[*ZMHC8^;;+$[[^P(VTS3-;N[B949H(;J\MHXXRQRJY1YRQ](S]:\>^-'@?QYX! MG\=^#?!,7C*&/Q5H=M9RC2_#"ZE9ZK=+8K:&6&\$@73RRQHDGG@@!=Z'->Z7 M'[-=[XP^!&H^"-;NK:QOK]-)M7D5/M$2VUC]GVQE21D.892?3S3UQ3TU:_K? M_@"[7_K;_@EN[_:TT^Z\/1:OX;\*:KXEMM8UA-#\*M;RPQ+XBGVNTDL+.W[N MW012$S/@,$)4$8ST_P %?CA&1I&9.F!TO['?A[QB=<^*7C3Q?_:COXHU.SDL[C6- M*_LJXFB@M$B+"S+,T$8;*H'.\A=S7'W]6]O:@+DD?[QB_;HOT]:>RAE(/(- M%+0,CB8\HWWE_4=C4E1RQLV&0[7'0GI]#48N''#H%;_>X- B2;'EG/X8ZY[4 MEOGR_F_UF?F^M*J%F#.>1T4=!2M&=VY3AN_H: 'TR1]J\?>/ J-IW'RA S>B MM3HD?[\A!?L%Z#VH ?&HC4*.U.HHH&%%%% !1110 4444 %1)^[D*?PGE?ZB MI:;(GF+C.#U!]* '4AQ@YZ5!YTL?$BJ?]H' /^%/VM+C?@+_ '5.<_C0(9;9 MRV[K_#_N]JL4QX]V"#AAT-,:9X^&52>V#U_"@-B1F"*6/04D:D L?O-R?\*C MC621@T@"J.50?S-3T %%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 8T*,<[>?4<4GDK[_P#?1J2B M@!BQ(IR%&?7O3Z** "BBB@ I&4,,$9'O2UR'@+QW)XSU/Q?:/9K:C0=8?2U9 M9-WG!8HY-YX&#^\QCGI42G&+47NRU!R3DMD=7Y*=ACZ$T>2GH?S-25C>,]?; MPKX0US6DA%R^G6,UV(6;:',:%MN<<9QC-:QBYR45NS*4E"+D]D;"J%&% ]J M6LCPCKC>)O">BZP\(MVU"R@NS"K;@ADC5]N>^,XS6O1*+C)Q>Z",E**DMF%% M%%24%%%% !1110 4444 %%%% !4?DIV7'TXJ2N,TWQ_)??%G6O!ILE2+3]+M MM1%YYA+.99)$*;<<8\O.<]ZTA3E44G%;*[]-OU,YU(P<5+J[+\_T.O\ )7W_ M .^C3EC6/[J@4ZBLS0**** "BBB@ HHHH **** "BBB@ HKBO'_Q"D\%^(/! M6FI8K=KXAU7^SGD:0J8!Y+R;P,'=]S&..M=K6LJG:M*=.56<:<-V[+YF=2I&E"52>R5W\CKZ*9$_F1H^, M;@#3ZS- HKC_ !UX\D\'Z[X-T]+-;I=?U3^SFD:3;Y(\F23>!@[O]7C''6NP MK25.48QD]GM]]C.-2,I2BMUO^8445Q5O\0I)OC%=^"?L2B*#1(]6%YYAW$M, M8_+VXZ<9SG\*<*E-:5(P2SJH'4DXQ M61H/HIJR*RJ0P(;H0>M+N'/(XZ^U "T4A8*,D@#UH+ $ D GI[T +1110 45 MP_QG\0>)O#/P\U*]\'Z6=6\0C:EM#\NU,GYG;<1D 9_'%=3H5]64] MG,(WSY<@29$8HV#A@"#CK78T %%%% !1110 4444 %%%% !1110 44C':">O MTKR#4M7^-OB2X>?P]HWA'PEIH8B*/Q/)/>WDR]F9+=D2+/\ =\QSZX/% 'L% M%>>_#'QAXNUN:>R\4:-I.80XCUWPWJ'VK3[AT?8\95P)(I%8$%2&'!&_(Q7? M7%Q':P233.L<4:EW=C@*H&23[8H DKC_ (N_%30O@E\.=:\;^)FN$T/2(TEN MFM83+(%:18QM7O\ ,XK(^&'[1/PY^,^I7=AX*\4VWB"ZM81<3);Q2J%C+;0P M9E ()(Z$UYE_P4@_Y,E^*?\ UY6__I7!0![G\/O'6E_$SP+H?BW16F;1]9LX M[ZU:XC,_$>E:QXH^*L=CJ5K>2/XFDN56"57)B-O H? M@_=W*PSZJ?2I?V,_^34/A+_V+5C_ .BEKKOAY\(?#_PSU3Q/J&C6_E3^(+\W MUQP $R/]6N.BAB[8]7-./!^G_$#PAJWAS58_,L-2 MMVMY.,EX%>CAY1A6A*>R:O]YY]>,ITIQANT[&3\&=2M-6^$_A": MRN8KN%=*M8C)"X90ZQ*K+D=P00?0BNSK$\%>$=/\!^$])\/:7'Y5AIMNEO$, M8)VCEC[DY)]R:VZ*\HRJSE#9MV'1C*%*,9[I*X4445@;!1110 4444 %%%% M!1110 5XAX9\1Z5/^UEXOM(]2M9+IO#]E;B%95+F1)9V=,9^\H()'8$5[?7$ M:;\(?#^E?%;5?B!!;[=BBBN$[@HHHH **** "BBB@ HHHH **** M/#/VAO$.EZ5\0/@_'>ZC:VDD?B+[0ZS2A2L?V>9-YSVW$+GU(%>YUQ/C[X1^ M'_B-KWA75]7M_-NO#M[]LMC@$.=OW&]5W!&QZH*[:N^O5ISHT80O>*=_O;T. M&A3J0K59RM:35ON2U"BBBN [@HHHH **** "BBB@ HHHH *\?_:TU.TT_P" M?BA+JYBMVN8XXH1*X7S'\U&VKGJ< G'L:]@KDOBG\--(^+G@F^\,ZTK?8KHJ MWF1XWQ,K!@RD]#QCZ$UV8.I"CB:=2I\*DF_DSCQE.=;#5*=/XFFE\T=!HVH6 MNK:3:7EE<17=I-$KQ3PL&1U(X((ZBKM5M-TVVT?3K6PLH5M[.UB6&&&,85$4 M *H]@!5FN65KOEV.J-[+FW/%/CYXDTK2/'?PEBOM2M;.5/$'GLD\JH1']FG3 M?R>FXJN?4@5[77$^/OA'X?\ B-KWA75M8MQ+=>';W[9;< ASM^XV>J[@C8]4 M%=M797J4YT:487O%._WMZ')1IU(5JLIVM)JWW):A7AFG^(M*;]L+4[4:C:FZ M/A2*U$(E&_SA"?-CTYKW.N(A^$/A^W^+5Q\0UM\:[-IZV#' VX#"SI4K0: MI9_;KRSDW,(_.2--J28_@<%D/LQ(Y%<%>:)+HM]K7_"02">6ZU_1+O5))26M M]SG,BC/'E* JCMA1FOI"D90P((!!]16M+'2I0C"VB^_XN;^OO,ZF"C4G*=]7 M]WP\O]?MZ"OB+6$M- GDT_0G\16\NF75F&$45REE.SR1CH8_,$>0/E)W MCN:5=;U3Q9I?B+2I-'N#J6MZ_%87VG+)Y6V.*UA-WLD; V,$*JV>?,'>OH, M 8 Z4>]7_:&UX7M:VO:W^2N9_4-;J=KWOIWO\ E=V/GKQ!-:S?"BUA\1/+ M9:YX>OH["&UN+DX)CN(MDN <2,("IWN-JD3737W$CW M1,<=L;:X^95SM56?;ENY"C/%>MM&K?>4'ZBD\F,_P+TQT%1]=5[\K^UU_F6J MVV+^INS7,OL]/Y7IU'*P8 @Y!Y%+117EGIF7XH_Y%^__ .N1K4K+\4?\B_?_ M /7(UH3S+;PR2O\ ^'/B/3K_0[GQ+97-E)' M-I-G(L<]TI7E(V+* _H=PYQR*YKX5_'(?%@V4]GX&\6:+I%[:?;+;5]8MK:* MVEC."F-D[OE@6T*H8);F M/R,%@65C@JKMN-7?"O@_QE\.OAG%XNT;3]:UZ[\/>(9+O3O#*:1-ISO82VZV M\]O!:RSRR",NPF D8$%&(4 C/U$WC*VGO-%.GFUU'2=1CGE.J07T/E1K&H(( M&[,@.2,ID+C)Q5_3?$VD:Q]J^P:K8WWV7'VC[-<))Y.1D;\$[>.>>U'<#XG^ M)GP6^(%CJ&B:=<7&JWL$/AZ 6&H:?I%SJDMOK+RRR7LZ/%=0K;R&26-EDE#) MM7&0%(/>^.OA+XQU)?C-K&DPZA)XT^S6%OH6JN[H)4^Q0+>&W02*@=]LJ_*5 M.X@!AP1]+VOB[0K[2_[3MM:T^XT[?Y7VR*ZC:'?G&W>#C.>V:YWQ5\7M"\,V M_A:\6YM]1TO7M3_LV/4;:ZC-O#^YFE,C/G;M @8'!ZD4>0=;GF7[)/@[5O"T M?BJ2=M0M-#N9+?['I=UH4^D0PR*C>;)%#<7$TGS;D#$E5+)D \D_0M<;XL^) M$'AO2_[5MK5-8TD:7>:HUW:WD."L$:N%12V9-X)PRY"XYQD4OA_XD6VKV*ZE M>01:/H[:5::H+Z\O80JB=6)1UW93: /F;"MNX)P:>XCL:*KV&H6NJV<-Y97, M-Y:3+OBGMY \;J>ZL."/I5BD,**** "BBB@ KY[\1?&7XQ^&+HIJ'P\\$V$$ MCN+>2_\ '*V[2J#U :VZXQD#.,U]!DX!.,U\[_$KXL>%_%=]8:9=:9X5MKU# M+')9_%"QGL",D "!I(&1PW?:W/'6D,Z7]DNUNK7X-QO?2Z;)>W6LZM>3II-T M;FWB>74)Y#&LI5=Y7?M)P.0:[CXM1PS?"WQ?'Y=OD1H MVQ3DL=HZ=*]/IR6EA)ZW/DSX6^)M4L=:/A3X2^.V^(V@KX*GN+>75_)D@T?4 M(UBCT^)I(8TV+("^Z!LLHA)XSS\W?M@-^V+_ ,,V^-_^%CK\.QX*^S1?VE_8 M_F_:]GGQ[?+SQG?L_#-?I_!:PVH<0PQPAV+MY:AI..]?.'_!2#_DR7XI_ M]>5O_P"E<%-NXC(_93C^++?LZ_#9;9D\$!/,U7S_EN\A#_ ,@S9[CCS\_\ K*_8S_Y-0^$ MO_8M6/\ Z*6O9:0SR!H?CQ_9YQ/\/Q>_8M,'*7OE_:A)_P 3(^OEF/\ U/<' M[_%:5FGQB&K0_:9/!3:6=4U R^4+L3#3_+/V +G@S"3'FY^7;]WFO3:* /'; MJ+X^-HK?9Y_AXNK?V';!?,2^,']K?:!]H)Q\WV8P9V#[_F8S\M;MK'\6/^$@ MS<2^$#HG]ORG$:W7VC^QO(_=#GY?M7G?>/W-G3FO1:* /&VA^/QT50MQ\/%U M;^PYE8^7>F#^UO/'DL._V?R<[A]_?TXK96/XP?VTY,O@O^RCK%J5&V[\X:9Y M'^DCT-QYWW/X-A^;FO2Z* /(DC^.QTF'?+X 74_[-U$2[5O3#]N,G_$O*]_) M"8\T'YMWW>*M"/XT_;VS-X&-E]MTG'RWGF"U$?\ Q-/;S#)_J.P7[_->IT4 M>7+'\9_(MMTO@@38U7S\+=E>3_Q+-GT_Y;Y_X!5/R?CM]E/^D> /M/V?2L?) M>[//#?\ $S]]A7_4]P?OUZ[10!YI&OQ@_M.'S'\%G3_[1U'S=HN_-^Q>6?[/ MV]O.\S'G?P[?N0SOX/_ +&_MZX+",77VC^Q_(Q;@9^7[5YV2_\ !MZ< MU@R0_'\Z&H2X^'8U?^PF4DQWWD?VOY_RM_>^S>1G(^_O]J]DHH \VCC^+O\ M;C%Y/!ITF'^T/-_T$COY BQYH^]N^[Q7KM% 'F,"?[/_ +0TS8 E MWYHLA&/[2SV\TR9\G^$+]_FJD MO\%>LT4 >2K%\<_+;,_@(R>7I.WY+S&\'_B:?@1_J.X_CJ[&OQB^V1^8_@D6 MGVW4_,VB[+_9/+/]FX[>9OQYW;;]SFO3:* /'GA^/7]CL$N/A]_:G]F:> 6C MO?)^WB;_ $XGOY)BSY0^]N^]Q6[&GQ7_ +8C,DGA Z9_;MP7"K=>=_9'D?Z. M!V^U>=RY^YMZV_%T:YD/X,.D'7HS@BZ\\:/Y'[P?W3=>=DK_ ;.O->DT4 >/M%\ M>FT=,3_#U=5_L>\5L)>F'^T_/_T5AW^S^3_K!][?]WBM-(_C#_:TA:;P7_9G M]J:>4 6[\[^SQ$/MX/;SS+GROX=OWN:]-HH \GDB^.!ABV3^ Q+Y&K"38,7A_E&//DCKN^_Q7KU% 'G$"?%K^UD,TG@[^S?[:NBPC6Z M\W^RO)/V4#/'VGS<;_X-OW>:Y]H?V@O[ P+GX<_VU_8D8W&.^^S_ -K?:?WA M_O?9OL_0??\ ,_V:]GHH \[8?%?^VL@^#_[)_MY>#]J\_P#L?R/F]OM7GJ!]R7FS[26/]F$=]@7'G]R<[*]:HH \LCC^-0FFWR^!6B,NE>7M M6\!$84?VIG_:+9\CV^_2R1_&DW,6R7P,MN)]5\S*WA8PE#_9F/1@V//[8^YS M7J5% 'DD94+=>=_9?DG[+ST^T"7!D_@V_=YKTNB@#QIH?V@/[#(6X^'?] ML?V+;@,4OO(_M7[3^_/][[.;?[H^_P"9U^6NA"_%?^W#D^#_ .Q_[=R/^/KS M_P"R/(Z?W?M7G<_W-GO7HE% 'C*P_M!?V" US\.O[9_L28%A'?>1_:OVG]R? M[WV<6_WA]_S.GRUOSI\6_P"U)##)X._L_P#MBS*"1;KS?[+\D?:P<?]LOGR.VW[_->IT4 >5R1_&LR0[)? JH'U M7S,K>$E2#_9>/<''G^WW*BCB^./V67?/X#-Q]FTH1X2\V^>&']ID_P"P5SY' M<'&^O6:* /.;6/XL_P#"269N9?!_]@#6[LW*Q+=?:CI/E_Z*$S\OVD2?ZS/R M;?N\UZ-110 4444 %%%% !1110!'<6\=U"\,R"2)QAE/0BF7T;36-Q&@!=XV M5<^I!KDOC!\1/^%6?#_4O$*:?-JMS;A5@LH$9FFD8X X!P.I)[ &ND\/ZU#X MDT.PU6V61(+R!)T29"CJ& .&!Y!'0BDU=6,XU(^TY$_>6I\C?"GX,^++7X3Z MGX,'AGQMX4\0W/A:;2O[7UKQ0M[I2W!0+B*!;J0QACG:RQC:N1QT.I?_ 5U MKQ99>)KN/X8GP9IC:+8Z8/#>F:E9137]S;W:SK<(RJ\!$2KM03#]X&*N%6OK M6BJZW_K^M33I;^OZT/E/P[\(_'UUIOAF74M M+%[1?$8$44=I:S)'=VZK;FX M2W/D^<[[MQB^7H3SFJ>I?LSZ^/#&GZ?H6A:?I,TGP]M='U)(I$@CO+R&YMI3 M;2E/O!T2XC\P@@"5O7GZXHI=;_UU7ZATM_73_(^,_'W@C4K:QU#Q!V?A1#)+H'AFRO- M.N#8W-T!:27+7*0"VGG36[[[>=_.7B +&A!=E9555#*V 003[%110 4444 %%%% M '+?% >(F\!ZL/"F[^WMB^1Y9C$FW>OF>7YGR>9Y>_9O^7=MSQFOGRX^).@_ M#WXI:?H'C;XOZ9K4-PET-9LO$FH6,4$,(P+2 VXQMN0=I=L!6 D)ZJ!]65\L M^$]#\;?"/1SX4T+3/ACXGTA)YFCUC4=8>RNI1)(S%[J(02"27YOF8/\ ,1G MSB@#Z,\'Z3X?T?P_:P^%[73[30Y 9[=-*1%MF#G<60)\N&)SD<'-;5>>? 7P M*WP[^&MGI+WVGWTKW-U>R?V/'Y=C"\\[RM#;)D[8D+E5&>@[=*] EF2")Y97 M6.- 69V. H'))/84V"'U\U_\%(/^3)?BG_UY6_\ Z5P5UOP:_:$;XM>.OB#9 M+IB:9X8T&*PN=+U2=RKZC;3K,3']4_8O\ MB?;6>NZ9=W,EE $A@O(W=O\ 2H3P V32 ](_8S_Y-0^$O_8M6/\ Z*6O9:\: M_8S_ .34/A+_ -BU8_\ HI:]EH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,SQ, M2/#NID*IO%^B>'?#.I:M??;9= M%\;Z1!;-:S%=LAMY)4VO'(5#XC=E!8D8SBOLFO#M4_::\.MXVUKPO=^!/&]] M+I"QN]Q#X4NKF%V9Y%^3;&$[^^O].L=7 MMFM9[G3)A%<*C8W!&((&1P<@Y!(H^'/C"?QWX7BUB;P]JGAA99IHX;#6(?(N M?*21D21H^J!U4,%;D!AFNGIO7<2\CYN^'7[)-SX5\>?$BXU[QGKOBKPGXIT* MVT,6.I7<9DDB$ [Y[5\S?MG?\$[?@=\&_V8O'?C+POX M;O+/7])M89+2XEU2XE5&:XB0DJSD'Y6/45^E5?-?_!2#_DR7XI_]>5O_ .E< M%,#K_P!C/_DU#X2_]BU8_P#HI:]EKQK]C/\ Y-0^$O\ V+5C_P"BEKV6D 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 9?BC_ )%S4_\ KWD_]!-:=9GBC_D7-3_Z M]Y/_ $$UIT$_:8M%'(6\5:GJ]IIWBK2YISC04>X2VE8D>6/QY\(:AXP'AZ*ZO!,]Y+IL6H26,RV$]Y&"9+:.Y M*^6TBA7RH/5& R017(1?M,:5X@^(7A"QT261/#&H0ZI<7>J:C836\,\-M$K" M:WF<*KQ@ELL,@C!'!!(![E17E$7[3G@0Z-JFJ7%UJ6GVMA:1:@1?:7<027%I M)(L:7,",@:6,NRC*@XW#(&1F_J7QZ\-Z&VG?VG9Z_ID%YY6^ZN]%N8X+/S93 M%$+B0IMB+O@ ,>-RDX!% 'I%%>2:?^T=HC:I\0(-5TS5M&L_"6H1:4*J+DL"C#AA7:^!?B'I'Q#L;R?2S=0SV-P;6]L=0MGMKJU MEVAMDD3@,I*LK ]"&!!-'F!TU%%% !1110 4444 %?)7[1EI9GXW^;XL\*>( M?&WAMM#MQI]OI/B6'3(K"X$TWG$Q->0-(TBF+YSG C '4X^M:^8/VK/%/AGP M?XJTNY\2^ OA?XACN+01P:AXVU6&VNSAV+1QQO:S,8UR#NS@%SP.Z>Z&NI[# M\"X]*B^%^CKHFA7WAO3?WOE:;J-\M[/#^]?.Z99I@V3DC]XV 0.,8'?5Y1^R M[X1'@OX*Z+8Q2Z&UI-+5O_P"E<%87@R)?V?\ XU>,M/L-"U*RT/\ X0^75-(T.TOGU%_$,UI( M3/=Y8GRKEA+!'MY,F\,22,#YO_;!_;FU;XJ?LU^./"UQ\"OB%X5@U*VB1M8U MBP:.UML3Q/ND8J, [-?L9_\ M)J'PE_[%JQ_]%+7LM( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R_%'_(N:G_U[ MR?\ H)K3K+\5.(_#6IL>GV=_Y4>*]4FT/PKK&HVZJ]Q9V4UQ&KC*ED0L ?;( MH>BN2M96,_XF>$7^('P[\3>&8[E;)]8TVXL%N63>(C)&R;BN1G&L6]M-IT=II>M/JVC:GJ6I);YDO_[/EC>-'(()^5"H)Z9[UY9\"_VE1X@\ M*W/BKQ1\4?"_B&SM-!CU:_T?0M$EM[BQ9@A(+&>3?AF\L*%!+$?2O0KS]IOP M_H^EZG-K.A^(-"U2Q>R7^Q=2M8H[J<7N3>(K+2TL"E]]IDDFE\J2X\PJT2R3NPP@8\ G MYR=)_9AUN6U\/Z%XB\66FI^$_#^DZAH%C;VFG&WNY+*YMEMU\Z4R,IE1!C8\=IY1=G?<<,H;Y C%7#D MYX%0V?[3WAB2QU:XOM+U_1Y;*QL]2AL[ZQ GOX+J3RK7$>T[6#$9 M !S2MI8.MSA-!_8_FTWPKK>E2WWAJVNKBTM=/M-1TG0FMIS##<13%YW:9RSO MY*@JFU 1G'II?&K]EO4OBMXRU;68_$.GI;WEK:BVCU2PENI=,GMW$B&V(F1$ MCD8 R H6..&'&.LF_:5T&SL9?MN@^(K/6H=5MM'ET"2S0WJS7"LT!PLA1HW" MMAPY'RG.,'&!X@_:*N+K4_!P=VMK M^VCA0B4&0"6!OLZ_(-K89OFZ$=C\$?A1_P *JT"_@GAT*+4M0N?M-S_PC^FF MRM^$5%7#2.[X"_>=B><< 5PWC#]H*+4O!=]K_A?4=0T^[;P?K6K6NFWVG1@ M17%FZ1.9BV662*4E/+&5;+')P*Z>S^+BZ;>>)WN#JVOW&EV.E32Z596,*B)K ME'^:.0LH8,5+,9&54"]<$TEMI_7]6#K;^OZU/6:*Y7X:_$C2OBGX9_MK24N( M8DN9K.>VNT598)XG*21MM+*2".JL00003754P"BBB@ HHHH *^9/&'BR^@\; M>,OBC\,Y/#?C>STVQ&@Z];ZBUTDMC):-)*PM988)3*/WQ$D2*?F0IV4-I>0M(SQO.LTJ2 M0R8;Y_E<;@6!.<4AGHO[,^DVFF_!W2+BQUC2]:9J5I#?Z=>0O;W-K<('CFC8%61E/!!!( M(/K7"?L_?#_5/AO\-;?3=<^QIK-W?7NJWEOIQ)M;:6ZN9+AH8B0"40R; ?@GX/^&FH2W^@Z9+%?26R60NKR]GNY8K93E8(VF=S'&#SL M7 X'H*\D_P""D'_)DOQ3_P"O*W_]*X*^E*^:_P#@I!_R9+\4_P#KRM__ $K@ MI#.O_8S_ .34/A+_ -BU8_\ HI:]EKQK]C/_ )-0^$O_ &+5C_Z*6O9: "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@#&\8?\BMJG_7!OY5:\0:2FOZ#J6ER2-$E[ M;26S2*,E0ZE21],U5\8?\BMJG_7!OY5LT;HE?$_Z[GAWAW]GGQ GP_N/ OBS MX@'Q+X4.D1Z5;6]OHT5C<6_EA!%,)5=MS+L!P5P3R?2IY?V>M5U2Q\076N>. M9=:\5:M;6]A_:MQHMH;>.TAD>1+=K1E,6T@@6UMK5)5C*6^=NQ/,)*DL6,C<],=EX5_ M9_\ [#U71=:U+Q+=:UX@MM;N-?U"^DMHX5OKB6S-F%$:\1(D6P*!D_)R2237 MKM%+^OR_R&>*-^S%I\FE7=@^O71CN=)U[2F984#!=3NA<.XYZQD;0.A'6J7B MC]EE/%>EWZWGBF1]5NET=VN)-.BDMGGL$D56EMF)22.3S23$3@$*0>!7O%%* MW0.MSS_X,_"9/@[H>J:3;ZG_ &A:7FHS:E&@LXK5;=I<&1%6,!=N_

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end GRAPHIC 10 pharmacodoses.jpg GRAPHIC begin 644 pharmacodoses.jpg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ⅅ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end GRAPHIC 11 lympexpan.jpg GRAPHIC begin 644 lympexpan.jpg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end GRAPHIC 12 stimulated.jpg GRAPHIC begin 644 stimulated.jpg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÷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treat.jpg GRAPHIC begin 644 treat.jpg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end

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end GRAPHIC 14 mdna223over.jpg GRAPHIC begin 644 mdna223over.jpg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end GRAPHIC 15 mdna223model.jpg GRAPHIC begin 644 mdna223model.jpg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�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